{"config":{"lang":["en"],"separator":"[\\s\\-]+","pipeline":["stopWordFilter"]},"docs":[{"location":"","title":"Getting Started","text":""},{"location":"#i-start-in-lu-lab","title":"I. Start in Lu Lab","text":""},{"location":"#welcome","title":"\ud83c\udf89 Welcome","text":"<p>\u201cThe mediocre teacher tells. The good teacher explains. </p> <p>The superior teacher demonstrates. The great teacher inspires.\u201d  - William A. Ward</p> <ul> <li>Lab Introduction</li> <li>Lab Meetings  &amp;  Lab Calendar</li> <li>FAQ </li> <li>\u6e05\u534e\u6821\u56ed\u5b9e\u7528\u4fe1\u606f \uff08 \u6821\u5386\uff0c\u5730\u56fe \uff0c... )</li> </ul>"},{"location":"#learning","title":"\ud83d\udcd6 Learning","text":"<p>\u201cI cannot teach anybody anything; I can only make them think.\" - Socrates</p> <p>\"Tell me and I forget. Teach me and I remember. Involve me and I learn.\"  - Benjamin Franklin</p> <ul> <li>\u6b63\u5f0f\u53c2\u4e0e\u751f\u7269\u4fe1\u606f\u79d1\u7814\u8bfe\u9898\u4e4b\u524d\u8be5\u505a\u54ea\u4e9b\u51c6\u5907\uff1f\uff08\u5305\u62ec\u9884\u4fee\u8bfe\u63a8\u8350\u7b49\uff09</li> <li>Courses @Tsinghua - Bioinformatics Tutorial by Lu Lab</li> <li>Tips for Literature Reading</li> <li>More Tips for Research @everhub </li> <li>PPT Templates</li> </ul>"},{"location":"#ii-research-in-lu-lab","title":"II. Research in Lu Lab","text":"<p>\u201c\u52e4\u800c\u5584\u609f\u201d ;  \u201c\u5929\u9053\u916c\u52e4\u201d -- \u300a\u5468\u6613\u300b</p> <p>\"Study while others are sleeping;  work while others are loafing;</p> <p> prepare while others are playing; dream while others are wishing.\"    - William A. Ward</p>"},{"location":"#files","title":"\ud83d\uddc2\ufe0f Files","text":"<ul> <li>\u6e05\u534e\u4e91\u76d8 (private) : </li> <li>Lu Lab - Shared (R and RW) (including Lab Guide,  Lab Logistics,  Lab Introduction, Manuscript, Metadata, Wetlab, Thesis, ...)</li> <li>Lu Lab - Photos</li> </ul>"},{"location":"#lab-training","title":"\ud83e\uddea Lab Training","text":"<ul> <li>Dry-lab Training</li> <li>Genomics</li> <li>Hardware, Software &amp; Instructions<ul> <li>@\u6e05\u534e\u4e91 (private) : Lu Lab Shared/Lab Guide, Experience Sharing, ...  (Public Link: Experience Sharing )</li> </ul> </li> <li>Wet-lab Training</li> <li>Wetlab Safety Guide</li> <li>Wetlab FAQ</li> <li>Instructions, Protocols &amp; Samples <ul> <li>@\u6e05\u534e\u4e91 (private): Lu Lab Shared/Lab Guide, Wetlab, Experience Sharing, ... (Public Link: Experience Sharing )</li> </ul> </li> <li>Data </li> <li>@\u6e05\u534e\u4e91 (private): Lu Lab Shared/Metadata</li> </ul>"},{"location":"#iii-publish-in-lu-lab","title":"III. Publish in Lu Lab","text":"<p>\"What sculpture is to a block of marble, education is to a human soul.\"  - Joseph Addison</p> <p>\u201cThe carving and chipping away to create a masterpiece take years of dedication. </p> <p>Teachers help students discover their interests, passions, and ultimately themselves.\u201d</p> <ul> <li>Software </li> <li>Patent</li> <li>Paper</li> <li>\u5386\u5c4a\u6bd5\u4e1a\u8bba\u6587: \u6e05\u534e\u4e91\u76d8 - Lu Lab Shared-R/3.Thesis</li> <li>Manuscripts: \u6e05\u534e\u4e91\u76d8 - Lu Lab Shared-R/5.Manuscript</li> <li>Tips for manuscript writing</li> </ul> \"\u751f\u7269\u4fe1\u606f\u5b66\"\u6559\u80b2\u90e8\u91cd\u70b9\u5b9e\u9a8c\u5ba4 MOE Key Lab of Bioinformatics \u6e05\u534e\u5927\u5b66 \u751f\u547d\u79d1\u5b66\u5b66\u9662 School of Life Sciences, Tsinghua University \u7535\u8bdd/\u4f20\u771f\uff1a010-627-89217 Tel/FAX: +86-010-627-89217 \u7f51\u5740\uff1ahttp://lulab.life.tsinghua.edu.cn Website: http://www.ncRNAlab.org <ul> <li>Lu Lab @ Tsinghua University</li> <li>Software:  software.ncRNAlab.org</li> <li>Courses:  courses.ncRNAlab.org</li> <li>Books: book.ncRNAlab.org ( bioinfo.gitbook.io ) </li> <li>Docs: docs.ncRNAlab.org  ( lulab.gitbook.io  |  lulab.github.io )</li> </ul>"},{"location":"faq/faq/","title":"FAQ","text":""},{"location":"faq/faq/#i","title":"I. \u79d1\u7814\u65b9\u6cd5","text":"<p>Tips</p> <ul> <li>\u7814\u7a76\u751f\u751f\u5b58\u6307\u5357 A grad school survival guide </li> <li>Want to get great at something? Get a coach ! TED (16:36)   Bilibili (2:50)</li> </ul>"},{"location":"faq/faq/#1","title":"1) \u79d1\u7814\u4e2d\u5efa\u8bae\u517b\u6210\u54ea\u4e9b\u597d\u7684\u4e60\u60ef\uff1f","text":"<p>\"What sculpture is to a block of marble, education is to a human soul.\"  - Joseph Addison</p> <p>\u201cThe carving and chipping away to create a masterpiece take years of dedication. </p> <p>Teachers help students discover their interests, passions, and ultimately themselves.\u201d</p> <p>\u80b2\u4eba\u7684\u76ee\u7684\u5e94\u8be5\u662f\u5e2e\u52a9\u5b66\u751f\u57f9\u517b\u597d\u7684\u4e60\u60ef\u91cd\u4e8e\u8ffd\u6c42\u6210\u679c\u7684\u5927\u5c0f\uff0c\u597d\u7684\u4e60\u60ef\u5305\u62ec\uff1a </p> <ul> <li>\u81ea\u5f3a\u4e0d\u606f\uff08\u6709\u4e0a\u8fdb\u5fc3\u4e0d\u61d2\u6563\uff0c\u6b62\u4e8e\u81f3\u5584\uff09</li> <li>\u539a\u5fb7\u8f7d\u7269\uff08\u5bf9\u4ed6\u4eba\u7684\u5c0a\u91cd\u548c\u5584\u610f\uff09</li> <li>\u4f5c\u606f\u89c4\u5f8b\u4e14\u6709\u6548\u7387</li> <li>\u52e4\u4e8e\u9605\u8bfb\u3001\u52e4\u4e8e\u601d\u8003 \uff08Stay Hungry &amp; Think Different\uff09</li> <li>\u7ecf\u5e38\u953b\u70bc\u8eab\u4f53 </li> <li>\u2026 \u2026 </li> </ul> <p>\u5b9e\u64cd\u5efa\u8bae\uff1a</p> <ol> <li>\u5bf9\u4e8e\u91cd\u8981\u800c\u4e0d\u7d27\u6025\u7684\u4e8b\u60c5\uff0c\u591a\u7528 email \u5c11\u7528\u5fae\u4fe1   \uff08see detail)</li> <li>\u505a\u4e8b\u8981\u63d0\u524d\uff08\u6bd4\u5982\u8bf7\u5047\u3001\u6bd4\u5982\u5b8c\u6210\u4efb\u52a1\uff09   (see detail)</li> <li>\"\u7814\u7a76\u201c \u4e3a\u4e3b  \"\u5b66\u4e60\u201c\u4e3a\u8f85   (see detail )</li> <li>\u5e26\u4e0a\u201c\u7eb8\u201d\u548c\u201c\u7b14\u201d  (\u624b\u5199\u7b14\u8bb0\u6709\u76ca\u5b66\u4e60 \u2013  \u300a\u73af\u7403\u79d1\u5b66\u300b  2024.5. \u8ba4\u77e5\u79d1\u5b66)</li> <li>\u9ad8\u7ea7\u51a5\u60f3 \u53ef\u80fd\u4f1a\u6fc0\u53d1\u4eba\u4eec\u7684\u7075\u611f\uff0c\u5e76\u4e3a\u5982\u4f55\u5b9e\u73b0\u751f\u547d\u7684\u610f\u4e49\u63d0\u4f9b\u6df1\u523b\u7684\u89c1\u89e3\u548c\u6e05\u6670\u7684\u601d\u8def\u3002\u2013  \u300a\u73af\u7403\u79d1\u5b66\u300b 2024.9.</li> </ol>"},{"location":"faq/faq/#2","title":"2) \u5982\u4f55\u5b66\u4e60\u65b0\u77e5\u8bc6\u548c\u65b0\u6280\u80fd\uff1f","text":"<p>\u542c\u3001\u8bfb\u3001\u89c6\u542c\u3001\u6f14\u793a\u90fd\u5c5e\u4e8e\u88ab\u52a8\u7684\u5b66\u4e60\uff1b\u8ba8\u8bba\u3001\u5b9e\u8df5\u3001\u6559\u6388\u522b\u4eba\u662f\u4e3b\u52a8\u5b66\u4e60\u3002 \u5176\u4e2d\u6559\u6388\u7ed9\u4ed6\u4eba\u7559\u5b58\u7387\u6700\u9ad8\uff0c\u8fbe\u523090%\u3002 \u8fd9\u4e00\u6b65\u662f\u8d39\u66fc\u5b66\u4e60\u6cd5\u7684\u7cbe\u9ad3\uff0c\u4e5f\u5c31\u662f\u201c\u4ee5\u6559\u4fc3\u5b66\u201d\u3002\u6240\u4ee5senior students mentor junior students\u4e0d\u4ec5\u662f\u4e00\u79cd\u56e2\u961f\u5408\u4f5c\u548c\u9886\u5bfc\u529b\u7684\u57f9\u517b\uff0c\u4e5f\u662f\u5bf9\u81ea\u5df1\u77e5\u8bc6\u7684\u5de9\u56fa\u3002</p> <p></p>"},{"location":"faq/faq/#3","title":"3) \u5982\u4f55\u6210\u4e3a\u4e00\u4e2a\u597d\u7684\u7814\u7a76\u751f\u548c\u79d1\u7814\u5de5\u4f5c\u8005\uff1f","text":"<p>\"Tell me and I forget. Teach me and I remember. Involve me and I learn.\"  - Benjamin Franklin</p> <p>\u505a\u597d\u4ece\u672c\u79d1\u751f\u5230\u7814\u7a76\u751f\u7684\u89d2\u8272\u8f6c\u53d8\uff0c\u4e0d\u80fd\u53ea\u77e5\u9053\u201c\u5b66\u4e60\u201d\uff0c\u8981\u4fa7\u91cd\u201c\u7814\u7a76\u201d\u3002</p> <ul> <li>\u79d1\u7814\u751f\u6daf\u7684\u56db\u6212\u5f8b </li> <li>1. \u8fb9\u5e72\u8fb9\u5b66\uff0c\u4e0d\u8981\u5f77\u5fa8\uff1b </li> <li>2. \u52c7\u4e8e\u521b\u65b0\uff0c\u6562\u4e8e\u6311\u6218\uff1b </li> <li>3. \u5fcd\u53d7\u5bc2\u5bde\uff0c\u6ce8\u91cd\u8fc7\u7a0b\uff1b </li> <li>4. \u638c\u63e1\u5386\u53f2\uff0c\u6811\u7acb\u4fe1\u5fc3\u3002</li> <li>\u5341\u51c6\u5219 </li> <li>1. Craft good questions </li> <li>2. Ask for help </li> <li>3. Respect and appreciate your lab mates </li> <li>4. Have at least two projects </li> <li>5. Sleep on it </li> <li>6. If you need guidance from your mentor, set up a meeting </li> <li>7. Learn when to be obsessive </li> <li>8. Start with the task you are least excited about, and do it right away </li> <li>9. Balance bouts of focused work with short breaks </li> <li>10. Get organized</li> <li>\u8036\u9c81\u5927\u5b66\u7684\u5fc3\u6001\u7406\u5ff5\uff08\u5bf9\u4e8e\u5fc3\u6001\u65b9\u9762\u7684\u4e03\u4e2a\u5efa\u8bae\uff09 \uff08\u89c6\u9891\u94fe\u63a5\uff1a \u4f18\u9177 | \u817e\u8baf | \u6296\u97f3@\u6e05\u534e\u4e91\uff09 </li> <li>1. \u8981\u65e0\u6761\u4ef6\u81ea\u4fe1\uff0c\u5373\u4f7f\u5728\u505a\u9519\u7684\u65f6\u5019\uff1b </li> <li>2. \u4e0d\u8981\u60f3\u592a\u591a\uff0c\u5b9a\u65f6\u6e05\u9664\u6d88\u6781\u601d\u60f3\uff1b </li> <li>3. \u5b66\u4f1a\u5fd8\u8bb0\u75db\u82e6\uff0c\u4e3a\u9633\u5149\u8bb0\u5fc6\u817e\u51fa\u7a7a\u95f4\uff1b </li> <li>4. \u6562\u4e8e\u5c1d\u8bd5\uff0c\u4e0d\u6015\u4e22\u8138\uff1b </li> <li>5. \u6bcf\u5929\u90fd\u662f\u65b0\u7684\uff0c\u70e6\u607c\u75db\u82e6\u4e0d\u8fc7\u591c\uff1b </li> <li>6. \u9762\u5bf9\u522b\u4eba\u7684\u4f18\u79c0\uff0c\u53d1\u81ea\u5185\u5fc3\u8d5e\u7f8e\uff1b </li> <li>7. \u505a\u4eba\u6700\u9ad8\u5883\u754c\u4e0d\u662f\u4e00\u5473\u4f4e\u8c03\uff0c\u4e5f\u4e0d\u662f\u4e00\u5473\u5f20\u626c\uff0c\u800c\u662f\u59cb\u7ec8\u5982\u4e00\u7684\u4e0d\u5351\u4e0d\u4ea2</li> <li>See More</li> <li>\u79d1\u7814\u751f\u6daf\u7684\u56db\u6212\u5f8b\u548c\u5341\u51c6\u5219</li> <li>\u597d\u5bfc\u5e08\u7684 16 \u4e2a\u6807\u51c6</li> <li>\u5982\u4f55\u6210\u4e3a\u5bfc\u5e08\u773c\u4e2d\u7684\u597d\u5b66\u751f\uff1f\u5982\u4f55\u6210\u4e3a\u5b66\u751f\u773c\u4e2d\u7684\u597d\u5bfc\u5e08\uff1f</li> </ul>"},{"location":"faq/faq/#4","title":"4) \u5982\u4f55\u624d\u80fd\u9ad8\u6548\u7387\u5730\u5b8c\u6210\u4e0d\u559c\u6b22\u7684\u5de5\u4f5c\u6216\u5b66\u4e60\u4efb\u52a1\uff1f","text":"<p>\"\u7edd\u62db\u53ea\u6709\u4e00\u4e2a\uff1a\u4e0d\u8981\u8fc7\u5ea6\u51c6\u5907\uff0c\u5148\u968f\u4fbf\u5f00\u4e2a\u5934\u3002\\ \u4eba\u7684\u5927\u8111\u5f88\u5947\u602a\uff0c\u5de5\u4f5c\u7684\u538b\u529b\u8d8a\u5927\uff0c\u5927\u8111\u8d8a\u4f1a\u627e\u501f\u53e3\u53bb\u62d6\u5ef6\u3002\u6709\u65f6\u5019\u5927\u8111\u544a\u8bc9\u4f60\uff0c\u8fd9\u4e48\u96be\u7684\u5de5\u4f5c\uff0c\u8fd8\u662f\u4e0a\u7f51\u67e5\u4e00\u4e0b\u8d44\u6599\u5427\uff0c\u8fd8\u662f\u627e\u627e\u76f8\u4f3c\u6848\u4f8b\u5427\uff0c\u4f60\u4f1a\u8bef\u4ee5\u4e3a\u81ea\u5df1\u5728\u505a\u5fc5\u8981\u51c6\u5907\uff0c\u5176\u5b9e\u662f\u5927\u8111\u5728\u5e2e\u4f60\u9003\u907f\u538b\u529b\u3002\u4f60\u4fe1\u4e86\u5b83\u7684\uff0c\u5c31\u4f1a\u628a\u65f6\u95f4\u6d6a\u8d39\u5230\u5237\u7f51\u9875\u4e0a\uff0c\u968f\u7740\u671f\u9650\u8d8a\u6765\u8d8a\u8fd1\uff0c\u4f60\u5c31\u8d8a\u6765\u8d8a\u7d27\u5f20\uff0c\u53cd\u800c\u4f1a\u66f4\u52a0\u62d6\u5ef6\u3002\\ \u5f88\u591a\u4eba\u7ed9\u81ea\u5df1\u6253\u6c14\u7684\u65b9\u5f0f\u662f\u544a\u8bc9\u81ea\u5df1\u8fd9\u9879\u5de5\u4f5c\u975e\u5e38\u91cd\u8981\uff0c\u4e00\u5b9a\u8981\u8ba4\u771f\u5bf9\u5f85\u3002\u8fd9\u4e48\u505a\uff0c\u4e00\u5b9a\u4f1a\u8d77\u53cd\u4f5c\u7528\u7684\uff01\u4f60\u8981\u76f8\u4fe1\uff0c\u4eba\u4ece\u6765\u90fd\u4e0d\u662f\u7406\u6027\u9a71\u52a8\u7684\u751f\u7269\uff0c\u4e0e\u5176\u4f9d\u8d56\u81ea\u5df1\u7684\u610f\u5fd7\u529b\uff0c\u4e0d\u5982\u987a\u5e94\u81ea\u5df1\u7684\u5929\u6027\u3002\u4eba\u7684\u5929\u6027\u662f\u4ec0\u4e48\uff1f\u8ffd\u6c42\u5b89\u9038\u548c\u8f7b\u677e\u554a\u3002\u591a\u6570\u4eba\u90fd\u6709\u62d6\u5ef6\u75c7\uff0c\u4f46\u6211\u6ca1\u89c1\u8fc7\u4e00\u4e2a\u73a9\u6e38\u620f\uff0c\u5403\u597d\u5403\u7684\u62d6\u5ef6\u7684\uff01\u6211\u4eec\u8981\u987a\u5e94\u5929\u6027\uff0c\u5c31\u4e0d\u8981\u628a\u5de5\u4f5c\u60f3\u5f97\u90a3\u4e48\u6c89\u91cd\u3002\u505a\u4e0d\u5230\u50cf\u5bf9\u5f85\u6e38\u620f\u673a\u90a3\u6837\u559c\u7231\u5de5\u4f5c\uff0c\u4e5f\u4e00\u5b9a\u8981\u63a7\u5236\u81ea\u5df1\uff0c\u4e0d\u8981\u628a\u601d\u7ef4\u805a\u7126\u5230\u538b\u529b\u4e0a\uff0c\u800c\u662f\u8981\u8f7b\u89c6\u5b83\u3002\\ \u4f60\u5c31\u8fd9\u4e48\u60f3\uff0c\u6211\u5148\u968f\u4fbf\u5f00\u4e2a\u5934\u518d\u8bf4\u5427\u3002\u5176\u5b9e\u4e00\u8d77\u5934\u4f60\u5c31\u4f1a\u53d1\u73b0\uff0c\u6839\u672c\u4e0d\u50cf\u4f60\u60f3\u7684\u90a3\u4e48\u75db\u82e6\uff0c\u5f88\u591a\u65f6\u5019\u4f60\u5f00\u4e86\u4e2a\u5934\u5c31\u5239\u4e0d\u4f4f\u4e86\uff0c\u4e0d\u77e5\u4e0d\u89c9\u5c31\u505a\u5b8c\u4e86\u3002\"</p> <p>\u4f5c\u8005\uff1a@\u82cd\u6ce0\\ \u66f4\u591a\u65b9\u6cd5\uff1a https://www.zhihu.com/question/50353727\\</p>"},{"location":"faq/faq/#ii","title":"II. \u79d1\u7814\u5b9e\u8df5","text":""},{"location":"faq/faq/#0","title":"0) \u6b63\u5f0f\u53c2\u4e0e\u751f\u7269\u4fe1\u606f\u79d1\u7814\u8bfe\u9898\u4e4b\u524d\u8be5\u505a\u54ea\u4e9b\u51c6\u5907\uff1f","text":"<p>\\ \u6211\u4eec\u51c6\u5907\u4e86\u4e00\u4e9b\u53ef\u4ee5\u53c2\u8003\u548c\u81ea\u5b66\u7684\u6750\u6599\uff0c\u5e0c\u671b\u5bf9\u5927\u5bb6\u6709\u6240\u5e2e\u52a9\uff0c\u4e3a\u4e4b\u540e\u505a\u79d1\u7814\u5b9e\u4e60\u751a\u81f3\u8bfb\u535a\u6253\u597d\u57fa\u7840\u3002</p> <p>\u5c24\u5176\u662f\u60f3\u505a\u7eafdrylab\u8bfe\u9898\u7684\u540c\u5b66\uff0c\u5efa\u8bae\u5b8c\u6210\u4e0b\u9762\u7684\u51e0\u4ef6\u4e8b\u4e4b\u540e\u518d\u5f00\u59cb\u6b63\u5f0f\u7684\u79d1\u7814\u5b9e\u4e60\u8bfe\u9898\u3002</p> <p>\\ (0) \u9884\u4fee\u8bfe\u7a0b\u51c6\u5907</p> <ul> <li>\u57fa\u672c\u6570\u5b66\u8bfe\u7a0b\uff1a \u5982\u300a\u5fae\u79ef\u5206\u300b\u548c\u300a\u7ebf\u6027\u4ee3\u6570\u300b</li> <li>\u57fa\u672c\u7edf\u8ba1\u8bfe\u7a0b\uff1a \u5982\u300a\u6982\u7387\u8bba\u300b\u6216\u300a\u751f\u7269\u7edf\u8ba1\u300b</li> <li>\u57fa\u672c\u8ba1\u7b97\u673a\u8bfe\u7a0b\uff1a\u5982\u300aLinux\u300b\u3001\u300aR\u300b\u3001\u300aPython\u300b\u7b49</li> <li>\u57fa\u672c\u751f\u7269\u8bfe\u7a0b\uff1a \u5982\u300a\u666e\u901a\u751f\u7269\u5b66\u300b\u300a\u9057\u4f20\u5b66\u300b\u6216\u300a\u5206\u5b50\u751f\u7269\u5b66\u300b</li> <li>\u673a\u5668\u5b66\u4e60\u8bfe\u7a0b\uff1a\u5982\u300a\u673a\u5668\u5b66\u4e60\u300b\u6216\u300a\u6df1\u5ea6\u5b66\u4e60\u300b</li> <li>\u751f\u7269\u4fe1\u606f\u8bfe\u7a0b\uff1a \u5982\u300a\u751f\u7269\u4fe1\u606f\u5b66\u300b\uff08\u672c\u79d1\u751f\u8bfe-\u6625\u5b63\u5b66\u671f\uff09</li> </ul> <p>\u6e05\u534e\u5927\u5b66Python \u8bfe\u7a0b\u63a8\u8350 \uff08\u4e09\u9009\u4e00\uff09\uff1a</p> <ul> <li>\u3010\u63a8\u8350\u3011 00310352 \u57fa\u4e8ePython\u7684\u79d1\u5b66\u4e0e\u6570\u503c\u8ba1\u7b97  2\u5b66\u5206</li> <li>00740282 \u8ba1\u7b97\u673a\u7a0b\u5e8f\u8bbe\u8ba1\u57fa\u7840 (Python)  2\u5b66\u5206</li> <li>00740292 Python\u7a0b\u5e8f\u8bbe\u8ba1\u8fdb\u9636  2\u5b66\u5206</li> </ul> <p>\u6e05\u534e\u5927\u5b66\u8fdb\u9636\u4eba\u5de5\u667a\u80fd\u8bfe\u7a0b\u63a8\u8350\uff1a</p> <p>\\ &amp;#xNAN;(a) \u6587\u732e\u9605\u8bfb\\ \u901a\u8fc7\u6587\u732e\u9605\u8bfb\u4e86\u89e3\u6211\u4eec\u5b9e\u9a8c\u5ba4\u7684\u7814\u7a76\u65b9\u5411\uff0c\u6839\u636e\u81ea\u5df1\u7684\u57fa\u7840\u548c\u7231\u597d\uff0c\u53ef\u4ee5\u53c2\u9605 Literature Reading - Startup\\ \u6b64\u5916\uff0c\u66f4\u591a\u7684\u6587\u732e\u6211\u6574\u7406\u653e\u5728\u4e86\uff1aTips for paper reading\\ \\ &amp;#xNAN;(b) Document your work </p> <p>\u5efa\u8bae\u5b66\u4f1a\u4f7f\u7528github\u548cmarkdown\u8bed\u8a00\uff0c\u53ef\u4ee5\u81ea\u5df1\u6ce8\u518c\u4e00\u4e2agithub\u8d26\u53f7\uff0c\u901a\u8fc7google\u7b49\u5de5\u5177\u81ea\u5df1\u5b66\u4e60\u5229\u7528markdown\u8bed\u8a00\uff0c\u751a\u81f3\u53ef\u4ee5\u5229\u7528github page\u6784\u5efa\u4e00\u4e2a\u81ea\u5df1\u7684\u7f51\u9875\u3002\\ \u5173\u4e8egithub\u548cmarkdown\uff0c\u6211\u4eec\u6709\u4e00\u4e2a\u7b80\u5355\u7684\u4ecb\u7ecd\uff1aGetting Started - Bioinformatics Tutorial\\ \\ &amp;#xNAN;(c) \u751f\u7269\u4fe1\u606f\u5b66\u7684\u57fa\u672c\u6280\u80fd\u7684\u5b66\u4e60</p> <p>\u5177\u4f53\u53ef\u4ee5\u53c2\u8003\u6211\u4eec\u7684\u751f\u7269\u4fe1\u606f\u5b66\u6559\u6750\uff1a\uff08 https://bioinfo.gitbook.io/\uff09\u3002\u8be5\u6559\u6750\u4e3b\u8981\u7528\u4e8e\u6211\u7ed9\u5927\u5bb6\u5f00\u7684\u300a\u751f\u7269\u4fe1\u606f\u5b66\u300b\uff08\u672c\u79d1\u751f\u8bfe-\u6625\u5b63\u5b66\u671f\uff09\u3002</p> <ul> <li>\u6ce8\u610f\u719f\u6089\u4e09\u4e2a\u8ba1\u7b97\u673a\u6280\u80fd\uff1aLinux, R, Python  </li> <li>\u6709\u4f59\u529b\u7684\u8bdd\uff0c\u8fd8\u53ef\u4ee5\u63d0\u524d\u5b66\u4e60\u4e0a\u8ff0\u6559\u6750\u7684PART I, II\u548cIII\uff08\u4e0d\u7740\u6025\u7684\u8bdd\u53ef\u4ee5\u7b49\u5165\u5b66\u540e\u9009\u4fee\u8fd9\u95e8\u8bfe\uff09</li> <li>\u8fd8\u53ef\u4ee5\u6839\u636e\u81ea\u5df1\u7684\u57fa\u7840\u5b66\u4e60\u6559\u6750\u91cc\u9762\u63a8\u8350\u7684\u4e00\u4e9b\u5176\u4ed6\u53c2\u8003\u5185\u5bb9\uff08Appendix I. Keep Learning - Bioinformatics Tutorial\uff09</li> </ul>"},{"location":"faq/faq/#1_1","title":"1) \u5982\u4f55\u5c3d\u5feb\u878d\u5165\u5230\u5b9e\u9a8c\u5ba4\u7684\u79d1\u7814\u6c1b\u56f4\u4e2d\uff1f","text":"<p>\"Study while others are sleeping; work while others are loafing; prepare while others are playing; dream while others are wishing.\"  - William A. Ward</p> <p>\u8981\u79ef\u6781\u4e86\u89e3\u5b9e\u9a8c\u5ba4\u7684\u51e0\u4e2a\u7814\u7a76\u65b9\u5411\uff0c\u8ba4\u6e05\u81ea\u5df1\u7684\u5174\u8da3\u6240\u5728\uff1b\u95f2\u6687\u65f6\u95f4\u8981\u591a\u548c\u5e08\u5144\u5e08\u59d0\u4ea4\u6d41\u4ed6\u4eec\u7684\u79d1\u7814\u7ecf\u9a8c\uff0c\u6c72\u53d6\u7cbe\u534e\uff0c\u8981\u591a\u95ee \uff08\u5f53\u7136\u5f88\u591a\u95ee\u9898\u53ef\u80fdGOOGLE\u66f4\u65b9\u4fbf\u66f4\u9ad8\u6548\uff09\u3002\u603b\u7ed3\u4e0b\u6765\u5c31\u662f\u8981\u505a\u5230\u4e3b\u52a8\u79ef\u6781\uff0c\u52e4\u5b66\u597d\u95ee\u3002</p>"},{"location":"faq/faq/#2_1","title":"2) \u5bfc\u5e08\u3001\u540c\u5b66\u3001\u540c\u4e8b\u4e4b\u95f4\u5982\u4f55\u4ea4\u6d41\u79d1\u7814\u8bfe\u9898\u7684\u8fdb\u5c55\uff1f","text":"<p>\u201cI cannot teach anybody anything; I can only make them think.\" - Socrates</p> <p>\u57fa\u672c\u539f\u5219\uff1a \u5bfc\u5e08\u5bf9\u5b66\u751f\u7684\u65f6\u95f4\u5e94\u5f53\u5c0a\u91cd\uff0c\u4e0d\u5e94\u5f53\u968f\u6027\u5c31\u5fae\u4fe1\u7d22\u8981\u5b9e\u9a8c\u7ed3\u679c\u6216\u8005\u5206\u6790\u7ed3\u679c\uff1b\u540c\u6837\u7684\uff0c\u5b66\u751f\u4e5f\u5e94\u5f53\u5c0a\u91cd\u5bfc\u5e08\u548c\u5176\u4ed6\u540c\u4e8b\u7684\u65f6\u95f4\uff0c\u6709\u4e8b\u60c5\u8981\u8ba8\u8bba\u5c3d\u91cf\u63d0\u524d\u9884\u7ea6\u3002\u56e0\u6b64\uff0c\u9664\u975e\u4e8b\u51fa\u7d27\u6025\uff0cemail \u4ea4\u6d41\u91cd\u8981\u800c\u4e0d\u7d27\u6025\u7684\u4e8b\u60c5\u4f1a\u7ed9\u5f7c\u6b64\u66f4\u591a\u7684\u7a7a\u95f4\u548c\u65f6\u95f4\uff0c\u5927\u5bb6\u7684\u8bfe\u9898\u8ba8\u8bba\u548c\u4f1a\u8bae\u7b49\u4ea4\u6d41\u65b9\u5f0f\u4e5f\u5e94\u5f53\u7ed3\u6784\u5316\u3002\u4e8b\u5b9e\u4e0a\uff0c\u7edd\u5927\u591a\u6570\u7684\u91cd\u8981\u7684\u4e8b\u60c5\u90fd\u4e0d\u7d27\u6025\uff0c\u9700\u8981\u7d27\u6025\u56de\u590d\u7684\u53cd\u800c\u662f\u5f62\u5f0f\u5316\u7684\u7410\u4e8b\u3002</p> <ul> <li>Group Meeting: sharing and talk practicing</li> <li>Subgroup Meeting: research results' report &amp; discussion</li> <li>WECHAT (urgent: need answer within 24 hours or less)</li> <li>EMAIL (not urgent, need answer in a day or more)</li> </ul> <p>\u201c\u4e3a\u4ec0\u4e48\u56fd\u5916\u628a\u90ae\u4ef6(email)\u5f53\u5fae\u4fe1\u4e00\u6837\u53d1\uff1f</p> <p>\u90ae\u4ef6(email)\u529e\u516c\u6700\u5927\u7684\u597d\u5904\uff0c\u662f\u4e0d\u4f1a\u671f\u5f85\u5bf9\u65b9\u201c\u79d2\u56de\u201d\uff0c\u6240\u4ee5\u6536\u4ef6\u65b9\u6709\u8db3\u591f\u7684\u65f6\u95f4\u53bb\u6574\u7406\u4fe1\u606f\uff0c\u6709\u66f4\u591a\u7684\u5f39\u6027\u65f6\u95f4\uff0c\u5373\u4fbf\u5468\u672b\u6536\u5230\u4e5f\u53ef\u4ee5\u7b49\u5230\u5468\u4e00\u4e0a\u73ed\u518d\u56de\u3002 \u800c\u4e14\u56e0\u4e3a\u90ae\u4ef6\u201c\u975e\u5373\u65f6\u6027\u201d\u7684\u7279\u70b9\uff0c\u53d1\u8d77\u90ae\u4ef6\u5bf9\u8bdd\u7684\u4e00\u65b9\uff08\u901a\u5e38\u662f\u8001\u677f\u3001\u6216\u8005\u7532\u65b9\uff09\u4f1a\u5bf9\u81ea\u5df1\u7f16\u5199\u7684\u4fe1\u606f\u66f4\u8ba4\u771f\uff0c\u4f1a\u60f3\u6e05\u695a\u81ea\u5df1\u5230\u5e95\u8981\u5e03\u7f6e\u4ec0\u4e48\u4efb\u52a1\u624d\u4f1a\u53d1\u9001\uff0c \u4e0d\u4f1a\u50cf\u5fae\u4fe1\u8fd9\u79cd\u201c\u5373\u65f6\u6027\u201d\u8f6f\u4ef6\u4e00\u6837\uff0c\u5f88\u591a\u662f\u7a81\u7136\u5174\u8d77 \u3002\u3002\u3002</p> <p>\u6240\u4ee5\uff0c\u5ba2\u89c2\u4e0a\u90ae\u4ef6(email)\u662f\u4e0d\u65b9\u4fbf\u7684\uff0c\u4f46\u5c31\u662f\u8fd9\u79cd\u4e0d\u65b9\u4fbf\u53cd\u800c\u5229\u4e8e\u52b3\u52a8\u8005\uff0c \u8fd9\u662f\u5bf9\u52b3\u52a8\u8005\u79c1\u4eba\u7a7a\u95f4\u7684\u5c0a\u91cd\uff0c \u662f\u5bf9\u4e0a/\u4e0b\u73ed\u754c\u9650\u7684\u660e\u6670\u3002\u201d</p> <p>\u674e\u5c0f\u7ca5@\u77e5\u4e4e</p>"},{"location":"faq/faq/#3_1","title":"3) \u7ec4\u4f1a\u548c\u8bfe\u9898\u8ba8\u8bba\u5c0f\u7ec4\u4f1a\u4e4b\u95f4\u7684\u5dee\u522b\u662f\u4ec0\u4e48\uff1f","text":"<ul> <li>\u8bfe\u9898\u8ba8\u8bba\u5c0f\u7ec4\u4f1a\u7684\u5f62\u5f0f\u968f\u610f\uff0c\u4e3b\u8981\u4ee5\u8ba8\u8bba\u7ed3\u679c\u548c\u7ec6\u8282\u4e3a\u76ee\u7684\u3002 \u4e0d\u8bba\u672c\u79d1\u751f\u8fd8\u662f\u7814\u7a76\u751f\uff0c\u505a\u7814\u7a76\u4e3b\u8981\u5305\u62ec\u4e09\u5757\uff0c\u6c47\u62a5\u4e5f\u662f\u8fd9\u4e09\u5757\uff1a</li> <li>\uff081\uff09\u6587\u732e\u8c03\u7814\u7ed3\u8bba\uff08\u5bf9\u4e00\u4e2a\u79d1\u5b66\u95ee\u9898\u6216\u8005\u6280\u672f\u7684\u8c03\u7814\u548c\u7406\u89e3\uff09</li> <li>\uff082\uff09\u6e7f\u5b9e\u9a8c\u7ed3\u679c</li> <li>\uff083\uff09\u5e72\u5b9e\u9a8c\uff08\u6570\u636e\u5206\u6790\uff09\u7ed3\u679c</li> <li>\u7ec4\u4f1a\u62a5\u544a\u8981\u6b63\u5f0f\u4e00\u4e9b\uff0c\u6bcf\u5468\u4e00\u6b21\uff0c\u6bcf\u4e2a\u540c\u5b66\u57fa\u672c\u6bcf\u5b66\u671f\u4f1a\u8f6e\u5230\u4e00\u6b21\u7684\u7ec4\u4f1a\u62a5\u544a\uff0c\u4ee5\u7ec3\u4e60\u6b63\u5f0f\u62a5\u544a\u751a\u81f3\u662f\u7b54\u8fa9\u62a5\u544a\u7684\u80fd\u529b\u4e3a\u76ee\u7684\uff0c\u53ef\u4ee5\u4eff\u7167\u201c\u7b54\u8fa9ppt\u201d\u7684\u5f62\u5f0f\uff0c\u5305\u62ecI. Background, II. Method, III. Result, IV. Perspective (Future Plan)\u51e0\u4e2a\u90e8\u5206\u3002</li> </ul> <p>\u5927\u5bb6\u505a\u5b8c\u62a5\u544a\u4e4b\u540e\u90fd\u9f13\u52b1ppt\u4e0a\u4f20\u5230\u6e05\u534e\u4e91\u8fd9\u4e2a\u6587\u4ef6\u5939\u4e0b\uff083a.PPT - Project Presentation\uff09\uff0c\u5bf9\u4e8e\u540c\u4e00\u4e2a\u8bfe\u9898\u7684\u540c\u5b66\uff0c\u5b9e\u9a8c\u5185\u90e8\u9ed8\u8ba4background\u7684slides\u662f\u5171\u4eab\u7684\uff0c\u505a\u62a5\u544a\u7684\u540c\u5b66\u53ef\u4ee5\u76f4\u63a5\u4f7f\u7528\u4e4b\u524d\u4eba\u505a\u8fc7\uff08\u5305\u62ecPI\u7684\uff09\u4e00\u4e9b\u597d\u7684background slides\uff0c\u8fd9\u6837\u53ef\u4ee5\u4e0d\u65ad\u4f18\u5316\u548c\u79ef\u7d2fbackground\u7684slides\u3002</p> <p>\u6e05\u534e\u4e91\u4e0a\u8fd8\u63d0\u4f9b\u4e86\u4e00\u4e9b\u6b63\u5f0f\u7684presentation\u7684\u6a21\u677f\uff1a4.Sharing - PPT and Poster Templates; 3.Thesis/\u4f18\u79c0\u7b54\u8fa9ppt\u3002</p>"},{"location":"faq/faq/#iii","title":"III. \u5b9e\u9a8c\u5ba4\u89c4\u8303","text":""},{"location":"faq/faq/#1_2","title":"1) \u5982\u4f55\u4f5c\u606f\u89c4\u5f8b\u4e14\u6709\u6548\u7387\uff1f","text":"<p>\u5230\u5e95\u9700\u8981\u6bcf\u5468\u5728\u5b9e\u9a8c\u5ba4\u5de5\u4f5c\u591a\u4e45\uff1f\u4e0d\u5c11\u6770\u51fa\u7684\u79d1\u5b66\u5bb6\u7ed9\u5b66\u751f\u505a\u51fa\u7684\u5de5\u4f5c\u65f6\u95f4\u7684\u770b\u6cd5\u548c\u5efa\u8bae\uff08\u8ba4\u4e3a\u6bcf\u5468\u9700\u8981\u5de5\u4f5c60\u4e2a\u5c0f\u65f6\u4ee5\u4e0a\uff09\uff0c\u90fd\u662f\u975e\u5e38\u503c\u5f97\u6211\u4eec\u501f\u9274\u7684\u3002 \u3010\u539f\u6587\u94fe\u63a5\u3011</p> <p>\u201c\u5929\u9053\u916c\u52e4\u201d  \u201c\u52e4\u800c\u5584\u609f\u201d   </p> <p>\"Study while others are sleeping;  work while others are loafing;</p> <p>prepare while others are playing; dream while others are wishing.\"    - William A. Ward</p> <p>\u89c4\u5f8b\u800c\u6709\u6548\u7684\u4f5c\u606f\u65f6\u95f4\u5efa\u8bae\uff1a</p> <p>{% hint style=\"success\" %} * 9:00am-12pm (3) + 1:30-6:00pm (4.5) + 7:30-10pm (2.5) = ~10  X 6 \u5929 = ~60 \u5c0f\u65f6 * 8:00am-12pm (4) + 1:00-6:00pm (5) + 9-10pm (1) = ~10  X 6 \u5929 = ~60 \u5c0f\u65f6</p> <p>\u6548\u7387\u5bf9\u6bd4\uff1a</p> <p>\u540c\u6837\u662f\u65e9\u4e0a\u201c9\u70b9\u591a\u201d\u6765\uff0c\u665a\u4e0a\u201c\u5feb10\u70b9\u201d\u8d70\uff0c\u4f46\u5982\u679c\u7a0d\u5fae\u653e\u677e\u61d2\u6563\u4e00\u70b9\uff0c\u611f\u89c9\u4e0a\u5dee\u4e0d\u591a\u7684\u4f5c\u606f\u65f6\u95f4\uff0c\u5b9e\u8d28\u4e0a\u4e00\u5468\u4e0b\u6765\u5c31\u5f88\u5bb9\u6613\u4f1a\u53d8\u6210\uff1a</p> <p>{% hint style=\"danger\" %} * 9:50-11:20am(1.5) + 2-5:30pm(3.5) + 7:30-9:30pm(2)= 7X5\u5929+5X1\u5929(SAT)=~40\u5c0f\u65f6</p> <p>\u6ce8\uff1a\u4ee5\u4e0a\u4e3a\u6bcf\u5929\u7684\u5e73\u5747\u65f6\u95f4\uff0c\u5b9e\u9645\u6267\u884c\u65f6\u5468\u4e00\u5230\u5468\u4e94\u591a\u4e00\u70b9\u3001\u5468\u516d\u5c11\u4e00\u70b9\uff0c\u66f4\u7b26\u5408\u5e38\u60c5\u4e5f\u66f4\u5bb9\u6613\u505a\u5230\u3002\u6bcf\u5929\u548c\u6bcf\u5468\u7684\u5de5\u4f5c\u65f6\u95f4\u548c\u65b9\u5f0f\uff0c\u8981\u56e0\u4eba\u800c\u5f02\uff0c\u9002\u5408\u81ea\u5df1\u624d\u662f\u6700\u91cd\u8981\u7684\u3002\u540c\u65f6\uff0c\u5de5\u4f5c\u6548\u7387\u8981\u6bd4\u7edd\u5bf9\u65f6\u95f4\u66f4\u4e3a\u91cd\u8981\u3002</p>"},{"location":"faq/faq/#2_2","title":"2) \u5047\u671f\u5982\u4f55\u5b89\u6392\uff1f","text":""},{"location":"faq/faq/#a","title":"A. \u7814\u7a76\u751f","text":"<ul> <li>\u3010\u57fa\u672c\u8981\u6c42\u3011 \u9075\u5b88\u56fd\u5bb6\u3001\u5b66\u6821\u548c\u5b66\u9662\u7684\u4f5c\u606f\u548c\u653e\u5047\u89c4\u5b9a\uff0c\u4e0d\u968f\u610f\u4e0d\u6765\u5b9e\u9a8c\u5ba4\u3002</li> <li>\u3010\u8f83\u9ad8\u8981\u6c42\u3011 \u5efa\u8bae\u5982\u4e0b\uff1a</li> <li>\u6691\u50471-2\u5468\u5de6\u53f3\uff0c\u5bd2\u50471-2\u5468\u5de6\u53f3\uff08\u5efa\u8bae\u4e0d\u8fde\u7eed\u957f\u65f6\u95f4\u8131\u4ea7\uff0c\u5426\u5219\u5047\u671f\u540e\u8981\u5f88\u957f\u65f6\u95f4\u624d\u80fd\u6062\u590d\u5de5\u4f5c\u72b6\u6001\uff09\uff1b</li> <li>\u4e94\u4e00\u3001\u5341\u4e00\u4f11\u606f\u4e00\u534a\u5de6\u53f3\u7684\u5929\u6570\uff1b</li> <li>\u6709\u7279\u6b8a\u9700\u6c42\u7684\uff0c\u4e0a\u8ff0\u5929\u6570\u53ef\u4ee5\u6539\u4e3a\u5e74\u5047\u5e73\u5e38\u4fee\u3002</li> <li>\u6ce8\u610f\u540c\u4e00\u8bfe\u9898\u4e0d\u540c\u4eba\u5458\u9519\u5cf0\uff08\u6700\u597d\u4fdd\u8bc1\u5b9e\u9a8c\u5ba4\u540c\u4e00\u8bfe\u9898\u6700\u591a\u53ea\u6709\u9664\u5915\u5230\u521d\u4e09\u7684\u56db\u5929\u6ca1\u6709\u4eba\uff09\u3002</li> <li>\u7279\u6b8a\u60c5\u51b5\u8005\u53ef\u4ee5\u7533\u8bf7\u8fdc\u7a0b\u5de5\u4f5c\u3002</li> <li>\u4e8b\u5047\u4ece\u4e0a\u8ff0\u5929\u6570\u4e2d\u6263\u9664\uff0c\u75c5\u5047\u89c6\u5177\u4f53\u60c5\u51b5\u914c\u60c5\u8bc4\u4f30\u3002</li> </ul>"},{"location":"faq/faq/#b","title":"B. \u535a\u58eb\u540e\u548c\u5176\u4ed6\u5de5\u4f5c\u4eba\u5458","text":"<ul> <li>\u53ef\u9009\u62e9\u548c\u5b66\u751f\u5047\u671f\u540c\u6b65\uff1b</li> <li>\u4e5f\u53ef\u9009\u62e9\u666e\u901a\u793e\u4f1a\u653e\u5047\u5236\u5ea6\uff08\u6bcf\u5468\u53cc\u4f11 + \u56fd\u5bb6\u6cd5\u5b9a\u5047\u65e5+\u5e26\u85aa\u5e74\u5047\uff1b \u5e26\u85aa\u5e74\u5047\u6309\u7167\u52b3\u52a8\u6cd5\u7684\u89c4\u5b9a\uff0c\u5de5\u4f5c\u6ee11\u5e74\u4e0d\u6ee110\u5e74\uff0c\u5e26\u85aa\u5e74\u4f11\u50475\u4e2a\u5de5\u4f5c\u65e5\uff1b\u5de5\u4f5c10-20\u5e74\uff0c\u5e26\u85aa\u5e74\u4f11\u504710\u4e2a\u5de5\u4f5c\u65e5\uff1b \u4e8b\u5047\u53ef\u4ece\u5e74\u5047\u4e2d\u6263\u9664\uff1b \u75c5\u5047\u89c6\u5177\u4f53\u60c5\u51b5\u914c\u60c5\u8bc4\u4f30\uff09\u3002 </li> </ul>"},{"location":"faq/faq/#3_2","title":"3) \u6709\u4e8b\u6ca1\u6cd5\u6765\u5b9e\u9a8c\u5ba4\u5982\u4f55\u8bf7\u5047\uff1f","text":"<p>\u5efa\u8bae\u517b\u6210\u505a\u4e8b\u63d0\u524d\u89c4\u5212\u7684\u4e60\u60ef:</p> <ul> <li>\u5982\u975e\u4e8b\u51fa\u7a81\u7136/\u7279\u6b8a\u56e0\u7531\uff0c\u8bf7\u63d0\u524d\u4e00\u5468\u53d1email\u7ed9PI\uff08\u6284\u9001\u5b9e\u9a8c\u5ba4\u7ba1\u7406\u5458\uff09\u8bf7\u5047\uff1b</li> <li>\u5bd2\u6691\u5047\u3001\u56fd\u5e86\u957f\u5047\u7b49\u63d0\u524d\u534a\u4e2a\u6708\u52301\u4e2a\u6708\u5b89\u6392\u597d\u5de5\u4f5c\u4ea4\u63a5\u548c\u5047\u65e5\u503c\u73ed\uff1b</li> <li>\u5982\u679c\u53ea\u662f\u77ed\u6682\u79bb\u5f00\u51e0\u4e2a\u5c0f\u65f6\uff0c\u53ef\u4ee5\u4e0d\u7528\u8bf7\u5047;</li> <li>\u5982\u9047\u5230\u75ab\u60c5\u5c01\u63a7\u3001\u5929\u707e\u7b49\u4e0d\u53ef\u6297\u529b\uff0c\u4e0a\u8ff0\u89c4\u5b9a\u6839\u636e\u5177\u4f53\u60c5\u51b5\u5177\u4f53\u8c03\u6574\u3002  </li> </ul>"},{"location":"faq/faq/#iv","title":"IV. \u751f\u6d3b\u548c\u8d22\u52a1","text":""},{"location":"faq/faq/#1_3","title":"1) \u6821\u56ed\u5185\u6709\u54ea\u4e9b\u9910\u5385\u53ef\u4ee5\u7528\u652f\u4ed8\u5b9d\u548c\u5fae\u4fe1\u652f\u4ed8\uff1f","text":"<p>\u9910\u5385\u3001\u6e05\u9752\u7cfb\u5217\u53ef\u4f7f\u7528\u5fae\u4fe1\u3001\u652f\u4ed8\u5b9d\u7ed3\u7b97\uff1a</p> <ul> <li>\u6e05\u9752\u7cfb\u5217\uff1a</li> <li>\u6e05\u9752\u725b\u62c9 \uff08\u542c\u6d9b\u56ed2\u5c42\uff09 - \u63a8\u8350</li> <li>\u6e05\u9752\u6c38\u548c\u9910\u5385 \uff08\u89c2\u7574\u56ed\uff08\u4e07\u4eba\u98df\u5802\uff091\u5c42\uff09- \u63a8\u8350</li> <li>\u6e05\u9752\u5496\u5561\u5385 \uff08\u89c2\u7574\u56ed\uff08\u4e07\u4eba\u98df\u5802\uff091\u5c42\uff09- \u63a8\u8350</li> <li>\u6e05\u9752\u5feb\u9910\u5385 \uff08\u6e05\u82ac\u56ed\u5730\u4e0b1\u5c42\uff09- \u63a8\u8350</li> <li>\u6e05\u9752\u4f11\u95f2\u9910\u5385 \uff08\u6843\u674e\u56ed\u5730\u4e0b1\u5c42\uff09</li> <li>\u6e05\u9752\u62ab\u8428\u9910\u5385 \uff08\u7d2b\u8346\u56ed\u5730\u4e0b1\u5c42\uff09</li> <li>\u7b80\u7ea6\u5feb\u9910\u5385\uff1a</li> <li>\u7389\u6811\u56ed\u4e8c\u5c42 \uff08\u7559\u5b66\u751f\u697c\uff09- \u63a8\u8350</li> <li>\u829d\u5170\u56ed \uff08\u7559\u5b66\u751f\u697c\uff09</li> <li>\u7b80\u7ea6\u9910\u5385\uff08\u6843\u674e\u56ed3\u5c42\uff09</li> <li>\u6c34\u6728\u9ea6\u539f\u9762\u5305\u574a</li> <li>\u684c\u9910\u9910\u5385\uff1a</li> <li>\u7199\u6625\u56ed</li> <li>\u7532\u6240\u9910\u5385</li> <li>\u89c2\u7574\u56ed\uff08\u4e07\u4eba\u98df\u5802\uff09\u4e09\u5c42</li> </ul> <p>\u8be6\u7ec6\u4fe1\u606f\u53ef\u4ee5\u5173\u6ce8 \u201d\u6e05\u534e\u540e\u52e4\u201c \u7b49\u5fae\u4fe1\u516c\u4f17\u53f7</p>"},{"location":"faq/faq/#2_3","title":"2) \u5927\u5bb6\u5e73\u65f6\u7528\u4ec0\u4e48\u65b9\u5f0f\u953b\u70bc\u8eab\u4f53\uff1f","text":"<p>\u5b9e\u9a8c\u5ba4\u6709\u4e24\u4e2a\u8fd0\u52a8\u5c0f\u7ec4\uff0c\u5176\u4e2d\u4e4b\u4e00\u662f\u7fbd\u6bdb\u7403\u5c0f\u7ec4\uff0c\u53e6\u4e00\u4e2a\u662f\u6e38\u6cf3\u5c0f\u7ec4\uff0c\u5b9a\u671f\u4f1a\u7ec4\u7ec7\u5927\u5bb6\u4e00\u8d77\u953b\u70bc\u3002</p>"},{"location":"faq/faq/#3_3","title":"3) \u8d2d\u4e70\u79d1\u7814\u76f8\u5173\u7684\u4e66\u7c4d\u6216\u8005\u529e\u516c\u7528\u54c1\u9700\u8981\u5f00\u53d1\u7968\u65f6\uff0c\u9700\u8981\u4e00\u822c\u7eb3\u7a0e\u4eba\u4fe1\u606f\u600e\u4e48\u529e\uff1f","text":"<p>\u6211\u6821\u7684\u589e\u503c\u7a0e\u53d1\u7968\u5f00\u7968\u4fe1\u606f\u5982\u4e0b\uff1a</p> <ul> <li>\u5355\u4f4d\u540d\u79f0\uff1a\u6e05\u534e\u5927\u5b66</li> <li>\u7eb3\u7a0e\u4eba\u8bc6\u522b\u53f7\uff1a12100000400000624D</li> <li>\u5176\u4ed6\uff08\u5730\u5740\u3001\u7535\u8bdd\u3001\u5f00\u6237\u884c\u53ca\u8d26\u53f7\u7b49\uff09\uff1a\u4e0d\u8981\u586b\uff0c\u4e00\u5b9a\u7a7a\u7740</li> </ul>"},{"location":"faq/faq/#v","title":"V. \u529e\u516c\u786c\u4ef6\u548c\u8f6f\u4ef6","text":""},{"location":"faq/faq/#1_4","title":"1) \u79d1\u7814\u529e\u516c\u4e2d\u7684\u4e2a\u4eba\u786c\u4ef6\u5982\u4f55\u8d2d\u4e70\uff1f","text":"<ul> <li>\u627e\u7ba1\u7406\u5458\u5148\u7533\u8bf7\u540e\u8d2d\u4e70\uff08\u548c\u7f6e\u6362\uff09\uff0c\u9700\u8981\u7ba1\u7406\u5458\u6574\u4f53\u534f\u8c03\u597d\u4e4b\u540e\u62a5PI\u5ba1\u6279\u540c\u610f\u3002</li> <li>\u6bcf\u5e74\u65b0\u5b9a\u5bfc\u7684\u7814\u7a76\u751f\u90fd\u4f1a\u6709\u4e00\u4e2a\u56fa\u5b9a\u91d1\u989d\uff08\u54a8\u8be2\u7ba1\u7406\u5458\uff09\u5c01\u9876\u7684\u4e2a\u4eba\u7535\u8111\u786c\u4ef6\u8d2d\u7f6e\u8d39\uff08\u4e2a\u4eba\u7535\u8111+\u5916\u56f4\u6bd4\u5982\u663e\u793a\u5668\u3001\u9f20\u6807\u952e\u76d8\u7b49\uff09\u3002 \u4e00\u822c\u5f97\u7b49\u5230\u5e74\u5e95\uff08\u4e00\u822c12\u6708\u4efd\u5de6\u53f3\uff09\u786c\u4ef6\u8d39\u4e0b\u6765\u4e4b\u540e\u518d\u8d2d\u7f6e\u3002 \u4f46\u662f\u5927\u5bb6\u5982\u679c\u7740\u6025\u60f3\u7528\u65b0\u7684\uff0c\u4e5f\u53ef\u4ee5\u6bcf\u5e74\u7684618\u671f\u95f4\u81ea\u5df1\u5728\u4eac\u4e1c\u4e0a\u5148\u4e70\u7740\uff08\u6bd4\u5982\u53ef\u4ee5\u5148\u4e70\u4e2a\u663e\u793a\u5668\u548c\u9f20\u6807\u952e\u76d8\u4e4b\u7c7b\u7684\uff09\uff0c\u5f00\u597d\u7535\u5b50\u53d1\u7968\uff08\u53d1\u7968\u62ac\u5934\u7a0e\u53f7\u7b49\u6709\u4e25\u683c\u8981\u6c42\uff0c\u95ee\u4e00\u4e0b\u7ba1\u7406\u5458\uff09\uff0c\u7b49\u5e74\u5e95\u7ecf\u8d39\u5230\u4e86\u518d\u62a5\u9500\u5c31\u597d\u3002</li> <li>\u7279\u522b\u63d0\u9192\uff1a \u5728\u603b\u989d\u5ea6\u4e00\u5b9a\u7684\u524d\u63d0\u4e0b\uff0c\u63a8\u8350\u5927\u5bb6\u4f18\u5148\u5c06\u9884\u7b97\u7528\u4e8e\u8d2d\u4e70\u4e00\u4e9b\u5bf9\u773c\u775b\u548c\u4eba\u4f53\u529f\u80fd\u6709\u76ca\u7684\u53c2\u6570\u548c\u6027\u80fd\u3002\u5c24\u5176\u662f\u7b14\u8bb0\u672c\u7535\u8111\u7684\u9884\u7b97\u8981\u6ce8\u610f\uff1a\u56e0\u4e3a\u7b14\u8bb0\u672c\u7535\u8111\u4e3b\u8981\u7528\u6765\u529e\u516c\u800c\u4e0d\u662f\u5927\u89c4\u6a21\u8ba1\u7b97\uff08\u79d1\u7814\u76f8\u5173\u7684\u8ba1\u7b97\u90fd\u662f\u5728\u5b9e\u9a8c\u5ba4\u7684\u5927\u578b\u673a\u5668\u4e0a\u8fdc\u7a0b\u8fd0\u7b97\uff09\uff0c\u4e0d\u63a8\u8350\u8ffd\u6c42 CPU\u3001GPU \u7b49\u53c2\u6570\uff0c\u6211\u4eec\u66f4\u662f\u53cd\u5bf9\u8d2d\u4e70\u9ad8\u6027\u80fd\u7b14\u8bb0\u672c\u7535\u8111\u540e\u8ba9\u81ea\u5df1\u6c89\u8ff7\u6e38\u620f\u3002</li> <li>\u4e2a\u4eba\u7535\u8111\u548c\u914d\u4ef6\u5e73\u5e38\u4f7f\u7528\u4e2d\u5982\u679c\u975e\u4e2a\u4eba\u884c\u4e3a\u4e0d\u5f53\u800c\u610f\u5916\u635f\u574f\u7684\uff0c\u53ef\u4ee5\u62a5\u7ba1\u7406\u5458\u7ef4\u4fee\u6216\u8005\u8d2d\u7f6e\u65b0\u7684\u3002 \u4e2a\u4eba\u7535\u8111\u914d\u4ef6\uff08\u9f20\u6807\u3001\u952e\u76d8\u3001\u7535\u8111\u652f\u67b6\u3001\u7535\u8111\u5305\u7b49\uff09\u4ece\u8d2d\u4e70\u65e5\u8d773\u5e74\u4ee5\u4e0a\u3001\u663e\u793a\u5668\u548c\u4e2a\u4eba\u7535\u8111\u4ece\u8d2d\u4e70\u65e5\u8d775\u5e74\u4ee5\u4e0a\u7684\uff0c\u53ef\u4ee5\u8ddf\u7ba1\u7406\u5458\u7533\u8bf7\u66ff\u6362\u6216\u8d2d\u7f6e\u65b0\u7684\u3002</li> </ul>"},{"location":"faq/faq/#2_4","title":"2) \u79d1\u7814\u529e\u516c\u4e2d\u7684\u5e38\u7528\u8f6f\u4ef6\u5982\u4f55\u83b7\u53d6\u548c\u8d2d\u4e70\uff1f","text":"<ul> <li>\u6e05\u534e\u5927\u5b66\u8d2d\u4e70\u548c\u63d0\u4f9b\u4e86\u5f88\u591a\u5e38\u7528\u7684\u8f6f\u4ef6\uff0c\u4f9b\u6821\u5185\u5e08\u751f\u4e0b\u8f7d\u548c\u4f7f\u7528\uff0c\u5305\u62ec Windows Pro, Office, WPS\uff0cAdobe, ENDNOTE, MATLAB\uff0cNOD32\uff0c\u5361\u5df4\u65af\u57fa\u7b49\u3002\uff08 \u4e0b\u8f7d\u5730\u5740\uff1a\u6e05\u534e\u5927\u5b66\u4fe1\u606f\u5316\u670d\u52a1\u5e73\u53f0 \uff09</li> <li>\u5982\u9700\u8d2d\u4e70\u5176\u4ed6\u7279\u5b9a\u8f6f\u4ef6\uff0c\u8bf7\u5411\u5b9e\u9a8c\u5ba4\u7ba1\u7406\u5458\u9012\u4ea4\u7533\u8bf7\uff0c\u5199\u660e\u9700\u8981\u54ea\u79cd\u8f6f\u4ef6\uff0c\u4ee5\u53ca\u7248\u672c\u53f7\u7b49\u4fe1\u606f\u3002</li> <li>\u6b64\u5916\uff0c\u5bf9\u5927\u591a\u7684\u5f00\u6e90\u8f6f\u4ef6\uff0c\u6e05\u534e\u4e5f\u63d0\u4f9b\u4e00\u4e2a\u955c\u50cf\u7f51\u7ad9\uff0c\u5730\u5740\uff1a \u6e05\u534e\u5927\u5b66\u5f00\u6e90\u8f6f\u4ef6\u955c\u50cf\u7ad9</li> </ul>"},{"location":"faq/faq/#3-how-to-automatically-receive-related-literature-update-every-week","title":"3) How to automatically receive related literature update every week?","text":"<p>see Tips for paper reading - Literature Search.</p>"},{"location":"faq/faq/#vi","title":"VI. \u7f51\u7edc\u548c\u6570\u636e","text":""},{"location":"faq/faq/#1_5","title":"1) \u6211\u4eec\u8981\u7ecf\u5e38\u5907\u4efd\u6570\u636e\u5417\uff1f","text":"<ul> <li>\u65e5\u5e38\u7684\u6570\u636e\u5907\u4efd\u662f\u5fc5\u9700\u7684\uff1aHow to backup your data\uff1f</li> </ul>"},{"location":"faq/faq/#2_5","title":"2) \u5728\u5b9e\u9a8c\u5ba4\u5982\u4f55\u4e0a\u7f51\uff1f","text":"<p>\u76ee\u524d\u5b9e\u9a8c\u5ba4\u5206\u6821\u56ed\u7f51\uff08\u5916\u7f51\uff1a166.156.\u3002\u3002\u3002\uff09\u53ca\u5185\u90e8\u7f51\uff08172.22.220\u2026.\uff09\uff08\u6bcf\u4e2a\u5ea7\u4f4d\u90fd\u6709\u6807\u7b7e\u6807\u660e\u5916\u7f51\u3001\u5185\u7f51\uff09\uff0c\u5bf9\u4e8e\u6821\u56ed\u7f51\u4e0a\u7f51\u539f\u5219\u4e0a\u4f7f\u7528\u4e2a\u4eba\u5e10\u53f7\u3002 \u6bcf\u95f4\u5c4b\u5b50\u90fd\u6709\u65e0\u7ebf\u4fe1\u53f7\u8986\u76d6\uff08\u63a5\u5185\u7f51\uff09\uff0c\u65e0\u7ebf\u540d\u4e3a\u6240\u5728\u623f\u95f4\uff0c\u5982:lulab2110,\u5bc6\u7801\u8054\u7cfb\u8ba1\u7b97\u673a\u7ba1\u7406\u5458\u83b7\u5f97\u3002</p>"},{"location":"faq/faq/#3-how-to-remove-cache-of-a-web-page","title":"3) How to remove cache of a web page?","text":"<p>\u6709\u4e9b\u65f6\u5019\u5b9e\u9a8c\u5ba4\u7684\u57df\u540d\u66f4\u6362\u4e86host\u7684\u670d\u52a1\u5668\uff0c\u4f46\u662f\u81ea\u5df1\u7535\u8111cache\u91cc\u8fd8\u662f\u5b58\u7684\u8001\u670d\u52a1\u5668\u5730\u5740\uff0c\u9020\u6210\u4e00\u4e9b\u94fe\u63a5\u6ca1\u6cd5\u8bbf\u95ee\uff0c\u53ef\u4ee5\u6e05\u9664\u81ea\u5df1\u6d4f\u89c8\u5668\u7684cache\uff0c\u91cd\u65b0\u5237\u65b0\u4e00\u4e0b\u3002</p> <p>To refresh the cache in Chrome and hard reload a page, you can use the shortcut Ctrl+Shift+R on Windows/Linux or Cmd+Shift+R on Mac. This forces the browser to load the latest version of the page, ignoring cached data. </p> <p>Alternatively, you can clear browsing data, including cache and cookies, by going to Chrome's settings, selecting \"Deleting browsing data,\" and choosing the desired time range and data to remove. </p>"},{"location":"faq/faq/#vii","title":"VII. \u8fdc\u7a0b\u5de5\u4f5c","text":""},{"location":"faq/faq/#1-vpn","title":"1) \u9700\u8981\u4e0b\u8f7d\u8bba\u6587\u6216\u8005\u767b\u5f55\u6821\u56ed\u7f51\uff0c\u5982\u4f55\u8fde\u63a5\u6e05\u534eVPN?","text":"<ul> <li>\u65b9\u6cd51. \u6e05\u534e\u5927\u5b66WebVPN</li> <li>\u65b9\u6cd52. SSL VPN</li> </ul> <p>\u66f4\u591a\u5e2e\u52a9\uff1ahttps://its.tsinghua.edu.cn</p>"},{"location":"faq/faq/#2_6","title":"2) \u5982\u4f55\u5f55\u5236\u8bb2\u8bfe\u89c6\u9891\uff1f","text":"<ul> <li>\u65b9\u6cd5\u4e00\uff1aPPT \u81ea\u5e26\u5f55\u97f3\u529f\u80fd (PPT\u5f55\u5236\u65b9\u6cd5\uff1a\u6253\u5f00PPT\u2014\u70b9\u51fb\u201c\u5e7b\u706f\u7247\u653e\u6620\u201d\u2014\u5f55\u5236\u5e7b\u706f\u7247\u6f14\u793a-\u4ece\u5934\u5f00\u59cb\u5f55\u5236\u2014\u5f55\u5236\u5b8c\u9009\u62e9\u201c\u6587\u4ef6\u201d \u2014 \u4fdd\u5b58 \u6216\u8005 \u53e6\u5b58\u4e3appsx\u683c\u5f0f \u6216\u8005 \u5bfc\u51famp4\u683c\u5f0f\uff09\uff08 \u5f55\u5236\u6307\u5357\u94fe\u63a5  |  \u89c6\u9891\u6559\u7a0b\u94fe\u63a5\uff09\uff08\u6ce8\uff1a\u53ef\u4ee5\u76f4\u63a5\u4fdd\u5b58\u548c\u5206\u4eabppt\u6587\u4ef6\uff0c\u70b9\u64ad\u653e\u65f6\u4f1a\u81ea\u52a8\u6709\u58f0\u97f3\uff1b\u5982\u679c\u4e0d\u60f3\u5206\u4eab\u6e90\u6587\u4ef6\uff0c\u53ef\u4ee5\u5b58\u4e3a\u5e26\u914d\u97f3\u7684\uff0a.pps\u6216\uff0a.ppsx\u6f14\u793a\u6587\u7a3f\uff0c\u4e5f\u53ef\u901a\u8fc7Powerpoint\u8f6f\u4ef6\u5bfc\u51famp4\uff08\u4f1a\u5f88\u6162\uff0c\u6ce8\u610f\u7b49\u5f85\u8f83\u957f\u65f6\u95f4\u5b8c\u6210\u5bfc\u51fa\uff09\uff09</li> <li>\u65b9\u6cd5\u4e8c\uff1a \u5728Mac\u4e0a\u4f7f\u7528Quicktime\u5f55\u5c4f, \u5feb\u6377\u952e\uff1a (shift+CMD+5) </li> </ul> <ul> <li> [Language] \u2013 Choose out of the 60+ supported languages or add a new one</li> <li> [Navigation] \u2013 Create a clear, concise, and comprehensive navigation structure</li> <li> [Header] \u2013 Customize the behavior of the header, add an announcement bar</li> <li> [Footer] \u2013 Add links to your social media profiles or websites in the footer</li> <li> [Search] \u2013 Set up and configure search, running entirely in the user's browser</li> <li> [Tags] \u2013 Categorize your pages with tags and group related pages</li> </ul>"},{"location":"faq/survival-guide/","title":"Survival Guide","text":""},{"location":"faq/survival-guide/#-a-grad-school-survival-guide","title":"\u7814\u7a76\u751f\u751f\u5b58\u6307\u5357 - a grad school survival guide","text":"<p>\u4f5c\u8005\uff1aAndrew Gaudet</p> <p>\u6253\u5370\u7248\uff1aPDF</p> <p>\u97f3\u9891\uff1a\u7814\u7a76\u751f\u751f\u5b58\u6307\u5357.mp3</p> <p>\u539f\u6587\uff1aA grad school survival guide, Science 2015</p> <p>\u81ea\u4ece\u6210\u4e3a\u535a\u58eb\u540e\u4ee5\u6765\uff0c\u6211\u6307\u5bfc\u4e86\u51e0\u4f4d\u5373\u5c06\u5165\u5b66\u7684\u7814\u7a76\u751f\u3002\u5728\u6b64\u671f\u95f4\uff0c\u6211\u53cd\u601d\u4e86\u81ea\u5df1\u5728\u810a\u9ad3\u635f\u4f24\u4fee\u590d\u7814\u7a76\u65b9\u9762\u7684\u79d1\u7814\u7ecf\u5386\u3002\u6211\u7f16\u5199\u4e86\u4e00\u4e2a\u7b80\u77ed\u7684\u6559\u7a0b\uff0c\u65e8\u5728\u8ba9\u535a\u58eb\u4e4b\u8def\u66f4\u52a0\u987a\u7545\uff0c\u91cd\u70b9\u4ecb\u7ecd\u7814\u7a76\u751f\u751f\u6d3b\u4e2d\u7684\u65e5\u5e38\u4e8b\u52a1\u3001\u9700\u8981\u907f\u514d\u7684\u5e38\u89c1\u98ce\u9669\u4ee5\u53ca\u53ef\u4ee5\u91c7\u53d6\u7684\u6377\u5f84\u3002\u8fd9\u4e9b\u6280\u5de7\u5c06\u5e2e\u52a9\u4f60\u5efa\u7acb\u548c\u4fdd\u6301\u52a8\u529b\uff0c\u8ba9\u4f60\u7684\u9879\u76ee\u4e0d\u65ad\u63a8\u8fdb\u3002\u4e0d\u59a8\u628a\u5b83\u770b\u4f5c\u662f\u7814\u7a76\u751f\u7684\u5b9e\u7528\u751f\u5b58\u6307\u5357\u3002</p> <ol> <li>\u6784\u601d\u548c\u6253\u78e8\u597d\u7684\u95ee\u9898\u3002\u4e0d\u8981\u53ea\u662f\u8ffd\u6c42\u8868\u73b0\uff0c\u5b8c\u6210\u773c\u524d\u7684\u5de5\u4f5c\u3002\u9605\u8bfb\u76f8\u5173\u8d44\u6599\uff0c\u601d\u8003\u95ee\u9898\uff0c\u4e0e\u5176\u4ed6\u79d1\u5b66\u5bb6\u4ea4\u6d41\uff0c\u5e76\u5236\u5b9a\u8ba1\u5212\u3002\u5c16\u9510\u7684\u95ee\u9898\u548c\u6df1\u5165\u7684\u601d\u8003\u80fd\u591f\u5e26\u6765\u65b0\u7684\u3001\u66f4\u597d\u7684\u60f3\u6cd5\u3002\u968f\u7740\u65b0\u6210\u679c\u7684\u6d8c\u73b0\uff0c\u91cd\u65b0\u5ba1\u89c6\u3001\u4fee\u6539\u548c\u6253\u78e8\u4f60\u7684\u95ee\u9898\u3002</li> <li>\u5bfb\u6c42\u5e2e\u52a9\u3002\u5411\u5934\u53d1\u82b1\u767d\u7684\u8001\u535a\u58eb\u540e\u8bf7\u6559\u5b9e\u9a8c\u8bbe\u8ba1\u65b9\u9762\u7684\u5efa\u8bae\uff0c\u6216\u8005\u5411\u5b9e\u9a8c\u5ba4\u6280\u672f\u5458\u5bfb\u6c42PCR\u65b9\u9762\u7684\u5e2e\u52a9\u3002\u4e3a\u4e86\u89e3\u51b3\u6211\u7684\u7ec6\u80de\u8fc1\u79fb\u5b9e\u9a8c\u95ee\u9898\uff0c\u6211\u54a8\u8be2\u4e86\u53e6\u4e00\u4e2a\u5b9e\u9a8c\u5ba4\u7684\u535a\u58eb\u540e\u3002\u4e00\u8def\u8d70\u6765\uff0c\u6211\u5b66\u5230\u4e86\u5f88\u591a\u7ec6\u80de\u57f9\u517b\u6280\u672f\uff0c\u5728\u4e00\u5bb6\u77e5\u540d\u671f\u520a\u4e0a\u53d1\u8868\u4e86\u8bba\u6587\uff0c\u5e76\u5b8c\u6210\u4e86\u535a\u58eb\u5b66\u4f4d\u3002\u72ec\u81ea\u4e00\u4eba\u5b8c\u6210\u8fd9\u4e9b\u4e8b\u4e0d\u4f1a\u83b7\u5f97\u989d\u5916\u7684\u52a0\u5206\u3002</li> <li>\u5c0a\u91cd\u5e76\u611f\u6fc0\u4f60\u7684\u5b9e\u9a8c\u5ba4\u4f19\u4f34\u3002\u5982\u679c\u4f60\u7ecf\u5e38\u548c\u672c\u79d1\u751f\u6216\u6280\u672f\u5458\u4e00\u8d77\u5de5\u4f5c\uff0c\u53ef\u4ee5\u8bf7\u4ed6\u4eec\u5403\u5348\u996d\u4ee5\u8868\u8fbe\u4f60\u7684\u611f\u6fc0\u4e4b\u60c5\u3002\u5982\u679c\u6709\u4eba\u5e2e\u4e86\u4f60\u4e00\u70b9\u5fd9\uff0c\u4e5f\u8981\u5728\u4f60\u7684\u62a5\u544a\u4e2d\u6177\u6168\u5730\u81f4\u8c22\u3002</li> <li>\u81f3\u5c11\u8981\u6709\u4e24\u4e2a\u9879\u76ee\u3002\u5982\u679c\u5176\u4e2d\u4e00\u4e2a\u9879\u76ee\u8ba9\u4f60\u505c\u5de5\uff0c\u4f60\u53ef\u4ee5\u4e13\u6ce8\u4e8e\u53e6\u4e00\u4e2a\u9879\u76ee\uff0c\u4fdd\u6301\u52a8\u529b\u3002\u6211\u5728\u4fc4\u4ea5\u4fc4\u5dde\u7acb\u5927\u5b66\u505a\u535a\u58eb\u540e\u671f\u95f4\uff0c\u7814\u7a76\u4e86\u4e00\u79cd\u810a\u9ad3\u635f\u4f24\u540e\u8868\u8fbe\u7684\u86cb\u767d\u8d28\uff0c\u8d77\u521d\u770b\u8d77\u6765\u5f88\u6709\u5e0c\u671b\uff0c\u4f46\u6700\u7ec8\u6ca1\u6709\u53d6\u5f97\u4efb\u4f55\u8fdb\u5c55\u3002\u5e78\u8fd0\u7684\u662f\uff0c\u7b2c\u4e8c\u79cd\u5206\u5b50\u4e0d\u4ec5\u5728\u810a\u9ad3\u635f\u4f24\u4e2d\u5f88\u91cd\u8981\uff0c\u800c\u4e14\u5728\u80a5\u80d6\u548c\u6291\u90c1\u75c7\u4e2d\u4e5f\u5f88\u91cd\u8981\u3002\u901a\u8fc7\u5c06\u7cbe\u529b\u5206\u6563\u5230\u591a\u4e2a\u9879\u76ee\u4e0a\uff0c\u4f60\u5c31\u80fd\u589e\u52a0\u53d1\u73b0\u65b0\u5947\u4e8b\u7269\u7684\u673a\u4f1a\u3002</li> <li>\u4e09\u601d\u800c\u540e\u884c\u3002\u5982\u679c\u5b9e\u9a8c\u5ba4\u4f19\u4f34\u6216\u5bfc\u5e08\u60f9\u607c\u4e86\u4f60\uff0c\u8bf7\u5199\u4e0b\u4f60\u7684\u60f3\u6cd5\uff08\u8c28\u614e\u800c\u7a33\u59a5\uff09\uff0c\u4f46\u4e0d\u8981\u7acb\u5373\u56de\u590d\u3002\u7761\u4e00\u89c9\u53ef\u4ee5\u6e05\u9192\u5934\u8111\uff0c\u8ba9\u4f60\u5728\u7b2c\u4e8c\u5929\u6784\u601d\u51fa\u5e73\u8861\u3001\u5c0a\u91cd\u7684\u56de\u590d\u2014\u2014\u5982\u679c\u4f60\u51b3\u5b9a\u56de\u590d\u7684\u8bdd\u3002</li> <li>\u5982\u679c\u4f60\u9700\u8981\u5bfc\u5e08\u7684\u6307\u5bfc\uff0c\u53ef\u4ee5\u9884\u7ea6\u4e00\u6b21\u4f1a\u9762\u3002\u9664\u975e\u5979\u559c\u6b22\u4fdd\u6301\u975e\u6b63\u5f0f\u7684\u6c14\u6c1b\uff0c\u5426\u5219\u6700\u597d\u5b89\u6392\u4e00\u4e2a\u65f6\u95f4\u6765\u5bfb\u6c42\u6307\u5bfc\u3002</li> <li>\u5b66\u4f1a\u4f55\u65f6\u4e13\u6ce8\u3002\u8bb8\u591a\u5b9e\u9a8c\u65b9\u6848\u90fd\u6709\u5fc5\u987b\u4ee5\u7279\u5b9a\u65b9\u5f0f\u6267\u884c\u7684\u90e8\u5206\uff0c\u800c\u5176\u4ed6\u90e8\u5206\u5219\u66f4\u7075\u6d3b\u3002\u5982\u679c\u4f60\u4e86\u89e3\u6bcf\u4e2a\u6b65\u9aa4\u7684\u529f\u80fd\uff0c\u4f60\u5c31\u77e5\u9053\u54ea\u4e9b\u6b65\u9aa4\u53ef\u4ee5\u5feb\u901f\u5b8c\u6210\uff0c\u54ea\u4e9b\u6b65\u9aa4\u4f1a\u8ba9\u4f60\u5bf9\u7ec6\u8282\u7684\u4e13\u6ce8\u83b7\u5f97\u56de\u62a5\u3002</li> <li>\u4ece\u4f60\u6700\u4e0d\u611f\u5174\u8da3\u7684\u4efb\u52a1\u5f00\u59cb\uff0c\u7acb\u5373\u5b8c\u6210\u3002\u5728\u7814\u7a76\u751f\u9662\u5b66\u4e60\u671f\u95f4\uff0c\u6211\u5927\u7ea6\u4e0a\u5348 10 \u70b9\u5230\u8fbe\u5de5\u4f5c\u5730\u70b9\uff0c\u7136\u540e\u5148\u9605\u8bfb\u7535\u5b50\u90ae\u4ef6\u3001\u65b0\u95fb\u548c \u300aPHD \u6f2b\u753b\u300b\uff0c\u7136\u540e\u518d\u8003\u8651\u6211\u7684\u7b2c\u4e00\u4e2a\u4efb\u52a1\u3002\u662f\u7684\uff0c\u6211\u5728\u62d6\u5ef6\u3002\u6709\u65f6\uff0c\u4e00\u4e2a\u7b80\u5355\u7684\u4efb\u52a1\u2014\u2014\u68c0\u67e5\u52a8\u7269\u6216\u66f4\u6362\u7ec6\u80de\u57f9\u517b\u57fa\u2014\u2014\u4f1a\u8ba9\u6211\u6574\u5929\u90fd\u96be\u4ee5\u5e94\u5bf9\uff1b\u6211\u4e0d\u60f3\u505a\u8fd9\u4ef6\u4e8b\uff0c\u6240\u4ee5\u5b83\u963b\u788d\u4e86\u5176\u4ed6\u4e00\u5207\u3002\u6240\u4ee5\uff0c\u65e9\u4e0a\u9192\u6765\u540e\uff0c\u5728\u67e5\u770b\u7535\u5b50\u90ae\u4ef6\u4e4b\u524d\uff0c\u5148\u5b8c\u6210\u4e00\u4e9b\u77ed\u671f\u7684\u5c0f\u4efb\u52a1\u3002\u4f60\u4f1a\u53d1\u73b0\uff0c\u5904\u7406\u597d\u8fd9\u4e9b\u4efb\u52a1\u540e\uff0c\u4f60\u4e00\u5929\u7684\u5269\u4f59\u65f6\u95f4\u4f1a\u8fc7\u5f97\u66f4\u597d\u3002\u53e6\u4e00\u65b9\u9762\uff0c\u5bf9\u4e8e\u66f4\u8270\u5de8\u3001\u66f4\u957f\u671f\u7684\u4efb\u52a1\uff0c\u8bf7\u5236\u5b9a\u8ba1\u5212\uff0c\u5e76\u5c3d\u5feb\u8fc8\u51fa\u7b2c\u4e00\u6b65\u3002</li> <li>\u5728\u4e13\u6ce8\u5de5\u4f5c\u548c\u77ed\u6682\u4f11\u606f\u4e4b\u95f4\u53d6\u5f97\u5e73\u8861\u3002\u95f4\u6b47\u6027\u7684\u4f11\u606f\u4ee4\u4eba\u7cbe\u795e\u7115\u53d1\uff0c\u5e76\u5e2e\u52a9\u4f60\u4fdd\u6301\u4e00\u6574\u5929\u7684\u4e13\u6ce8\u529b\u3002</li> <li>\u53d8\u5f97\u6709\u8c03\u7406\u3002\u5728\u7ebf\u65e5\u5386\u53ef\u4ee5\u786e\u4fdd\u4f60\u4e0d\u4f1a\u9519\u8fc7\u4efb\u4f55\u91cd\u8981\u7684\u4f1a\u8bae\u3001\u5b9e\u9a8c\u6216\u7814\u8ba8\u4f1a\u3002\u4e91\u7aef\u6574\u7406\u5de5\u5177\uff08\u4f8b\u5982 Evernote\uff09\u53ef\u4ee5\u8ba9\u4f60\u8bbf\u95ee\u5b9e\u7528\u4fe1\u606f\uff0c\u4f8b\u5982\u8ba2\u8d2d\u8017\u6750\u7684\u8be6\u7ec6\u4fe1\u606f\u3001\u5b9e\u9a8c\u5ba4\u6837\u54c1\u7684\u4f4d\u7f6e\u4ee5\u53ca\u672a\u6765\u5b9e\u9a8c\u7684\u60f3\u6cd5\u3002\\</li> </ol> <p>\u5728\u653b\u8bfb\u535a\u58eb\u5b66\u4f4d\u7684\u9053\u8def\u4e0a\uff0c\u98ce\u6d6a\u53ef\u4ee5\u88ab\u9a7e\u9a6d\u6216\u5b8c\u5168\u907f\u514d\u3002\u4f60\u9700\u8981\u6bcf\u5929\u53d6\u5f97\u8bb8\u591a\u5c0f\u6210\u5c31\uff0c\u624d\u80fd\u5b9e\u73b0\u4f60\u7684\u957f\u671f\u76ee\u6807\u3002\u6240\u4ee5\u8981\u4fdd\u6301\u4e13\u6ce8\u3002</p> <p>\u201cAlong the route to a Ph.D., rough seas can be navigated or avoided entirely.\u201d ILLUSTRATION: ROBERT NEUBECKER</p>"},{"location":"faq/survival-guide/#a-grad-school-survival-guide","title":"A grad school survival guide","text":"<p>Andrew Gaudet</p> <p>Science 20 Mar 2015. Vol 347, Issue 6228p. 1386 DOI: 10.1126/science.347.6228.1386</p> <p>Since becoming a postdoc, I've mentored several incoming graduate students. In doing so, I've reflected on my own scientific experiences studying spinal cord injury repair. I've compiled a short tutorial aimed at making the road to a Ph.D. less bumpy, with a focus on the day-to-day tasks that fill a graduate student's life, common hazards to avoid, and useful shortcuts you can take. These tips will help you build and maintain momentum and keep your projects moving forward. Think of it as a practical survival guide for graduate students.</p> <p>Craft good questions. Don't just show up and do the work in front of you. Read about it, think about it, talk about it with other scientists, and plan it out. Hard questions and deep thinking lead to new and better ideas. Revisit and revise your questions as new results come in.</p> <p>Ask for help. Ask that grizzled old postdoc for advice on experimental design, or ask the lab technician for assistance with PCR. To troubleshoot my cell migration assays, I sought the advice of a postdoc in a different lab. Along the way I learned a lot about cell culture techniques, published a paper in a respectable journal, and finished my Ph.D. You don't get extra points for doing it on your own.</p> <p>Respect and appreciate your lab mates. If you often work with undergraduates or technicians, take them to lunch to show your appreciation. If someone helps you even a little, acknowledge them generously in your presentations.</p> <p>Have at least two projects. If you have downtime on one, you can focus on another and keep your momentum. During my postdoc at Ohio State University, a certain protein expressed after spinal cord injury looked promising at first but didn't lead anywhere. Fortunately, a second molecule turned out to be important not only in spinal cord injury but also in obesity and depression. By spreading energy among multiple projects, you increase the chances of discovering something novel and exciting.</p> <p>Sleep on it. If a lab mate or mentor irritates you, write down your thoughts (discreetly and securely), but don't respond right away. Sleeping on it will clear your head and allow you to compose a balanced, respectful response the next day\u2014if you decide to reply at all.\\</p> <p>If you need guidance from your mentor, set up a meeting. Unless she prefers to keep things informal, schedule a time to seek direction.</p> <p>Learn when to be obsessive. Many protocols have parts that must be performed in a specific manner and other parts that are more flexible. If you know each step's function, you know which steps you can do quickly and which will reward your obsessive attention to detail.</p> <p>Start with the task you are least excited about, and do it right away. Midway through graduate school, I was arriving at work around 10 a.m. and then reading email, news, and PHD Comics before thinking about my first task. Yes, I was procrastinating. Sometimes a simple task\u2014checking animals or changing cell culture media\u2014hung over my head all day; I didn't want to do it, so it blocked everything else. So finish small, short-term tasks first thing in the morning, before you check your e-mail. You'll find the rest of your day goes better with that out of the way. For more daunting, longer term tasks, plan them out and take the first steps as soon as you can.</p> <p>Balance bouts of focused work with short breaks. Intermittent breaks are invigorating and help you maintain focus for the entire day.</p> <p>\\ Get organized. Online calendars can ensure that you never miss an important meeting, experiment, or workshop. Cloud-based aggregators (e.g., Evernote) allow you to access practical information such as details for ordering supplies, locations of samples in the lab, and ideas for future experiments.</p> <p>Along the route to a Ph.D., rough seas can be navigated or avoided entirely. It takes many small successes, achieved day by day, to reach your long-term goals. So stay focused.</p>"},{"location":"meeting/cal/","title":"Lab Calendar","text":""},{"location":"meeting/cal/#lab-calendar_1","title":"Lab Calendar","text":"<ul> <li>Lu Lab Calendar</li> <li>html: https://outlook.live.com/owa//calendar/0c7950ee-9f96-427e-8229-e0fcdd915b44/ac41d38f-f582-4f44-91d7-a776ae33b6be/cid-0AFBF18A0971099A/index.html</li> <li>ics: https://outlook.live.com/owa//calendar/0c7950ee-9f96-427e-8229-e0fcdd915b44/ac41d38f-f582-4f44-91d7-a776ae33b6be/cid-0AFBF18A0971099A/calendar.ics</li> <li>Seminar Calendar</li> <li>html: https://outlook.live.com/owa//calendar/00000000-0000-0000-0000-000000000000/082ecf9a-edd5-44f6-b84e-6e8ca8aec125/cid-0AFBF18A0971099A/index.html</li> <li>ics: https://outlook.live.com/owa//calendar/0c7950ee-9f96-427e-8229-e0fcdd915b44/ac41d38f-f582-4f44-91d7-a776ae33b6be/cid-0AFBF18A0971099A/calendar.ics</li> </ul> <p>You can copy the above links (*.ics: ical format) to subscribe Lu Lab Calendars on the Calendar app on your phone and computer. Apps:</p> <ul> <li>Windows APP: Outlook</li> <li>MAC APP: Outlook, Calendar</li> <li>iPhone APP: Outlook, Calendar</li> <li>Android APP: Outlook, etc</li> </ul>"},{"location":"meeting/cal/#holiday-calendars","title":"Holiday Calendars","text":""},{"location":"meeting/cal/#ics","title":"\u82f9\u679c\u63d0\u4f9b\u7684\u5730\u5740ics\u683c\u5f0f:","text":"<ul> <li>\u4e2d\u56fd\u519c\u5386:  webcal://ical.mac.com/ical/China32Lunar32Simplified32Holidays.ics</li> <li>\u4e2d\u56fd\u8282\u65e5:  webcal://ical.mac.com/ical/China32Holidays.ics</li> <li>US Holidays:  webcal://ical.mac.com/ical/US32Holidays.ics</li> </ul>"},{"location":"meeting/cal/#ics_1","title":"\u8c37\u6b4c\u63d0\u4f9b\u7684\u5730\u5740 ics\u683c\u5f0f:","text":"<p>\u8c37\u6b4c\u8bbf\u95ee\u52a9\u624b</p> <ul> <li>\u4e2d\u56fd\u8282\u6c14: webcal://www.google.com/calendar/ical/orp22j75kcj10gqhol530ftucs@group.calendar.google.com/public/basic.ics</li> <li>\u4e2d\u56fd\u519c\u5386: http://www.google.com/calendar/ical/lunar__zh_cn@holiday.calendar.google.com/public/basic.ics</li> <li>\u4e2d\u56fd\u8282\u5047\u65e5: http://www.google.com/calendar/ical/china__zh_cn@holiday.calendar.google.com/public/basic.ics</li> <li>U.S. Holidays: https://calendar.google.com/calendar/ical/en.usa%23holiday%40group.v.calendar.google.com/public/basic.ics</li> </ul>"},{"location":"meeting/meeting/","title":"Lab Meetings","text":"<p>{% hint style=\"info\" %} Lab Calendar: html (ics link for subscribe\uff09</p>"},{"location":"meeting/meeting/#group-meeting","title":"Group Meeting","text":"<p>Weekly meeting for all</p> <ul> <li>Group Meeting  Schedule:  [\u6e05\u534e\u4e91] Lu Lab - Shared-R/0.Lab Logistics/</li> <li>Formal Presentation (Practice Talk)\uff08[\u6e05\u534e\u4e91] Lu Lab Shared/PPT - Project Presentation/)</li> <li>Journal Club </li> <li>Experience Sharing </li> <li>5min Paper Reading Sharing </li> </ul>"},{"location":"meeting/meeting/#subgroup-meetings","title":"Subgroup Meetings","text":"<p>Project discussion for subgroups</p> <ul> <li>Project Report and Minutes</li> <li>Students' Reports: [\u6e05\u534e\u4e91] Lu Lab Shared/Project Progress/</li> <li>PI's Project Note and PPTs: [\u6e05\u534e\u4e91] Lu Lab Shared/Project Progress/11' Zhi John Lu - Project Design/</li> </ul> <p>{% hint style=\"info\" %} \u517b\u6210\u597d\u7684\u4e60\u60ef\uff1a</p> <ul> <li>\u5f00\u4f1a\u524d\uff1a\u63d0\u524d\u4e0a\u4f20PPT (\u6e05\u534e\u4e91Lu Lab Shared/1.Project Progress/)\u3002</li> <li>\u5f00\u4f1a\u540e\uff1a\u5c3d\u5feb\u6574\u7406Meeting Minutes\uff08\u5f62\u5f0f\uff1a\u6e05\u534e\u4e91 ppt \u6700\u540e\u4e00\u9875\uff0c\u7535\u5b50\u7b14\u8bb0\u6216email\uff09\u3002</li> </ul>"},{"location":"reading/reading/","title":"Tips for Paper Reading","text":"<ul> <li>PDFs</li> <li>Startup Reading</li> <li>Lu Lab Publications</li> <li>PDFs of 5min Paper Reading Sharing (Recommended Reading List)</li> <li>PPTs</li> <li>Journal Club</li> <li>Experience Sharing </li> </ul>"},{"location":"reading/reading/#recommended-reading-organized-by-pi","title":"Recommended Reading organized by PI","text":"<ul> <li>Omics Data Analysis</li> <li>Precision Medicine</li> <li>Artificial Intelligence</li> </ul>"},{"location":"reading/reading/#tips-for-literature-search","title":"Tips for Literature Search","text":"<p>How to automatically receive related literature update every week?</p>"},{"location":"reading/reading/#1-using-pubmed","title":"1. Using Pubmed","text":"<ul> <li>(1) Register for an NCBI account</li> <li>(2) Create a search rules, for example:</li> </ul> <p>((\"Nature\"[Jour] OR \"Science\"[Jour] OR \"Nature biotechnology\"[Journal] OR \"Nature Methods\"[Jour] OR \"Nature Medicine\"[Journal] OR \"Cell Systems\"[Jour] OR \"Nature COMMUNICATIONS\"[Jour] ) AND (RNA[Title] OR cancer[Title] OR biomarker[Title] )) OR ((\"Genome Research\"[Jour] OR \"Genome Biology\"[Jour]) AND (RNA[Title] OR cancer[Title] OR biomarker[Title] ))</p> <ul> <li>(3) Search in Pubmed Search box and click 'Creat alert' button to creat search notifications.</li> </ul>"},{"location":"reading/reading/#2-using-scopus","title":"2. Using Scopus","text":"<ul> <li>(1) Register for an Scopus account</li> <li>(2) User Center\u2014My Scopus\u2014Alerts to creat search notifications.</li> </ul>"},{"location":"reading/reading/#3-google-scholar-searching-tips","title":"3. Google Scholar Searching Tips","text":"<p>http://www.educatorstechnology.com/2013/04/9-tips-every-teacher-should-know-about.html</p>"},{"location":"reading/ai/","title":"Artificial Intelligence","text":"<p>{% hint style=\"info\" %} * Course:  Machine Learning (CS229) -- Andrew Ng : coursera * Book:    \u300a\u673a\u5668\u5b66\u4e60\u300b-- \u5468\u5fd7\u534e (link)  (\u66f4\u591a\u4e66\u7c4d\u8bfe\u7a0b\u63a8\u8350) * Link of PDFs </p> <ul> <li>Deep Learning on RNA</li> <li>3D Structure prediction of RNA: 2021 Science - Geometric deep learning of RNA structure</li> <li>RNA/DNA-Protein Binding (DeepBind): 2015 Nature Biotech. - DeepBind: Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning</li> <li>Deep Learning on DNA</li> <li>2022 Nature - The evolution, evolvability and engineering of gene regulatory DNA</li> <li>Deep Learning on Protein</li> <li>2022 Nature Biotech. - Using deep learning to annotate the protein universe</li> <li>AlphaFold2 - 2021 Nature - Highly accurate protein structure prediction with AlphaFold</li> <li>Baker et al. - 2021 Science - Accurate prediction of protein structures and interactions using a three-track neural network</li> </ul> <p>4 steps of Machine Learning</p> <p></p>"},{"location":"reading/ai/deep-learning/","title":"Deep Learning","text":""},{"location":"reading/ai/deep-learning/#i-deep-learning-on-rna","title":"I. Deep Learning on RNA","text":"<ul> <li>Course:  Machine Learning (CS229) -- Andrew Ng : coursera****</li> <li>Book:    \u300a\u673a\u5668\u5b66\u4e60\u300b-- \u5468\u5fd7\u534e (link)  (\u66f4\u591a\u4e66\u7c4d\u8bfe\u7a0b\u63a8\u8350)</li> </ul> <ul> <li>AS of RNA: 2019 Cell - Predicting Splicing from Primary Sequence with Deep Learning</li> <li>AS of RNA (DARTS): 2019 Nature Methods - Deep-learning augmented RNA-seq analysis of transcript splicing</li> <li>APA of RNA: 2019 Cell - A Deep Neural Network for Predicting and Engineering Alternative Polyadenylation</li> <li>RNA/DNA-Protein Binding (DeepBind): 2015 Nature Biotech. - DeepBind: Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning</li> <li>RNA secondary structure (Transfer learning): 2019 Nature Commn. - SPOT-RNA: RNA secondary structure prediction using an ensemble of two-dimensional deep neural networks and transfer learning</li> <li>Cancer prediction using exRNA-seq</li> </ul> <p>PDFs</p>"},{"location":"reading/ai/methods-for-liquid-biopsy/","title":"Methods for exRNA","text":""},{"location":"reading/ai/methods-for-liquid-biopsy/#i-imputation-normalization-and-batch-correction","title":"I. Imputation, Normalization and Batch Correction","text":"<ul> <li>Methods for Single Cell RNA-seq </li> <li>(1) Dropout/Sparseness and Imputation</li> <li>(2) Heterogeneity and Normalization</li> <li>(3) Batch effect and Confounder</li> <li>(Pseudo-time and Others)</li> <li>Recommendations:</li> <li>2020 Nature COMMN - Embracing the dropouts in single-cell RNA-seq analysis</li> <li>2019 - Nature Methods - A discriminative learning approach to differential expression analysis for single-cell RNA-seq</li> <li>2017 - Nature Methods - Normalizing single-cell RNA sequencing data: challenges and opportunities</li> </ul> <p>PDFs</p> <ul> <li>(1) Dropout/Sparseness and Imputation</li> <li>(2) Heterogeneity and Normalization</li> <li>(3) Batch effect and Confounder</li> <li>(Pseudo-time and Others)</li> </ul> <p>Tutorial</p>"},{"location":"reading/ai/methods-for-liquid-biopsy/#ii-feature-selection-method","title":"II.  Feature Selection Method","text":"<p>PDFs</p>"},{"location":"reading/ai/methods-for-liquid-biopsy/#iii-network-approach-and-clustering","title":"III. Network Approach and Clustering","text":"<ul> <li>2020 Bioinformatics - Deeptype - Deep-learning approach to identifying cancer subtypes using high-dimensional genomic data</li> <li>2018 Nature COMMN. - Pathway based subnetworks enable cross-disease biomarker discovery</li> </ul> <p>PDFs</p>"},{"location":"reading/ai/methods-for-liquid-biopsy/#iv-tumor-location-method","title":"IV. Tumor Location Method","text":"<ul> <li>Methods for Metagenomics: tumor locator (tissue match), ranking, etc</li> <li>Methods for Tumor Location: tumor locator (tissue match), etc</li> </ul>"},{"location":"reading/ai/multi-modal/","title":"Multi-modal","text":""},{"location":"reading/ai/multi-modal/#0-foundation-models","title":"0. Foundation Models","text":"<ul> <li>2024 Nature - A pathology foundation model for cancer diagnosis and prognosis prediction</li> <li>[RNA] 2024 Nature Machine Intelligence - Multi-purpose RNA language modelling with motif-aware pretraining and type-guided fine-tuning</li> <li>[scRNA-seq] 2024 Nature Methods - Large-scale foundation model on single-cell transcriptomics</li> </ul>"},{"location":"reading/ai/multi-modal/#i-llms-for-multi-modal-data","title":"I. LLMs for Multi-modal Data","text":"<ul> <li>\u2705 2024 Nature machine intelligence  - A transformer-based weakly supervised computational pathology method for clinical-grade diagnosis and molecular marker discovery of gliomas</li> <li>2024 Nature Methods - scGPT: toward building a foundation model for single-cell multi-omics using generative AI</li> <li>\u2705  2023 Nature - Foundation models for generalist medical artificial intelligence</li> </ul>"},{"location":"reading/ai/multi-modal/#ii-deep-learning-models-for-multi-modal-data","title":"II. Deep Learning Models for Multi-modal Data","text":"<ul> <li>2022 Nature Reviews - Obtaining genetics insights from deep learning via explainable artificial intelligence</li> <li>2022 Genome Biology - A benchmark study of deep learning\u2011based multi\u2011omics data fusion methods for cancer</li> <li>\u2705 2022 Cancer Cell - Pan-cancer integrative histology-genomic analysis via multimodal deep learning</li> <li>2022 Nature Biotech. - Multi-omics single-cell data integration and regulatory inference with graph-linked embedding</li> <li>\u2728 2021 Nature Communications - MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification</li> <li>\u2728 2021 Bioinformatics - PathCNN: interpretable convolutional neural networks for survival prediction and pathway analysis applied to glioblastoma</li> <li>2021 Nature Machine Intelligence - Integration of multiomics data with graph convolutional networks to identify new cancer genes and their associated molecular mechanisms</li> <li>2021 Bioinformatics -  Subtype-GAN: a deep learning approach for integrative cancer subtyping of multi-omics data</li> <li>2018 Clinical Cancer Research - Deep Learning\u2013Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer</li> </ul>"},{"location":"reading/ai/multi-modal/#iii-other-models-for-multi-modal-data","title":"III. Other Models for Multi-modal Data","text":"<ul> <li>2024 Nature Communications -  Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights</li> <li>2023 Nature - Transfer learning enables predictions in network biology</li> <li>2022 BIB - Blood-based transcriptomic signature panel identification for cancer diagnosis: benchmarking of feature extraction methods</li> <li>\u2705 2022 Bioinformatics - MOMA: a multi-task attention learning algorithm for multi-omics data interpretation and classification</li> <li>\u2728 2022 BIB - A computational framework to unify orthogonal information in DNA methylation and copy number aberrations in cell-free DNA for early cancer detection</li> <li>2019 Bioinformatics - DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays</li> <li>2019 Bioinformatics - Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy</li> </ul>"},{"location":"reading/ai/multi-omics/","title":"Multi-Omics","text":""},{"location":"reading/ai/multi-omics/#1-review","title":"1. Review","text":"<ul> <li>2021 Systems Med - Multiple Omics Data Integration</li> <li>\u27282019 Nature Reviews - Current and future perspectives of liquid biopsies in genomics-driven oncology</li> <li>\u27282017 Genome Biology - Multi-omics approaches to disease</li> <li>2017 Trend in Genetics - Single-Cell Multiomics: Multiple Measurements from Single Cells</li> <li>2014 Nature Reviews - Principles and methods of integrative genomic analyses in cancer</li> </ul>"},{"location":"reading/ai/multi-omics/#2-research-article","title":"2. Research Article","text":"<ul> <li>2021 Nature Commn - An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer</li> <li>2020 Cell - Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer</li> <li>2020 Nature - PCAWG - Genomic basis for RNA alterations in cancer</li> <li>2020 Nature Medicine - Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer.</li> <li>2018 Science - Comprehensive functional genomic resource and integrative model for the human brain</li> <li>\u2728 2018 Science - Single-cell multiomics sequencing and analyses of human colorectal cancer</li> <li>2015 Nature - Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer\u2019s disease</li> <li>2014 NMETH - Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics </li> </ul>"},{"location":"reading/ai/multi-omics/#3-method","title":"3. Method","text":"<ul> <li>\u2728 2021 Bioinformatics -  Subtype-GAN: a deep learning approach for integrative cancer subtyping of multi-omics data</li> <li>2020 Bioinformatics - Varmole: A biologically drop-connect deep neural network model for prioritizing disease risk variants and genes</li> <li>2019 Bioinformatics - DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays</li> <li>\u2728 2019 Bioinformatics - Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy.</li> <li>2018 Clinical Cancer Research - Deep Learning\u2013Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer</li> </ul>"},{"location":"reading/ai/multi-omics/#4-tool","title":"4. Tool","text":"<ul> <li>\u2728 2021 Brief Bioinfo - A comparative study of multi-omics integration tools</li> <li>\u2728 2017 PLoS computational biology - mixOmics: An R package for \u2018omics feature selection and multiple data integration</li> </ul> <p>PDFs</p>"},{"location":"reading/ai/rna-and-protein-design/","title":"RNA &amp; Protein Design","text":"<p>{% hint style=\"success\" %} Autoregressive Approach:</p> <ul> <li>AlphaFold 2, Nature, 2021</li> <li>RoseTTAFold2, bioRxiv, 2023</li> </ul> <p>Diffusion Approach: </p> <ul> <li>RFDiffusion, Nature, 2023</li> <li>RoseTTAFold All-Atom, Science, 2024</li> <li>AlphaFold 3 (All-Atom), Nature, 2024</li> </ul>"},{"location":"reading/ai/rna-and-protein-design/#0-protein-design","title":"0. Protein Design","text":"<ul> <li>\u2705 [review] 2024 NBT - Machine learning for functional protein design</li> <li>\u2705 2024 Science - Generalized biomolecular modeling and design with RoseTTAFold All-Atom</li> <li>\u2705 2023 Nature - De novo design of protein structure and function with RFdiffusion</li> <li>[benchmark] 2024 NBT - Computational scoring and experimental evaluation of enzymes generated by neural networks</li> <li>2023 Nature - Illuminating protein space with a programmable generative model </li> <li>2022 Nature Biotech. - Large language models generate functional protein sequences across diverse families</li> </ul>"},{"location":"reading/ai/rna-and-protein-design/#i-rna-design","title":"I. RNA Design","text":"<ul> <li>\u2705 [RfamGen] 2024 Nature Methods - Deep generative design of RNA family sequences</li> <li>2024 Nature Machine Intelligence - Multi-purpose RNA language modelling with motif-aware pretraining and type-guided fine-tuning</li> <li>\u2705 2024 Nature machine intelligence - A 5\u2032 UTR language model for decoding untranslated regions of mRNA and function predictions</li> <li>2024 Cell Genome - Revealing the grammar of small RNA secretion using interpretable machine learning</li> <li>2024 Nature Methods - Deep generative design of RNA family sequences</li> <li>2023 bioRXiv - CodonBERT- Large Language Models for mRNA Design and Optimization</li> <li>2023 BIB - Integrated mRNA sequence optimization using deep learning</li> <li>2021 NAR - Theoretical basis for stabilizing messenger RNA through secondary structure design</li> </ul>"},{"location":"reading/ai/rna-and-protein-design/#ii-rna-vaccine-design","title":"II. RNA Vaccine Design","text":"<ul> <li>\u2705 2023 Nature reviews drug discovery - Tailor made: the art of therapeutic mRNA design </li> <li>[LinearDesign]: 2023 Nature - Algorithm for optimized mRNA design improves stability and immunogenicity</li> </ul>"},{"location":"reading/ai/rna-pairing-and-talk/rna-motif-and-dsrnafinder/","title":"RNA Motif &amp; dsRNAfinder","text":""},{"location":"reading/ai/rna-pairing-and-talk/rna-motif-and-dsrnafinder/#0-overview","title":"0. Overview","text":"<ul> <li>Short-distance folding:  RNAstructure; RNAfold (free energy minimization methods) see RNA Secondary Structure Prediction</li> <li>\u2705 Long distance (&gt;200nt) pairing:   SuperFold for long distance base pairs (folding)  2014 Nature Methods</li> <li>Motif finder:</li> <li>CGF: 2012 Nature  - TESISER: Systematic discovery of structural elements governing stability of mammalian messenger RNAs</li> <li>HMM+SHAPE: 2018 Genome Biology - PATTERNA - 2018 Genome Biology PATTERNA: transcriptome-wide  search for functional RNA elements via structural data signatures</li> <li>Graph Kernel: GraphProt - 2014 Genome Biology </li> <li>CFG: TEISER (2012 Nature)</li> <li>SCFG: Rfam/Infernal;  CMfinder (2006 Bioinformatics); RNApromo - 2008 PNAS </li> </ul> <ul> <li>RNAstructure/Mfold and RNAfold perform good for sequence less than 200nt.</li> <li>SuperFold uses partition in RNAstructure package to predict partition functions for subsequences of long RNA, then merge the results. Therefore, it claims to perform better on long distance base pairs.</li> </ul>"},{"location":"reading/ai/rna-pairing-and-talk/rna-motif-and-dsrnafinder/#i-motif-finding-methods","title":"I. Motif finding methods","text":"<ul> <li>1994 Proc Int Conf Intell Syst Mol Biol Fitting a mixture model by expectation maximization to discover motifs in biopolymers</li> <li>2005 NBT Assessing computational tools for the discovery of transcription factor binding sites</li> <li>2006 Bioinformatics CMfinder: a covariance model based RNA motif finding algorithm</li> <li>2008 Plos Computational Biology Discovering Sequence Motifs with Arbitrary Insertions and Deletions</li> <li>2008 PNAS Computational prediction of RNA structural motifs involved in post transcriptional regulatory processes</li> <li>2014 Nature Method RNA motif discovery by SHAPE and mutational profiling (SHAPE-MaP)</li> <li>2015 Plos Computational Biology Structure-Based Alignment and Consensus Secondary Structures for Three HIV-Related RNA Genomes</li> </ul>"},{"location":"reading/ai/rna-pairing-and-talk/rna-motif-and-dsrnafinder/#i1-dsrnafinder","title":"I.1 dsRNAfinder","text":"<ul> <li>2023 BioRxiv - dsRID: Editing-free in silico identification of dsRNA region using long-read RNA-seq data</li> <li>\u2705 Long distance (&gt;200nt) pairing:   SuperFold for long distance base pairs (folding)  2014 Nature Methods</li> </ul>"},{"location":"reading/ai/rna-pairing-and-talk/rna-motif-and-dsrnafinder/#ii-rna-motif-in-human","title":"II. RNA motif in human","text":"<ul> <li>2021 Science [TEISER] - A prometastatic splicing program regulated by SNRPA1 interactions with structured RNA elements</li> </ul>"},{"location":"reading/ai/rna-pairing-and-talk/rna-rna-interaction/","title":"RNA-RNA Interaction","text":""},{"location":"reading/ai/rna-pairing-and-talk/rna-rna-interaction/#i-rna-rna-sequencing-methods","title":"I. RNA-RNA sequencing methods","text":"<ul> <li>\u2705 [review] 2024 Molecular Cell - Technological advancements in deciphering RNA-RNA interactions</li> <li>2024 Nature Biotechnology - KARR-seq reveals cellular higher-order RNA structures and RNA\u2013RNA interactions</li> <li>\u2705 [review] 2022 Current Opinion in Genetics &amp; Development - Architecture of RNA\u2013RNA interactions</li> <li>\u2705  2020 Nature - RIC-seq for global in situ profiling of RNA\u2013RNA spatial interactions. </li> <li>2023 Nature - Complementary Alu sequences mediate enhancer\u2013promoter selectivity</li> </ul>"},{"location":"reading/ai/rna-pairing-and-talk/rna-rna-interaction/#ii-rna-rna-interaction-prediction","title":"II. RNA-RNA Interaction Prediction","text":"<ul> <li>2022 Symmetry - Recent Deep Learning Methodology Development for RNA\u2013RNA Interaction Prediction</li> <li>[book] 2023 RNA Structure Prediction - Web Services for RNA-RNA Interaction Prediction</li> <li>2020 Nature Methods - Predicting 3D genome folding from DNA sequence with Akita</li> <li>2017 Bioinformatics - A comprehensive benchmark of RNA\u2013RNA interaction prediction tools for all domains of life</li> </ul>"},{"location":"reading/ai/rna-pairing-and-talk/rna-structure/","title":"RNA 2nd Structure Prediction","text":"<ul> <li>PDFs</li> <li>\u2705 : Recommended</li> </ul>"},{"location":"reading/ai/rna-pairing-and-talk/rna-structure/#i-rna-secondary-structure-prediction","title":"I. RNA Secondary Structure Prediction","text":""},{"location":"reading/ai/rna-pairing-and-talk/rna-structure/#1-basics","title":"1. Basics","text":"<ul> <li>\u2705 Course: \u751f\u7269\u4fe1\u606f\u5b66\uff08\u6e05\u534e\u5927\u5b66\uff09;  \u751f\u7269\u7269\u7406\u5b66\uff08\u6e05\u534e\u5927\u5b66\uff09</li> <li>\u2705 Teaching Slides and Videos:  Models for RNA secondary structure prediction</li> <li>Book:   \u300aBiological Sequence Analysis: Probabilistic Models of Proteins and Nucleic Acids\u300bby Richard Durbin, Sean R. Eddy, Anders Krogh, Graeme Mitchison  (English | \u4e2d\u6587)</li> </ul> <ul> <li>Energy Model - RNAstructure/Mfold  and RNAfold </li> <li>\u2705 How do RNA folding algorithms work? (Sean R Eddy) 2004 Nature Biotech </li> <li>What is dynamic programming? (Sean R Eddy) 2004 Nature Biotech</li> <li>SCFG Model (Rfam/Infernal)</li> <li>\u2705 What is a hidden Markov model? (Sean R Eddy) 2004 Nature Biotech </li> <li>You can read the SCFG section in the book above (\u300aBiological Sequence Analysis\u300b). </li> </ul>"},{"location":"reading/ai/rna-pairing-and-talk/rna-structure/#2-recent-research-articles-and-reviews","title":"2. Recent Research Articles and Reviews","text":"<ul> <li>\u2705 [review] 2023 BIB - Recent trends in RNA informatics: a review of machine learning and deep learning for RNA secondary structure prediction and RNA drug discovery</li> <li>[review] 2022 PNAS - Thoughts on how to think (and talk) about RNA structure</li> <li>2020 ICLR - RNA Secondary Structure Prediction By Learning Unrolled Algorithms (Chinese comments)</li> <li>(Transfer learning) 2019 Nature Commn. - SPOT-RNA: RNA secondary structure prediction using an ensemble of two-dimensional deep neural networks and transfer learning</li> </ul>"},{"location":"reading/ai/rna-pairing-and-talk/rna-structure/#ii-structure-probing-experiments","title":"II. Structure Probing Experiments","text":""},{"location":"reading/ai/rna-pairing-and-talk/rna-structure/#1-structure-probing-methods","title":"1. Structure probing methods","text":"<p>\u5173\u4e8eRNA \u4e8c\u7ea7\u7ed3\u6784\u9ad8\u901a\u91cf\u6d4b\u5e8f\u65b9\u6cd5 (see more in PDFs)</p>"},{"location":"reading/ai/rna-pairing-and-talk/rna-structure/#2-structure-probing-data-analysis","title":"2. Structure probing data analysis","text":"<ul> <li>2022 Nature Methods - RNA secondary structure packages evaluated and improved by high-throughput experiments</li> <li>2021 Genome Biology - diffBUM-HMM a robust statistical modeling approach for detecting RNA flexibility changes in high-throughput structure probing data</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/","title":"RNA Target &amp; Drug","text":"<ul> <li>2022 Nature Reviews | Genetics - Drug delivery systems for RNA therapeutics</li> <li>\u2705 2022 Cell Death and Disease - RNA-based therapeutics: an overview and prospectus</li> <li>\u2705 2021 Nature Reviews | Drug Discovery - Noncoding RNA therapeutics \u2014 challenges and potential solutions </li> <li>2021 Nature Nanotechnology -  The current landscape of nucleic acid therapeutic</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-3d-structure-prediction/","title":"RNA 3D Structure Prediction","text":"<p>{% hint style=\"success\" %} Autoregressive Approach:</p> <ul> <li>AlphaFold 2, Nature, 2021</li> <li>RoseTTAFold2, bioRxiv, 2023</li> </ul> <p>Diffusion Approach: </p> <ul> <li>RFDiffusion, Nature, 2023</li> <li>RoseTTAFold All-Atom, Science, 2024</li> <li>AlphaFold 3 (All-Atom), Nature, 2024</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-3d-structure-prediction/#0-protein-tertiary-structure-prediction","title":"0. Protein Tertiary Structure Prediction","text":"<p>Learn from Protein structure prediction</p> <ul> <li>All Atom Models</li> <li>\u2705 2024 Nature - Accurate structure prediction of biomolecular interactions with AlphaFold\u20093</li> <li>\u2705 2024 Science - Generalized biomolecular modeling and design with RoseTTAFold All-Atom</li> <li>\u2705 2024 Nature - Conformational ensembles of the human intrinsically disordered proteome</li> <li> 2021 Nature \u2013 AlphaFold2: Highly accurate protein structure prediction with AlphaFold</li> <li> 2017 Science - Protein structure determination using metagenome sequence data </li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-3d-structure-prediction/#1-rna-tertiary-structure-prediction","title":"1. RNA Tertiary Structure Prediction","text":"<ul> <li>2022 PNAS - Thoughts on how to think (and talk) about RNA structure</li> <li>2022 bioRxiv - Accurate de novo prediction of RNA 3D structure with transformer network</li> <li>2022 bioRxiv - DeepFoldRNA: De Novo RNA Tertiary Structure Prediction at Atomic Resolution using Geometric Potentials from Deep Learning</li> <li>2022 arxiv - E2Efold-3D: End-to-End Deep Learning Method for accurate de novo RNA 3D Structure Prediction</li> <li>2022 bioRxiv - Accurate prediction of nucleic acid and protein-nucleic acid complexes using RoseTTAFoldNA</li> <li>\u2705 2021 Science - ARES: Geometric deep learning of RNA structure</li> <li>[Graphical Modeling] 2021 Methods Mol Biol - Modeling and Predicting RNA Three-Dimensional Structures</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-ligand/","title":"RNA-Ligand","text":"<p>{% hint style=\"success\" %} Autoregressive Approach:</p> <ul> <li>Pocket2Mol, ICML, 2022</li> <li>PocketFlow, Nature Mach. Intell., 2024</li> <li>Lingo3DMol, Nature Mach. Intell., 2024</li> </ul> <p>Diffusion Approach: </p> <ul> <li>TargetDiff, ICLR, 2023</li> <li>PMDM, Nature Commn., 2024</li> <li>[Review] Diffusion Models for Molecules: A Survey of Methods and Tasks, 2025, arXiv:2502.09511</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-ligand/#rna-ligand-small-molecule-interaction-prediction","title":"RNA-ligand (small molecule) Interaction Prediction","text":"<p>Reviews</p> <ul> <li>\u2705 2024 Nature reviews chemistry - Small molecule approaches to targeting RNA</li> <li>\u2705 2022 Nature Reviews Drug Discovery - Targeting RNA structures with small molecules</li> <li>2021 Nature Reviews Drug Discovery - Advances in targeting \u2018undruggable\u2019 transcription factors with small molecules</li> <li>2020 J. of Med. Chem. - How We Think about Targeting RNA with Small Molecules</li> <li>\u2705 2018 Nature Reviews Drug Discovery - Principles for targeting RNA with drug-like small molecules</li> <li>\u4ee5RNA\u4e3a\u9776\u6807\u7684\u5c0f\u5206\u5b50\u836f\u7269\u7684\u7814\u7a76\u8fdb\u5c55 - \u77e5\u4e4e</li> <li>\u836f\u7269\u7814\u53d1\u7684\u5168\u65b0\u9886\u57df\uff1a\u9776\u5411RNA\uff0c\u9a76\u5411\u65b0\u84dd\u6d77 - \u5fae\u4fe1</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-ligand/#0-protein-ligand-prediction-methods","title":"0. Protein-ligand prediction methods","text":"<ul> <li>2024 Nature Machine Intelligence - Generic protein\u2013ligand interaction scoring by integrating physical prior knowledge and data augmentation modelling</li> <li>2023 Nature machine intelligence - Calibrated geometric deep learning improves kinase\u2013drug binding predictions</li> <li>2023 Nature machine intelligence - Learning characteristics of graph neural networks predicting protein\u2013ligand affinities</li> <li>2023 Nature Machine Intell. - Interpretable bilinear attention network with domain adaptation improves drug\u2013target prediction</li> <li>2022 Nature Biotech. - Prediction of protein\u2013ligand binding affinity from sequencing data with interpretable machine learning</li> <li>2020 Cell - A Deep Learning Approach to Antibiotic Discovery</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-ligand/#i-known-examples-experiments","title":"I. Known Examples &amp; Experiments","text":"<ul> <li>\u2705 Targeting miRNA precursor and mRNA\u2019s UTR:  Programming inactive RNA-binding small molecules into bioactive degraders, Nature 2023</li> <li>\u2705 Targeting lncRNA Xist with compounds that disrupt RNA structure and X inactivation,  Nature 2022</li> <li>2021 Nature Biotech. - First small-molecule drug targeting RNA gains momentum</li> <li>2020 SLAS Discovery - Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical Space</li> <li>Targeting mRNA splicing (SMN2 exon7): A small molecule (SMN-C5) targeting RNA for a specific splicing correction of SMN2 exon7 to treat spinal muscular atrophy,  Nature Chem. Biol. 2019</li> <li>Targeting Ribo-switch: Selective small-molecule inhibition of an RNA structural element, Nature 2015</li> <li>Targeting HIV TAR: Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble, Nature Chem. Biol.  2011 </li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-ligand/#ii-rna-element-druggable-by-ligand","title":"II. RNA element druggable by ligand","text":"<ul> <li>2023 BIB - Structural interaction fingerprints and machine learning for predicting and explaining binding of small molecule ligands to RNA</li> <li>2022 BIB - RLBind: a deep learning method to predict RNA\u2013ligand binding sites</li> <li>2021-Bioinformatics-Recognition of small molecule\u2013RNA binding sites using RNA sequence and structure</li> <li>2019 Nature Chem. Biol. - Structural basis of a small molecule targeting RNA for a specific splicing correction</li> <li>2019 Methods in Enzymology Volume 623 - Differentiation and classification of RNA motifs using small molecule-based pattern recognition</li> <li>2018 Nature Chemical Biology - Small molecules that target group II introns are potent antifungal agents</li> <li>[Riboswitch] </li> <li>2017 PNAS - Bioinformatic analysis of riboswitch structures uncovers variant classes with altered ligand specificity</li> <li>2014 PNAS - Functional conservation despite structural divergence in ligand-responsive RNA switches</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-ligand/#iii-rna-ligand-interaction-prediction","title":"III. RNA-ligand interaction prediction","text":"<ul> <li>\u2705 2023 Nature Machine Intell. - Large-scale chemical language representations capture molecular structure and properties</li> <li>2023 Nature Communications - Sequence-based drug design as a concept in computational drug design</li> <li>\u2705  [Drug RNA] 2020 NAR - Augmented base pairing networks encode RNA-small molecule binding preferences</li> <li>[Graphical Modeling] 2021 Methods Mol Biol - Modeling and Predicting RNA Three-Dimensional Structures</li> <li>2015 WIREs Comput Mol Sci - Modeling of ribonucleic acid ligand interactions</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-ligand/#iv-ribotac","title":"IV. RIBOTAC","text":"<ul> <li>RIBOTAC (Ribonuclease Targeting Chimera) and PROTAC: </li> <li>[review] PROTAC targeted protein degraders: the past is prologue, Nature Reviews Drug Discovery 2022</li> <li>RIBOTAC &amp; PROTAC \u4ecb\u7ecd</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-oligo/","title":"RNA-Oligo","text":""},{"location":"reading/ai/rna-target-and-drug/rna-oligo/#i-sirnaaso","title":"I. siRNA/ASO","text":""},{"location":"reading/ai/rna-target-and-drug/rna-oligo/#1-efficacy-prediction","title":"1. Efficacy prediction","text":"<ul> <li>Our papers: NAR 2008a, 2008b, 2008c</li> <li>2018 BMC Genomics, SiRNA silencing efficacy prediction based on a deep architecture </li> <li>2008 Bioinformatics, siDRM: an effective and generally applicable online siRNA design tool</li> <li>2007 NAR - Comparison of approaches for rational siRNA design leading to a new efficient and transparent method</li> <li>2006 BMC Bioinformatics  - Computational models with thermodynamic and composition features improve siRNA design</li> <li>2006 BMC Bioinformatics - An accurate and interpretable model for siRNA efficacy prediction</li> <li>2005 Nature Biotech. - Design of a genome-wide siRNA library using an artificial neural network</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-oligo/#2-off-target","title":"2. Off-target","text":"<ul> <li>\u2705 2024 Bioinformatics - SeedMatchR: identify off-target effects mediated by siRNA seed regions in RNA-seq experiments</li> <li>\u2705 2017 Cell Systems - Explicit Modeling of siRNA-Dependent On- and Off-Target Repression Improves the Interpretation of Screening Results</li> <li>2013 Biomed Res Int.  - SeedSeq: Off-Target Transcriptome Database</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-oligo/#3-modification-toxicity","title":"3. Modification &amp; Toxicity","text":"<ul> <li>2023 Advanced Drug Delivery Reviews  - A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics</li> <li>2020 Signal Transduction and Targeted Therapy - Therapeutic siRNA: state of the art</li> <li>2016 Scientific Reports - siRNAmod: A database of experimentally validated chemically modified siRNAs</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-oligo/#ii-sgrna","title":"II. sgRNA","text":""},{"location":"reading/ai/rna-target-and-drug/rna-oligo/#1-sgrna-activity","title":"1. sgRNA activity","text":"<ul> <li>\u2705 2018 Nature Biotech. - Deep learning improves prediction of CRISPR\u2013Cpf1 guide RNA activity</li> <li>more sgRNA papers </li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-oligo/#2a-sgrna-offtarget-computational-methods","title":"2a. sgRNA offtarget - computational methods","text":"<ul> <li>[Benchmark] 2023 BIB - Benchmarking deep learning methods for predicting CRISPR/Cas9 sgRNA on- and off-target activities</li> <li>[review] 2023 BIB - Using traditional machine learning and deep learning methods for on- and off-target prediction in CRISPR/Cas9: a review</li> <li>2023 Nature Communications - Genome-wide CRISPR off-target prediction and optimization using RNA-DNA interaction fingerprints</li> <li>\u2705 [off-target] 2016 Nature Biotech. -Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-oligo/#2b-sgrna-offtarget-experimental-methods","title":"2b. sgRNA offtarget - experimental methods","text":"<ul> <li>2024 Nat. Biotech. - Tracking-seq reveals the heterogeneity of off-target effects in CRISPR\u2013Cas9-mediated genome editing</li> <li>2023 Nat. Methods - Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-Seq+</li> <li>2019 Science - Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq</li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-protein/","title":"RNA-Protein","text":""},{"location":"reading/ai/rna-target-and-drug/rna-protein/#rna-protein-interaction-prediction","title":"RNA-Protein Interaction Prediction","text":""},{"location":"reading/ai/rna-target-and-drug/rna-protein/#reviews","title":"Reviews","text":"<ul> <li>2018 Nature Reviews - A brave new world of RNA-binding proteins</li> <li>2018 Mol Cell - Advances in CLIP Technologies for Studies of Protein-RNA Interactions.pdf</li> <li>2018 Annual Reviews - Data Science Issues in Studying Protein\u2013RNA Interactions with CLIP Technologies </li> </ul>"},{"location":"reading/ai/rna-target-and-drug/rna-protein/#research","title":"Research","text":"<ul> <li>NMF: 2017 Genome Biology - Identification of high-confidence RNA regulatory elements by combinatorial classification of RNA\u2013protein binding sites</li> <li>Deep Learning: 2015 Nature Biotech. - DeepBind: Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning</li> </ul>"},{"location":"reading/med/cancer/cancer-immunotherapy/","title":"Cancer Immunotherapy","text":""},{"location":"reading/med/cancer/cancer-immunotherapy/#1-cancer-immunotherapy","title":"1. Cancer Immunotherapy","text":"<ul> <li>2024 Cell - Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer </li> <li>2024 Cancer Cell - Integrated multi-omics profiling to dissect thespatiotemporal evolution of metastatichepatocellular carcinoma</li> <li>[review] 2023 Cell - Delivering the next generation of cancer immunotherapies with RNA</li> <li>2023 Cancer Cell - ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome</li> <li>2023 Cancer Cell - The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients</li> <li>\u2705 (neoadjuvant biomarker) 2022 Mol. Cancer - A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer</li> <li>\u2705 (neoadjuvant) 2022 Cell - Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy</li> <li>(neoadjuvant) 2022 Nature Med  - Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer</li> <li>2021 Cancer Cell - Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer</li> <li>(non-neo adjuvant) 2021 Nature - ctDNA guiding adjuvant immunotherapy in urothelial carcinoma</li> <li>2020 Science Advance - Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy</li> </ul>"},{"location":"reading/med/cancer/cancer-immunotherapy/#2-cancer-microenvironment","title":"2. Cancer microenvironment","text":"<ul> <li>2019 - Nat Genetics - Landscape of B cell immunity and related immune evasion in human cancers</li> <li>2018 - Nat Biotech - Evaluation of immune repertoire inference methods from RNA-seq data</li> <li>2016 - Nature Genetics - Landscape of tumor-infiltrating T cell repertoire of human cancers</li> <li>[srpRNA] 2021 Cell - The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function</li> <li>[srpRNA] 2017 Cell - Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer</li> </ul>"},{"location":"reading/med/cancer/cancer-immunotherapy/#3-neoantigen","title":"3. Neoantigen","text":"<ul> <li>[review] 2021 Nature - Advances in the development of personalized neoantigen-based therapeutic cancer vaccines</li> <li>[review] 2017 Cell - Applications of Immunogenomics to Cancer</li> <li>2020 NCOMM - Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate</li> </ul>"},{"location":"reading/med/cancer/ncrna/","title":"ncRNA in Cancer","text":"<p>PDFs</p> <p>\u2705 : recommended readings</p>"},{"location":"reading/med/cancer/ncrna/#0-basics","title":"0. Basics","text":"<ul> <li>\u2705 [Review] 2021 Nature Review | Cancer - Long noncoding RNAs in cancer metastasis</li> <li>2021 Nature Biotechnology - The RNA Atlas expands the catalog of human non-coding RNAs</li> <li>2020 Nature - PCAWG - Analyses of non-coding somatic drivers in 2,658 cancer whole genomes</li> <li>2020 Nature - PCAWG - Genomic basis for RNA alterations in cancer</li> <li>\u2705  [Review] 2019 Cell The Role of Non-coding RNAs in Oncology</li> <li>[lncRNA Profiling] 2015 Nature Genetics - MiTranscriptome - The Landscape of Long Noncoding RNAs in the Human Transcriptome</li> </ul>"},{"location":"reading/med/cancer/ncrna/#i-novel-ncrnas","title":"I. Novel ncRNAs","text":"<ul> <li>\u2705 2024 Nature Genetics - Computational prediction and experimental validation identify functionally conserved lncRNAs from zebrafish to human</li> <li>[Perspective] 2022 Nature Cell Biology - Exploring the expanding universe of small RNAs </li> <li>\u2705 2021 Nature Cell Biology - PANDORA-seq expands the repertoire of regulatory small RNAs by overcoming RNA modifications </li> </ul>"},{"location":"reading/med/cancer/ncrna/#ii-te-rnarepeats","title":"II. TE-RNA/Repeats","text":"<ul> <li>2024 Nature reviews cancer -  Towards targeting transposable elements for cancer therapy</li> <li>\u2705 2024 Genome Biology - Divergent composition and transposon-silencing activity of small RNAs in mammalian oocytes</li> <li>[review] 2017 Nature Reviews Cancer - Transposable elements in cancer</li> <li>2022 Nature Genetics - LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion</li> </ul>"},{"location":"reading/med/cancer/ncrna/#iii-tsrnarsrna-and-mt-rna","title":"III. tsRNA/rsRNA and MT-RNA","text":"<ul> <li>[Function] 2022 Cell Metab. - Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth</li> <li>[Marker] 2022 Frontier Medicine - Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis</li> <li>[Function] 2021 Mol. Cancer - A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer</li> <li>[Profiling] 2020 NAR - Fragmentation of extracellular ribosomes and tRNAs shapes the extracellular RNAome</li> <li>[Marker] 2019 Mol. Cancer - Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis</li> <li>[Function] 2015 Cell - Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement</li> </ul>"},{"location":"reading/med/cancer/ncrna/#iv-circrna","title":"IV. circRNA","text":"<ul> <li>[Review] 2021 Mol Cancer Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies</li> <li>[Function] 2020 Signal Transduction and Targeted Therapy CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX</li> <li>[Review] 2019 EMBJ Past, present, and future of circRNAs</li> <li>2013 Nature Circular RNAs are a large class of animal RNAs with regulatory potency</li> </ul>"},{"location":"reading/med/cancer/ncrna/#v-other-noncoding-rnas","title":"V. Other noncoding RNAs","text":"<ul> <li>[srpRNA] 2021 Cell - The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function</li> <li>[srpRNA] 2017 Cell - Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer</li> </ul>"},{"location":"reading/med/immunity/cancer-immunology/","title":"RNA in Immune System","text":"<p>PDFs</p> <p>\u2705 : recommended readings</p>"},{"location":"reading/med/immunity/cancer-immunology/#1-dsrna-and-immunity","title":"1. dsRNA and immunity","text":"<ul> <li>[IRAlus Review] 2024 Experimental &amp; Molecular Medicine - Inverted Alu repeats: friends or foes in the human transcriptome</li> <li>2024 Molecular Cell - The competitive landscape of the dsRNA world</li> <li>2024 Nature - dsRNA formation leads to preferential nuclear export and gene expression</li> <li>\u2705 2024 Nature Reviews Immunology - Novel insights into double-stranded RNA-mediated immunopathology</li> <li>\u2705  2022 Nature Review - Mol Cell Biol. - Cellular origins of dsRNA, their recognition and consequences</li> <li>2021 Cancer Discovery - Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin</li> <li>2022 Nature Reviews Immunology - The roles of extracellular vesicles in the immune system</li> <li>2022 Immunity - Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity</li> <li>2021 Genome Biology - Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways</li> <li>[review] 2019 noncoding RNA - Endogenous Double-Stranded RNA</li> <li>2018 - JCO - Immune checkpoint molecule expression measured using circulating cell-free RNA isolated from the blood of metastatic prostate cancer patients.</li> <li>\u2705  2016 Cell Host &amp; Microbe - The Evolution of Antiviral Defense Systems</li> </ul>"},{"location":"reading/med/immunity/cancer-immunology/#dsrna-identification-and-prediction","title":"dsRNA identification and prediction","text":"<ul> <li>see RNA Motif &amp; dsRNAfinder#i.1-dsrnafinder</li> </ul>"},{"location":"reading/med/immunity/cancer-immunology/#2-ncrna-te-rna-and-immunity","title":"2. ncRNA, TE-RNA and immunity","text":"<ul> <li>\u2705 2024 Immunity - Single-cell chromatin accessibility and transposable element landscapes reveal shared features of tissue-residing immune cells</li> <li>2023 Science Immunology - Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elements</li> <li>[review] 2022 Journal of Autoimmunity - Evolving understandings for the roles of non-coding RNAs in autoimmunity and autoimmune disease</li> <li>[review] 2022 Journal of Autoimmunity - Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations</li> <li>[srpRNA] 2021 Cell - The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function</li> <li>[srpRNA] 2017 Cell - Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer</li> <li>2012 Nature Reviews Rheumatology - MicroRNAs\u2014novel regulators of systemic lupus erythematosus pathogenesis</li> </ul>"},{"location":"reading/med/immunity/cancer-immunology/#3-rna-editing-and-immunity","title":"3. RNA editing and immunity","text":"<ul> <li>\u2705  2022 Nature - RNA editing underlies genetic risk of common inflammatory diseases</li> <li>2022 Cancer Res. - Single-cell analysis in lung adenocarcinoma implicates RNA editing in cancer innate immunity and patient prognosis</li> <li>2020 Genome Biology - Human A-to-I RNA editing SNP loci are enriched in GWAS signals for autoimmune diseases and under balancing selection</li> <li>2018 Cell - Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown</li> </ul>"},{"location":"reading/med/immunity/cancer-immunology/#4-rna-modification-and-immunity","title":"4. RNA modification and immunity","text":"<ul> <li>\u2705  [review] 2023 Trends in Immunology - \u2018(m 6 )A\u2019 stands for \u2018autoimmunity\u2019: reading, writing, and erasing RNA modi\ufb01cations during in\ufb02ammation</li> <li>\u2705 2020 Immunity  - m6A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development</li> </ul>"},{"location":"reading/med/immunity/immune-diseases/","title":"Immune Diseases","text":""},{"location":"reading/med/immunity/immune-diseases/#i-reviews","title":"I. Reviews","text":"<ul> <li>\u2705 [review] 2024 Nature Immunology - The immunology of systemic lupus erythematosus</li> <li>[review] 2023 Nature Reviews Nephrology - Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants</li> <li>[review] 2023 Nature Reviews Rheumatology - Precision medicine in systemic lupus erythematosus</li> <li>[review] 2023 Nature Reviews Rheumatology - Post-transcriptional checkpoints in autoimmunity </li> <li>[review] 2022 Nature Reviews Rheumatology - The role of mitochondria in rheumatic diseases</li> </ul>"},{"location":"reading/med/immunity/immune-diseases/#ii-scrna-profiling","title":"II. scRNA Profiling","text":"<ul> <li>2024 Cell Reports Medicine - Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE</li> <li>2022 Signal transduction and targeted therapy - Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia</li> <li>\u2705 2022 Science - Single-cell RNA-seq reveals cell type\u2013specific molecular and genetic associations to lupus</li> <li>\u2705 2022 Cell - Distinct transcriptome architectures underlying lupus establishment and exacerbation</li> <li>\u2705 2021 Cell - Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases</li> <li>2022 Nature Med - Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial</li> <li>2021 PNAS - The dynamic epigenetic regulation of the inactive X chromosome in healthy human B cells is dysregulated in lupus patients</li> <li>2020 Nature Immunology - Mapping systemic lupus erythematosus heterogeneity at the single-cell level</li> <li>2019 Nature - Analysis of the B cell receptor repertoire in six immune-mediated diseases</li> </ul>"},{"location":"reading/med/immunity/immune-diseases/#iii-scmulti-omics-profiling","title":"III. scMulti-Omics Profiling","text":"<ul> <li>\u2705 2023 Immunity - Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection</li> <li>\u2705 2023 Nature - Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes</li> <li>2023 Nature cell biology - Single-cell analysis reveals transcriptomic and epigenomic impacts on the maternal\u2013 fetal interface following SARS-CoV-2 infection</li> <li>2022 Cell Reports - Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4+ T cell subset in systemic lupus erythematosus</li> <li>2021 Science Immunology - Integrated single-cell transcriptomics and epigenomics reveals strong germinal center\u2013associated etiology of autoimmune risk loci</li> </ul>"},{"location":"reading/med/immunity/immune-diseases/#iv-cart-t","title":"IV. CART-T","text":"<ul> <li>2022 Nature Leukemia - Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction</li> </ul>"},{"location":"reading/med/immunity/immune-diseases/#v-biomarkers","title":"V. Biomarkers","text":"<ul> <li>(SLE biomarker) 2022 Lancet Rheumatol - Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial</li> </ul>"},{"location":"reading/med/liquid-biopsy/","title":"Liquid Biopsy","text":"<p>PDFs</p> <p>\u2705 or \u2728 : recommended readings</p> <p>\u5173\u4e8e\u6db2\u4f53\u6d3b\u68c0\u6280\u672f\u7684\u79d1\u666e:</p> <ul> <li>News</li> <li>2022 Nature - GRAIL and the quest for earlier multi-cancer detection</li> <li>2022 - \u80bf\u7624\u65e9\u7b5b\uff0c\u7fa4\u96c4\u8c01\u80fd\u9010\u9e7f\uff1f(Wechat link | Everhub link) </li> <li>2022 - New genomic technologies for multi-cancer early detection: Rethinking the scope of cancer screening (Cancer Cell Commentary)</li> <li>2022 - Omics and AI advance biomarker discovery for liver disease (Nature Medicine News)</li> <li>2019 - \u4e3a\u4f55\u6295\u8d44\u8005\u5bf9\u764c\u75c7ctDNA\u6db2\u4f53\u6d3b\u68c0\u4f9d\u65e7\u201c\u4fe1\u5fc3\u6ee1\u6ee1\uff0c\u70ed\u60c5\u9ad8\u6da8\u201d - NBT\u89e3\u6790\u80cc\u540e\u539f\u56e0 ( Wechat link | Nature Biotech. )</li> <li>2019 - \u5f00\u542f\u80bf\u7624\u65e9\u7b5b\u65b0\u7eaa\u5143\uff0c\u6db2\u6001\u6d3b\u68c0\u84c4\u52bf\u5f85\u53d1 ( Everhub link; Wechat link )</li> <li>Patents </li> <li>2019 - Nature Biotech. - Recent patents in cancer detection </li> <li>Collections of exRNA Consortium (ERCC) @ Cell</li> <li>Outlook collection of Nature (Could tracking RNA in body fluids reveal disease? )</li> </ul>"},{"location":"reading/med/liquid-biopsy/#0-representative-publications","title":"0. Representative Publications","text":""},{"location":"reading/med/liquid-biopsy/#cfdna-cancer","title":"cfDNA - cancer","text":"<ul> <li>2024 Nature Communications - Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology</li> <li>2024 Science Translational Medicine - Genome-wide repeat landscapes in cancer and cell-free DNA</li> <li>2024 The New England Journal of Medicine -  A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening</li> <li>2023 Nature Medicine - Liquid biopsy epigenomic profiling for cancer subtyping</li> <li>2023 Nature Genetics - Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer</li> <li>2023 Science Translational Med. - Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer</li> <li>2023 Cancer Discovery - Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA</li> <li>2022 Cancer Cell - Evaluation of cell-free DNA approaches for multi- cancer early detection</li> <li>2020 Nature - Integrating genomic features for noninvasive early lung cancer detection</li> <li>2020 Nature - Microbiome analyses of blood and tissues suggest cancer diagnostic approach</li> <li>2020 Science - Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention</li> <li>2019 Nature - Genome-wide cell-free DNA fragmentation in patients with cancer</li> <li>2018 Nature - Sensitive tumour detection and classification using plasma cell-free DNA methylomes</li> <li>2018 Science - Detection and localization of surgically resectable cancers with a multi-analyte blood test</li> </ul>"},{"location":"reading/med/liquid-biopsy/#cfrna-cancer","title":"cfRNA - cancer","text":"<ul> <li>2025 Nature - An ultrasensitive method for detection of cell-free RNA</li> <li>2025 Genome Biology - Peak analysis of cell-free RNA finds recurrently protected narrow regions with clinical potential. </li> <li>2023 Nature BME - Nature Profiling of repetitive RNA sequences in the blood plasma of patients with cancer</li> <li>2022 Cancer Cell - Detection and localization of early- and late-stage cancers using platelet RNA</li> <li>2022 eLife - Cancer type classification using plasma cell-free RNAs derived from human and microbes</li> <li>2018 Nature Med. - Cancer cells exploit an orphan RNA to drive metastatic progression</li> </ul>"},{"location":"reading/med/liquid-biopsy/#cfrna-pregnancy","title":"cfRNA - pregnancy","text":"<ul> <li>2022 Nature - Early prediction of preeclampsia in pregnancy with cell-free RNA</li> <li>2022 Nature - RNA profiles reveal signatures of future health and disease in pregnancy</li> <li>2022 Nature Biotech. - Cell types of origin of the cell-free transcriptome</li> <li>2020 Science Translational Med. - Circulating transcripts in maternal blood reflect a molecular signature of early-onset preeclampsia</li> <li>2018 Science - Noninvasive blood tests for fetal development predict gestational age and preterm delivery</li> </ul>"},{"location":"reading/med/liquid-biopsy/#i-reviews-of-liquid-biopsy","title":"I. Reviews of Liquid Biopsy","text":"<ul> <li>2022 Nature Reviews - Circulating tumour DNA \u2014 looking beyond the blood</li> <li>2022 Science - Early Detection of Cancer</li> <li>\u2728 2022 Nature Biomedical Engineering - Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics</li> <li>2021Mol. Cancer - The role and application of small extracellular vesicles in gastric cancer</li> <li>\u2728 2021 Science - Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies</li> <li>\u2728 2020 Nature - Outlook - Putting extracellular RNA to the diagnostic test</li> <li>2020 Nature Reviews - RNA delivery by extracellular vesicles in mammalian cells and its applications</li> <li>2020 Science - The biology, function, and biomedical applications of exosomes</li> <li>\u2728 2020 Genome Biology - The promise and challenge of cancer microbiome research</li> <li>2019 Cell - Review - The Role of Non-coding RNAs in Oncology</li> <li>\u2728 2018 Nature Reviews | clinica l oncology - Clinical utility of circulating non-coding RNAs \u2014 an update</li> <li>\u2728 2018 Nature Reviews | Genetics - Current and future perspectives of liquid biopsies in genomics-driven oncology</li> <li>2018 Nature Reviews | Clin Oncol. - Extracellular vesicles in cancer - implications for future improvements in cancer care</li> <li>2018 NEJM - Circulating Extracellular Vesicles in Human Disease (\u7ffb\u8bd1\u7248)</li> <li>2018 NEJM - Application of Cell-free DNA Analysis to Cancer Treatment (\u7ffb\u8bd1\u7248)</li> <li>2018 NEJM - Sequencing of circulating cell-free dna during pregnancy (\u7ffb\u8bd1\u7248)</li> </ul> <p>Comparison of different liquid biopsy tech. : Comparison Table</p>"},{"location":"reading/med/liquid-biopsy/#ii-cfdna","title":"II. cfDNA","text":"<ul> <li>Multianalyte &amp; Multiomics </li> <li>2024 Cell Reports Medicine - Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis</li> <li>\u2705 cfDNA+cfDNAmet+cfRNA-S+cfRNA-L - 2023 Cell Reports Medicine - Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients\u2019 blood</li> <li>\u2705 cfDNA+cfDNAmet - 2023 Cancer Discovery - Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA </li> <li>cf-WGS+cf-WGBS - 2022 Cancer Cell - Evaluation of cell-free DNA approaches for multi- cancer early detection</li> <li>CancerSEEK+PET-CT: 2020 Science - Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention</li> <li>\u2705 ~60 cfDNA + 8 proteins (CancerSEEK): 2018 Science - Detection and localization of surgically resectable cancers with a multi-analyte blood test</li> <li>cfDNA/mbDNA </li> <li>2024 Science Translational Medicine - Machine learning to detect the SINEs of cancer</li> <li>2023 GB - The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection</li> <li>2023 Nature Genetics - Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer</li> <li>2023 STM - Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer</li> <li> \u2705 [end-motif] 2023 PNAS - Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs</li> <li>2022 Cancer Discovery - Nucleosome patterns in circulating tumor DNA reveal transcriptional regulation of advanced prostate cancer phenotypes</li> <li>cfDNA SNV+met: 2022 Science Trans. Med. - Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection</li> <li>Captured ctDNA SNV+CNV: 2020 Nature - Integrating genomic features for noninvasive early lung cancer detection</li> <li>Microbiome: 2020 Nature - Microbiome analyses of blood and tissues suggest cancer diagnostic approach </li> <li>Fragmentome (DELFI): 2022 Cancer Discovery - Detecting liver cancer using cell-free DNA fragmentomes</li> <li>Fragmentome (DELFI): 2021 Nature Commn. - Detection and characterization of lung cancer using cell-free DNA fragmentomes</li> <li>\u2705 Fragmentome (DELFI): 2019 Nature - Genome-wide cell-free DNA fragmentation in patients with cancer</li> <li>cfDNA Methylation </li> <li>\u2705 [Grail, cfDNA vs. cfDNAmet] - 2022 Cancer Cell - Evaluation of cell-free DNA approaches for multicancer early detection</li> <li>[Grail, Targeted BS] 2022 ESMO congress - PATHFINDER: A Prospective Study of a Multi-Cancer Early Detection Blood Test</li> <li>[Grail, Targeted BS] 2021 Annals of Oncology - Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set</li> <li>[Grail, Targeted BS] 2020 Annals of Oncology - Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA</li> <li>\u2728 [meDIP] 2018 Nature - Sensitive tumour detection and classification using plasma cell-free DNA methylomes</li> <li>cfDNAmet and histone modification</li> <li>2023 Nature Medicine - Liquid biopsy epigenomic profiling for cancer subtyping</li> <li>2021 Nature Biotech. - ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin</li> </ul>"},{"location":"reading/med/liquid-biopsy/#iii-cfrna-exrna","title":"III. cfRNA (exRNA)","text":"<p>cfRNA (cell-free RNA) is also called exRNA (extracellular RNA)</p>"},{"location":"reading/med/liquid-biopsy/#pregnancy","title":"Pregnancy","text":"<ul> <li> <p>(ccfDNA - 2023 Lancet Cell-free fetal DNA for genetic evaluation in Copenhagen</p> <p>Pregnancy Loss Study (COPL): a prospective cohort study) * \u2705 long cfRNA-seq: 2022 Nature  Early prediction of preeclampsia in pregnancy with cell-free RNA * Captured long cfRNA-seq: 2022 Nature RNA profiles reveal signatures of future health and disease in pregnancy * 2020 Science translational medicine - Circulating transcripts in maternal blood reflect a molecular signature of early-onset preeclampsia * \u2705 Long cfRNA-seq: 2018 Science - Noninvasive blood tests for fetal development predict gestational age and preterm delivery * long cfRNA-seq: 2017 Clinical chemistry - Simultaneously Monitoring Immune Response and Microbial Infections during Pregnancy through Plasma cfRNA Sequencing</p> </li> </ul>"},{"location":"reading/med/liquid-biopsy/#cancer","title":"Cancer","text":"<ul> <li>Long</li> <li>\u2705 Captured long cfRNA-seq: 2025 Nature - An ultrasensitive method for detection of cell-free RNA</li> <li>\u2705 cfDNA+cfDNAmet+cfRNA-S+cfRNA-L - 2023 Cell Reports Medicine - Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients\u2019 blood</li> <li>2023 Nature biomedical engineering - Nature Profiling of repetitive RNA sequences in the blood plasma of patients with cancer</li> <li>2023 Nature Commn. - Terminal modi\ufb01cations independent cell-free RNA sequencing enables sensitive early cancer detection and classi\ufb01cation</li> <li>2022 NPJ precision oncology - Plasma cell-free RNA pro\ufb01ling distinguishes cancers from premalignant conditions in solid and hematologic malignancies</li> <li>2021 Clinical Chem. - Single Cell and Plasma RNA Sequencing for RNA Liquid Biopsy for Hepatocellular Carcinoma</li> <li>long cfRNA-mRNA: 2021 Nature Commn. - Grail - A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection</li> <li>long evRNA-mRNA: 2021 Mol Cancer - Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer </li> <li>long cfRNA-ncRNA - 2021 Theranostics - Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer</li> <li>\u2728 long evRNA-seq: 2020 GUT Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma</li> <li>mRNA/lncRNA fragments: 2019 EMBO J.  - Phospho\u2010RNA\u2010seq: a modified small RNA\u2010seq method that reveals circulating mRNA and lncRNA fragments as potential biomarkers in human plasma</li> <li>SILVER-seq: 2019 PNAS - Extracellular RNA in a single droplet of human serum reflects physiologic and disease states</li> <li>long evRNA-seq: 2019 Clinical Chemistry - Extracellular Vesicles Long RNA Sequencing Reveals Abundant mRNA, circRNA, and lncRNA in Human Blood as Potential Biomarkers for Cancer Diagnosis</li> <li>exoRBase: 2018 NAR - exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes</li> <li>2018 PNAS - Human plasma and serum extracellular small RNA reference profiles and their clinical utility</li> <li>exRNA Components: 2017 Nature Communication - Coding and noncoding landscape of extracellular RNA</li> <li>Prospective Review: 2017 Noncoding RNA - RNA Biomarkers: Frontier of Precision Medicine for Cancer</li> <li>Long - Platelet </li> <li>\u2705 Platelet RNA: 2022 Cancer Cell - Detection and localization of early- and late-stage cancers using platelet RNA</li> <li>2022 Genome Medicine - RNA profiling of blood platelets noninvasively differentiates colorectal cancer from healthy donors and noncancerous intestinal diseases: a retrospective cohort study</li> <li>Platelet RNA: 2015 Cancer Cell - RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics</li> <li>Platelet RNA: 2017 Cancer Cell - Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets</li> <li>Small/Frag.</li> <li>\u2728 2025 Genome Biology - Peak analysis of cell-free RNA finds recurrently protected narrow regions with clinical potential. </li> <li>\u2728 oncRNA: 2024 bioRxiv - Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers</li> <li>unannotated exRNAs: 2021 GUT - Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer</li> <li>small exosomal RNA: 2019 Molecular Cancer - Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis</li> <li>small cfRNA: 2015 Scientific Report - Plasma extracellular RNA profiles in healthy and cancer patients</li> <li>structured ncRNA domain (small cfRNA-seq): 2019 Clinical chemistry  - Noncoding RNAs serve as diagnosis and prognosis biomarkers for hepatocellular carcinoma</li> <li>\u2728 oncRNA: 2018 Nature Med. - Cancer cells exploit an orphan RNA to drive metastatic progression</li> <li>miRNA7: 2011 JCO - Jia Fan - Plasma MicroRNA Panel to Diagnose Hepatitis B Virus\u2013Related Hepatocellular Carcinoma</li> </ul>"},{"location":"reading/med/liquid-biopsy/#infectious-diseases","title":"Infectious Diseases","text":"<ul> <li>2024 Nature Communications - Circulating cell-free RNA in blood as a host response biomarker for detection of tuberculosis</li> <li>2022 Genome Res. - Plasma cell-free RNA characteristics in COVID-19 patients</li> </ul>"},{"location":"reading/med/liquid-biopsy/#neural-diseases","title":"Neural Diseases","text":"<ul> <li>small cfRNA - 2021 PNAS -  - Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology</li> <li>long cfRNA-mRNA: 2020 Science Advance - Noninvasive characterization of Alzheimer\u2019s disease by circulating cell-free messenger RNA next-generation sequencing</li> <li>cfRNA: 2020 Current Biology - Presymptomatic increase of an extracellular RNA in blood plasma is associated with the development of Alzheimer\u2019s disease</li> </ul>"},{"location":"reading/med/liquid-biopsy/#ercc-2019-cell-papers","title":"ERCC  (2019 Cell papers)","text":"<ul> <li>exceRpt: Cell system 2019 - exceRpt: A Comprehensive Analytic Platform for Extracellular RNA Profiling</li> <li>Extracellular carriers: Cell minireview 2019 - Mapping Extracellular RNA Sheds Lights on Distinct Carriers</li> <li>ERCC perspective: Cell perspective 2019 - The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research</li> <li>Exosome preview: Cell preview 2019 - Explicating Exosomes: Reclassifying the Rising Stars of Intercellular Communication</li> <li>\u2728 Exosome composition: Cell article 2019 - Reassessment of Exosome Composition</li> <li>exRNA carriers: Cell resource 2019 - exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids</li> <li>Small exRNA-seq: Cell resource 2019 - Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation</li> <li>Exosome PD-L1: Cell article 2019 - Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory</li> </ul>"},{"location":"reading/med/liquid-biopsy/#iv-others-proteome-etc","title":"IV. Others - Proteome etc","text":""},{"location":"reading/med/liquid-biopsy/#tcr","title":"TCR","text":"<ul> <li>2020 - Science Transl. Med. - De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection</li> </ul>"},{"location":"reading/med/liquid-biopsy/#proteome","title":"Proteome","text":"<ul> <li>\u2705 [Plasma proteome] 2023 Nature - Organ aging signatures in the plasma proteome track health and disease</li> <li>[Plasma proteome] 2022 Nature Medicine - Noninvasive proteomic biomarkers for alcohol-related liver disease</li> <li>\u2705  [MS-EVP] Exosomic proteins: 2020 Cell - Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers</li> <li>[APPA] 2020 Sci Adv - Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response</li> </ul>"},{"location":"reading/med/liquid-biopsy/#metabolome","title":"Metabolome","text":"<ul> <li>2024 Nature Commn. - Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer</li> </ul>"},{"location":"reading/med/liquid-biopsy/panel-and-screen/","title":"Panel and Database","text":"<p>PDFs</p>"},{"location":"reading/med/liquid-biopsy/panel-and-screen/#0-databases","title":"0. Databases","text":"<ul> <li>2024 NAR - cfOmics: a cell-free multi-Omics database for diseases</li> <li>2021 NAR - exoRBase 2.0: an atlas of mRNA, lncRNA and circRNA in extracellular vesicles from human bio\ufb02uids</li> <li>2020 NAR - Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles</li> <li>2020 NAR - CFEA a cell-free epigenome atlas in human disease</li> <li>2019 NAR - BBCancer: an expression atlas of blood-based biomarkers in the early diagnosis of cancers</li> </ul>"},{"location":"reading/med/liquid-biopsy/panel-and-screen/#i-ngs-analysis","title":"I. NGS Analysis","text":""},{"location":"reading/med/liquid-biopsy/panel-and-screen/#rna-seq-analysis-differential-expression","title":"RNA-seq Analysis - Differential Expression","text":"<ul> <li>2021 Theranostics - Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer</li> <li>circRNA: 2020 PLOS Comp. Bio. - seekCRIT: Detecting and characterizing differentially expressed circular RNAs using high-throughput sequencing data</li> </ul>"},{"location":"reading/med/liquid-biopsy/panel-and-screen/#rna-seq-analysis-more","title":"RNA-seq Analysis - More","text":"<ul> <li>see more RNA-seq analysis pipelines in Tutorial: RNA Regulation Analysis</li> </ul>"},{"location":"reading/med/liquid-biopsy/panel-and-screen/#ii-meta-analysis","title":"II. Meta-Analysis","text":"<ul> <li>[Protein markers] 2016 Lancet Neurol - CSF and blood biomarkers for the diagnosis of Alzheimer's disease- a systematic review and meta-analysis</li> <li>[DNA markers] 2014 Nat Genetics - Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk</li> <li>[lncRNA markers] 2005 Cancer Res. - Identification of GATA3 as a Breast Cancer Prognostic Marker by Global Gene Expression Meta-analysis</li> <li>[Practical Review] 2015 Korean J Radiol Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers</li> <li>Part I. General Guidance and Tips</li> <li>Part II. Statistical Methods of Meta-Analysis</li> </ul> <p>PDFs</p>"},{"location":"reading/med/liquid-biopsy/panel-and-screen/#iii-large-cohort-validationscreen","title":"III. Large-cohort Validation/Screen","text":"<p>PDFs</p>"},{"location":"reading/med/liquid-biopsy/panel-and-screen/#cfrna-panels","title":"cfRNA Panels","text":"<ul> <li>2022 Mol Cancer - A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study</li> <li>\u2728 miRNA panel: 2022 Mol Cancer - A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study</li> <li>\u2728 circRNA  panel: 2022 Mol Cancer - Diagnostic efcacy of circular RNAs as noninvasive liquid biopsy biomarkers for early detection of gastric cancer</li> <li>\u2728 mRNA panel: 2021 Mol Cancer - Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer</li> <li>lncRNAs+miRNAs: 2021 Theranostics -Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer</li> <li>miRNAs: 2020 Gut - Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population</li> <li>miRNAs: 2020 PNAS - Development of a serum miRNA panel for detection of early stage non-small cell lung cancer</li> <li>\u2728 small exosomal RNA: 2019 Molecular Cancer - Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis</li> <li>\u2728 miRNA7: 2011 JCO - Jia Fan - Plasma MicroRNA Panel to Diagnose Hepatitis B Virus\u2013Related Hepatocellular Carcinoma</li> </ul>"},{"location":"reading/med/liquid-biopsy/panel-and-screen/#other-detectiondiagnosis-panels","title":"Other Detection/Diagnosis Panels","text":"<ul> <li>\u2705 (neoadjuvant biomarker) 2022 Mol. Cancer - A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer</li> <li>\u2705 (SLE biomarker) 2022 Lancet Rheumatol - Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial</li> <li>ctDNA+Protein (CancerSEEK): 2018 - Science - Detection and localization of surgically resectable cancers with a multi-analyte blood test</li> <li>2019 - iScience - Early Cancer Detection from Multianalyte Blood Test Results</li> <li>2021 - Bioinformatics - CancerEMC frontline non-invasive cancer screening from circulating protein biomarkers and mutations in cell-free DNA</li> <li>ctDNA+Protein+Clinical Info: 2019 - PNAS - Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy</li> </ul>"},{"location":"reading/med/liquid-biopsy/panel-and-screen/#other-prognosis-panels","title":"Other Prognosis Panels","text":"<ul> <li>Progosis ctDNA: 2019 JCO - Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma</li> <li>Prognosis ctDNA: 2019 JAMA Oncology - Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer</li> <li>Prognosis ctDNA: 2019 Translational Med. - Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer</li> <li>Prognosis ctDNA\uff1a2019 JAMA Oncology - Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer</li> <li>Liquid vs. tissue biopsy\uff1a 2019 Nature Medicine - Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers</li> </ul>"},{"location":"reading/omics/cfrna/","title":"cfRNA-seq Analysis","text":"<p>PDFs</p> <p>\u2705 or \u2728 : recommended readings</p>"},{"location":"reading/omics/cfrna/#i-pipelines","title":"I. Pipelines","text":"<ul> <li>[small cfRNA-seq] 2019 Cell Sys. - exceRpt: A Comprehensive Analytic Platform for Extracellular RNA Profiling</li> <li>[long and small cfRNA-seq] exSEEK Tutorial</li> <li>[long cfRNA-seq] cfRNA-SEEK Github </li> </ul>"},{"location":"reading/omics/cfrna/#ii-rna-feature-extraction","title":"II. RNA Feature Extraction","text":"<p>{% hint style=\"info\" %} * see more in RNA Regulation: editing, splicing, modification, APA, chimeric RNA, etc * learn from cfDNA features</p>"},{"location":"reading/omics/cfrna/#ii1-rna-motif","title":"II.1. RNA motif","text":"<ul> <li>( \u2705 2023 PNAS - Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs )</li> <li>\u2705 miRNA motif - 2021 Nature - MicroRNA sequence codes for small extracellular vesicle release and cellular retention</li> <li>G-quadruplex - 2020 Genome biology - RNA G-quadruplex structures exist and function in vivo in plants</li> <li>G-quadruplex - 2016 Science - RNA G-quadruplexes are globally unfolded in eukaryotic cells and depleted in bacteria</li> </ul>"},{"location":"reading/omics/cfrna/#ii2-rna-fragment-novel-sncrna","title":"II.2. RNA fragment (novel sncRNA)","text":"<ul> <li>Peak calling: 2022 Genome Biology - GoPeaks: histone modification peak calling for CUT\\&amp;Tag</li> <li>2021 PNAS - Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology</li> <li>2021 NAR - Computational meta-analysis of ribosomal RNA fragments: potential targets and interaction mechanisms</li> <li>sRNA cluster: 2021 Gut - Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer</li> <li>2020 Mol. Cancer - Peripheral blood non-canonical small non-coding RNAs as novel biomarkers in lung cancer</li> <li>Fragmented ribosomes: 2020 NAR - Fragmentation of extracellular ribosomes and tRNAs shapes the extracellular RNAome</li> <li>\u2705 mRNA frag. :  2020 elife - Identification of protein-protected mRNA fragments and structured excised intron RNAs in human plasma by TGIRT-seq peak calling</li> <li>tsRNA: 2019 Molecular Cancer - Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis</li> <li>mRNA/lncRNA frag.: 2019 EMBO J. - Phospho\u2010RNA\u2010seq: a modified small RNA\u2010seq method that reveals circulating mRNA and lncRNA fragments as potential biomarkers in human plasma</li> <li>srpRNA domain (RNA7SL1): 2019 Clinical Chem. - Noncoding RNAs serve as diagnosis and prognosis biomarkers for hepatocellular carcinoma</li> </ul>"},{"location":"reading/omics/cfrna/#iii-feature-selection","title":"III. Feature Selection","text":""},{"location":"reading/omics/cfrna/#iii1-signature-genes","title":"III.1.  Signature Genes","text":"<ul> <li>\u2705  [TmS: total mRNA expression] 2022 Nature Biotech. - Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression</li> <li>\u2705  2021 Nature Biotech. - Gene signature extraction and cell identity recognition at the single-cell level with Cell-ID</li> <li>2021 Nature Machine Intelligence - Integration of multiomics data with graph convolutional networks to identify new cancer genes and their associated molecular mechanisms</li> <li>2021 Genome Res. - NS-Forest: A machine learning method for the discovery of minimum marker gene combinations for cell type identification from single-cell RNA sequencing</li> <li>2019 Briefings in Bioinformatics - A comprehensive evaluation of connectivity methods for L1000 data Briefings in Bioinformatics</li> </ul>"},{"location":"reading/omics/cfrna/#iii2-network-approach","title":"III.2. Network Approach","text":"<ul> <li>2022 Nature Commn. - Network-based machine learning approach to predict immunotherapy response in cancer patients</li> <li>\u2705 [P-Net] 2021 Nature -  Biologically informed deep neural network for prostate cancer discovery</li> <li>2021 Nature Computational Science -  Modeling gene regulatory networks using neural network architectures</li> <li>2021 Cell - A modular master regulator landscape controls cancer transcriptional identity</li> <li>2020 Bioinformatics - Varmole: A biologically drop-connect deep neural network model for prioritizing disease risk variants and genes</li> <li>2017 Nature Methods - SCENIC: single-cell regulatory network inference and clustering</li> <li>2018 Nature COMMN. - Pathway based subnetworks enable cross-disease biomarker discovery</li> </ul>"},{"location":"reading/omics/cfrna/#iv-data-clean-normalization-batch-correction-etc","title":"IV. Data Clean - normalization, batch correction, etc","text":"<p>Issues for single-cell and cell-free RNA-seq data</p> <ul> <li>(1) Dropout/Sparseness and Imputation</li> <li>(2) Heterogeneity and Normalization</li> <li>(3) Batch effect and Confounder</li> <li>(Pseudo-time and Others)</li> </ul> <p>Tutorial</p> <ul> <li>\u2705  Review:  2021 Nature Biotech. - Computational principles and challenges in single-cell data integration</li> <li>2019 Nature Methods - A discriminative learning approach to differential expression analysis for single-cell RNA-seq</li> <li>\u2705 2018 Nature Biotech. - Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors</li> <li>MNN: 2017 Nature Biotech. - Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors</li> <li>\u2705 Review: 2017 Nature Methods - Normalizing single-cell RNA sequencing data: challenges and opportunities</li> </ul>"},{"location":"reading/omics/cfrna/#v-tissue-of-origin","title":"V. Tissue of Origin","text":"<ul> <li>\u2705 2024 Cell Genomics - Revealing the grammar of small RNA secretion</li> <li>\u2705 Deconvolution: 2022 Nature Biotech. - Cell types of origin of the cell-free transcriptome</li> <li>2021 Nature Biotech. - ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin</li> <li>\u2705 miRNA motif - 2021 Nature - MicroRNA sequence codes for small extracellular vesicle release and cellular retention</li> <li>\u2705 2017 Genome Biology - CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA</li> </ul>"},{"location":"reading/omics/cfrna/#vi-classification-models","title":"VI. Classification Models","text":""},{"location":"reading/omics/cfrna/#pre-training-and-transfer-learning","title":"Pre-training and Transfer Learning","text":"<ul> <li>\u2705 2023 Nature Methods - SEVtras delineates small extracellular vesicles at droplet resolution from single-cell transcriptomes</li> <li>2022 BIB - A universal approach for integrating super large-scale single-cell transcriptomes by exploring gene rankings</li> <li>2022 bioRxiv - Generative pretraining from large-scale transcriptomes: Implications for single-cell deciphering and clinical translation</li> <li>\u2705 2021 bioRxiv - scBERT: a Large-scale Pretrained Deep Langurage Model for Cell Type Annotation of Single-cell RNA-seq Data</li> </ul>"},{"location":"reading/omics/cfrna/#_1","title":"cfRNA-seq Analysis","text":""},{"location":"reading/omics/genetic-and-function-analysis/","title":"Genetic &amp; Function Analysis","text":""},{"location":"reading/omics/genetic-and-function-analysis/#i-rna-epigenetics","title":"I. RNA &amp; Epigenetics","text":""},{"location":"reading/omics/genetic-and-function-analysis/#1-genetics-post-gwas","title":"1. Genetics &amp; Post-GWAS","text":"<ul> <li>\u2705 2024 Nature Genetics - Genetic mapping across autoimmune diseases reveals shared associations and mechanisms</li> <li>2024 Nature Communications - Integrating single cell expression quantitative trait loci summary statistics to understand complex trait risk genes</li> <li>2022 Nature genetics - Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data</li> <li>2022 Cancer Discovery - Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles Somatic Mutations and 3D Genomic Architecture</li> <li>2019 Nature Communications - SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell speci\ufb01c enhancer that controls disease-critical microRNA expression</li> </ul>"},{"location":"reading/omics/genetic-and-function-analysis/#2-rna-function-analysis","title":"2. RNA &amp; Function Analysis","text":"<ul> <li>2024 Cell Reports Medicine - Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE</li> </ul>"},{"location":"reading/omics/genetic-and-function-analysis/#ii-rna-editing-and-splicing","title":"II. RNA editing and splicing","text":""},{"location":"reading/omics/genetic-and-function-analysis/#1-genetics-post-gwas_1","title":"1. Genetics &amp; Post-GWAS","text":"<ul> <li>2024 Nature Communications - Long-read sequencing for 29 immune cell subsets reveals disease-linked isoforms</li> <li>\u2705 2022 Nature - RNA editing underlies genetic risk of common inflammatory diseases</li> <li>2022 Nature Genetics - Genetic control of RNA splicing and its distinct role in complex trait variation</li> <li>\u2705  2020 Nature - PCAWG - Genomic basis for RNA alterations in cancer</li> <li>2020 Genome Biology - Human A-to-I RNA editing SNP loci are enriched in GWAS signals for autoimmune diseases and under balancing selection</li> <li>2019 Nature Genetics - An atlas of alternative polyadenylation quantitative trait loci contributing to complex trait and disease heritability</li> </ul>"},{"location":"reading/omics/genetic-and-function-analysis/#2-functional-regulation","title":"2. Functional Regulation","text":"<ul> <li>2017 Genome Research - Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.  </li> <li>2015 Cancer cell - The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers </li> </ul>"},{"location":"reading/omics/genetic-and-function-analysis/#iii-rna-modification","title":"III. RNA modification","text":""},{"location":"reading/omics/genetic-and-function-analysis/#1-genetics-post-gwas_2","title":"1. Genetics &amp; Post-GWAS","text":"<ul> <li>[m6a-qtl in 129 tissue m6a-seq] 2021 Nature Genetics - Genetic drivers of m 6 A methylation in human brain, lung, heart and muscle</li> <li>\u2705 [m6a-qtl in 60 celllines] 2020 Nature Genetics - Genetic analyses support the contribution of mRNA N 6 -methyladenosine (m 6 A) modification to human disease heritability</li> </ul>"},{"location":"reading/omics/genetic-and-function-analysis/#2-functional-regulation_1","title":"2. Functional Regulation","text":"<ul> <li>\u2705 [m6a regulators in public 9804 samples] 2021 Molecular Cancer - Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types</li> <li>[rna mod. regulators in 1697 public crc samples] 2021 Molecular Cancer - Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer</li> <li>[rna mod. regulators in 13358 public tissue rna-seq] 2020 Genome Biology - Integrative analyses of the RNA modification machinery reveal tissue- and cancer-specific signatures</li> </ul>"},{"location":"reading/omics/microbiome/","title":"Microbiome Analysis","text":"<p>PDFs</p> <p>\u2705 : recommended readings</p>"},{"location":"reading/omics/microbiome/#0-virome","title":"0. Virome","text":"<ul> <li>\u2705 2024 Cell - Using artificial intelligence to document the hidden RNA virosphere</li> <li>\u2705 2023 Cell - Mining metatranscriptomes reveals a vast world of viroid-like circular RNAs</li> </ul>"},{"location":"reading/omics/microbiome/#i-ncrnasrna-in-microbiome","title":"I. ncRNA/sRNA in microbiome","text":"<ul> <li> 2024 Cell Host and Microbe - The RNA landscape of the human commensal Segatella copri reveals a small RNA essential for gut colonization</li> <li>2024 Science - Hydrolytic endonucleolytic ribozyme (HYER) is programmable for sequence-specific DNA cleavage</li> <li>2023 Science - Uncovering the functional diversity of rare CRISPR-Cas systems with deep terascale clustering</li> <li>2021 Genome Biology - Comparative genomics identifies thousands of candidate structured RNAs in human microbiomes</li> <li>2019 Cell - Large-Scale Analyses of Human Microbiomes Reveal Thousands of Small, Novel Genes</li> <li>2017 Science - Protein structure determination using metagenome sequence data</li> <li>2019 Molecular Systems Biology - Unraveling the hidden universe of small proteins in bacterial genomes</li> <li>2009 Nature - Metatranscriptomics reveals unique microbial small RNAs in the ocean\u2019s water column. </li> </ul>"},{"location":"reading/omics/microbiome/#ii-cancer-microbiome","title":"II. Cancer microbiome","text":"<ul> <li>\u2705 2024 Cell - A pan-cancer analysis of the microbiome in metastatic cancer</li> <li>[Review] 2022 Science - Engineering bacteria as interactive cancer therapies</li> <li>2022 Nature - Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer</li> <li>\u2705 2022 Cell - Pan-cancer analyses reveal cancer-type-speci\ufb01c fungal ecologies and bacteriome interactions</li> <li>2022 Cell - A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors</li> <li>[Review] 2021 Cancer Cell  - Microbiome and cancer</li> <li>[Review] 2021 Science  - The microbiome and human cancer</li> <li>2020 Science - The human tumor microbiome is composed of tumor type\u2013specific intracellular bacteria</li> <li>2020 Cell - A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma</li> </ul>"},{"location":"reading/omics/microbiome/#iii-microbiome-in-cfrnas-and-cfdnas","title":"III. Microbiome in cfRNAs and cfDNAs","text":"<ul> <li>2022 Nature Communications - A metagenomic DNA sequencing assay that is robust against environmental DNA contamination</li> <li>2020 Nature - Microbiome analyses of blood and tissues suggest cancer diagnostic approach </li> <li>2020 Microbiome - Separating the signal from the noise in metagenomic cell-free DNA sequencing</li> <li>2019 PNAS -  A cell-free DNA metagenomic sequencing assay that integrates the host injury response to infection</li> </ul>"},{"location":"reading/omics/microbiome/#iv-host-microbe","title":"IV. Host &amp; Microbe","text":"<ul> <li>\u2705 2022 Nature Microbe - Identification of shared and disease-specific host gene\u2013microbiome associations across human diseases using multi-omic integration</li> <li>2020 EMBO J. -  Mouse circulating extracellular vesicles contain virus-derived siRNAs active in antiviral immunity</li> <li>2018 Cell Host &amp; Microbe - Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota. </li> <li>2016 Cell Host &amp; Microbe - The Host Shapes the Gut Microbiota via Fecal MicroRNA</li> </ul>"},{"location":"reading/omics/postar/","title":"RNA Regulation Analysis","text":"<p>{% hint style=\"info\" %}</p>"},{"location":"reading/omics/postar/#rna-regulation-postar","title":"RNA Regulation - POSTAR","text":"<p>POSTAR: POST-trAnscriptional Regulation http://POSTAR.ncRNAlab.org</p> <p>PDFs</p>"},{"location":"reading/omics/postar/#0-postar-genetics","title":"0. POSTAR &amp; Genetics","text":"<ul> <li>2024 Nature Communications - Systematic identi\ufb01cation of posttranscriptional regulatory modules</li> </ul>"},{"location":"reading/omics/postar/#1-as-alternative-splicing","title":"1. AS: Alternative splicing","text":"<p>Reviews</p> <ul> <li>Alternative splicing as a regulator of development and tissue identity. (Nature Reviews, 2017)</li> <li>RNA mis-splicing in disease. (Nature Reviews, 2015)</li> </ul> <p>Research</p> <ul> <li>Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. (Science, 2018)</li> <li>An Arabidopsis PWI and RRM motif-containing protein is critical for pre-mRNA splicing and ABA responses. (Nature communications, 2015)</li> </ul>"},{"location":"reading/omics/postar/#11-splicing-cancer","title":"1.1 Splicing &amp; Cancer","text":"<ul> <li>2020 - Nature Reviews - Roles and mechanisms of alternative splicing in cancer \u2014 implications for care</li> </ul>"},{"location":"reading/omics/postar/#2-apa-alternative-polyadenylation","title":"2. APA: Alternative polyadenylation","text":"<p>Reviews</p> <ul> <li>Alternative polyadenylation of mRNA precursors. (Nature Reviews, 2017)</li> <li>Alternative cleavage and polyadenylation: extent, regulation and function. (Nature Reviews, 2013)</li> </ul> <p>Research</p> <ul> <li>Dynamic analysis of alternative polyadenylation from RNA-seq reveal a 30-UTR landscape across seven tumour types. (Nature communications, 2014)</li> <li>Cellular stress alters 3\u2032UTR landscape through alternative polyadenylation and isoform-specific degradation. (Nature communications, 2018)</li> </ul>"},{"location":"reading/omics/postar/#3-rna-editing","title":"3. RNA editing","text":"<p>Review</p> <ul> <li>A-to-I RNA editing \u2014 immune protector and transcriptome diversifier. (Nature Reviews, 2018)</li> <li>RNA editing-dependent epitranscriptome diversity in cancer stem cells. (Nature Reviews, 2017)</li> </ul> <p>Research</p> <ul> <li>Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers. (Genome Research, 2017) </li> <li>The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. (Cancer cell, 2015)</li> </ul>"},{"location":"reading/omics/postar/#4-dna-mutation-using-rna-seq","title":"4. DNA mutation using RNA-seq","text":"<ul> <li>RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues (Science, 2019) </li> </ul>"},{"location":"reading/omics/postar/#5-rna-modification","title":"5. RNA modification","text":"<ul> <li>2022 Nature Methods - Detection of m6A from direct RNA sequencing using a multiple instance learning framework</li> </ul>"},{"location":"reading/omics/postar/#6-rna-velocity","title":"6. RNA Velocity","text":"<ul> <li>2020 - Nature Biotech. - Generalizing RNA velocity to transient cell states through dynamical modeling</li> </ul>"},{"location":"reading/omics/postar/#7-translation-ribo-seq","title":"7. Translation: Ribo-seq","text":"<p>\u5173\u4e8eRNA\u7ffb\u8bd1\uff08Ribo-seq\uff09</p> <ul> <li>ORF finding </li> <li>RiboCode: 2018 NAR</li> <li>RiboWave: 2018 NAR</li> <li>RiboTaper: 2016 Nature Methods</li> <li>Difference of Translation Efficiency</li> <li>RiboDiff: 2017 Bioinformatics </li> <li>Xtail: 2016 Nature Communications</li> </ul> Preprocessing ORF Iden. Quantification TE Translation elongation Integrative &amp; visualization Rfoot DeepRibo scikit-ribo diricore Plastid RiboWaltz FLOSS RiboDiff I\u03c7nos Rfeet RiboWave ORF-RATER riborex PausePred RiboGalaxy PRICE Xtail ROSE RiboProfiling RiboCode RiboMiner riboSeqR RiboHMM RiboTools RibORF RIVIT RiboTaper Shoelaces RP-BP tRanslatome SPECtre POSTAR TITER"},{"location":"reading/omics/postar/#71-riboshape","title":"7.1. RiboShape","text":"<ul> <li>\u2705 2023 Nature - Pervasive downstream RNA hairpins dynamically dictate start-codon selection</li> <li>2021 Genome Biology Wheat in vivo RNA structure landscape reveals a prevalent role of RNA structure in modulating translational subgenome expression asymmetry</li> <li>\u2705 2018 Cell (e. coli, proposed a model)  Pervasive regulatory functions of mRNA structure revealed by high-resolution SHAPE probing</li> <li>2018 Mol. Cell (e. coli)- A Stress Response that Monitors and Regulates mRNA Structure Is Central to Cold Shock Adaptation</li> <li>2020 Genome Biology (zebrafish) RNA structural dynamics regulate early embryogenesis through controlling transcriptome fate and function</li> <li>\u2705 2017 Nature - Global translational reprogramming is a fundamental layer of immune regulation in plants</li> <li>2014 NAR (proposed a model) - Deciphering the rules by which dynamics of mRNA secondary structure affect translation efficiency in Saccharomyces cerevisiae</li> </ul>"},{"location":"reading/omics/postar/#72-motif","title":"7.2 Motif","text":"<ul> <li>2015 Cell - polyU hairpin -  EIN2-Directed Translational Regulation of Ethylene Signaling in Arabidopsis</li> <li>2021 PNAS - polyU internal loop - Structural analyses of an RNA stability element interacting with poly(A)</li> </ul>"},{"location":"reading/omics/postar/#8-quantum-biology","title":"8. Quantum Biology","text":"<ul> <li>2014 Nature Physics - Quantum coherence in photosynthesis for efficient solar-energy conversion</li> </ul> <p>see more in PDFs</p>"},{"location":"reading/omics/single-cell-data-analysis/","title":"Single Cell Data Analysis","text":""},{"location":"reading/omics/single-cell-data-analysis/#i-scmultiomics","title":"I. scMultiOmics","text":""},{"location":"reading/omics/single-cell-data-analysis/#i1-representative-integration-analysis","title":"I.1 Representative Integration Analysis","text":"<ul> <li>\u2705 2024 Science - Single-cell genomics and regulatory networks for 388 human brains</li> <li>\u2705 2018 Science (machine learning model) - Comprehensive functional genomic resource and integrative model for the human brain</li> </ul>"},{"location":"reading/omics/single-cell-data-analysis/#i2-others","title":"I.2 Others","text":"<ul> <li>\u2705 2024 Nature - Single-cell multiplex chromatin and RNA interactions in ageing human brain</li> <li>\u2705 2023 Nature - Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes</li> <li>\u2705 2023 Nature Genetics - Integrated single-cell chromatin and transcriptomic analyses of human scalp identify gene-regulatory programs and critical cell types for hair and skin diseases</li> <li>2023 Nature - Epigenetic regulation during cancer transitions across 11 tumour types</li> <li>2023 Nature Methods - SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks</li> <li>2022 Cell - Human prefrontal cortex gene regulatory dynamics from gestation to adulthood at single-cell resolution</li> <li>2021 Cancer Cell - Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer</li> <li>2021 Nature Genetics - Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer\u2019s disease </li> <li>2021 Nature Genetics - Single-cell chromatin accessibility identifies pancreatic islet cell type\u2013 and state-specific regulatory programs of diabetes risk</li> <li>2021 Genome Biology - Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways</li> <li>2018 Science - Single-cell multiomics sequencing and analyses of human colorectal cancer</li> </ul> <p>(1) Multi-Omics Data Integration Tools</p> <ul> <li>2021 Brief Bioinfo - A comparative study of multi-omics integration tools</li> <li>2017 PLoS computational biology - mixOmics: An R package for \u2018omics feature selection and multiple data integration</li> </ul> <p>(2) Bulk Multi-Omics Studies</p> <ul> <li>\u2705 2023 Immunity - Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection</li> <li>\u2705  2023 Nature Genetics - Dynamic regulatory elements in single-cell multimodal data implicate key immune cell states enriched for autoimmune disease heritability</li> <li>\u2705  2021 Nature - Multi-omic machine learning predictor of breast cancer therapy response</li> <li>2021 Cell - Integrated analysis of multimodal single-cell data</li> <li>2021 Nature Commn - An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer</li> <li>\u2705  2020 Nature Medicine - Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer</li> </ul>"},{"location":"reading/omics/single-cell-data-analysis/#ii-scrna","title":"II. scRNA","text":"<ul> <li>\u2705 2023 Nature Genetics - Mapping the dynamic genetic regulatory architecture of HLA genes at single-cell resolution </li> <li>\u2705 2021 Science - The coding and long noncoding single-cell atlas of the developing human fetal striatum</li> <li>2021 PNAS - Single-cell quanti\ufb01cation of a broad RNA spectrum reveals unique noncoding patterns associated with cell types and states</li> <li>2020 Nature Cell Biol. - Differentiation of transplanted haematopoietic stem cells tracked by single-cell transcriptomic analysis</li> </ul>"},{"location":"reading/omics/single-cell-data-analysis/#iii-scrna-post-transcriptional-regulation","title":"III. scRNA: Post-transcriptional Regulation","text":"<ul> <li>2024 Nature Commn - Interrogations of single-cell RNA splicing landscapes with SCASL define new cell identities with physiological relevance</li> <li>2024 Nature Commn - Divergent landscapes of A-to-I editing in postmortem and living human brain</li> <li>2022 Nature Commn - Cellular and genetic drivers of RNA editing variation in the human brain</li> </ul>"},{"location":"reading/omics/single-cell-data-analysis/#iv-scatac-seq","title":"IV. scATAC-seq","text":"<ul> <li>\u2705 2024 Immunity -  Single-cell chromatin accessibility and transposable element landscapes reveal shared features of tissue-residing immune cells</li> <li>2024 Nature Cell Biology - Mapping the chromatin accessibility landscape of zebrafish embryogenesis at single-cell resolution by SPATAC-seq</li> <li>2024 Nature Cell Biology - A single-cell atlas of chromatin accessibility in mouse organogenesis</li> </ul>"},{"location":"reading/seq.-tech./cfdna-seq-tech./","title":"cfDNA-seq Tech.","text":"<p>PDFs</p>"},{"location":"reading/seq.-tech./cfdna-seq-tech./#i-cfdna-tech","title":"I. cfDNA Tech.","text":"<p>Nanopore</p> <ul> <li>2021 Mol. Cancer - Nanopore sequencing from liquid biopsy analysis of copy number variations from cell-free DNA of lung cancer patients</li> </ul>"},{"location":"reading/seq.-tech./cfdna-seq-tech./#ii-cfdna-methylation-tech","title":"II. cfDNA Methylation Tech.","text":"<ul> <li>TAPS</li> <li>2022 NAR - Whole-genome long-read TAPS deciphers DNA methylation patterns at base resolution using PacBio SMRT sequencing technology</li> <li>\u2728[cfTAPS] 2021 Science Advances - Cell-free DNA TAPS provides multimodal information for early cancer detection</li> <li>\u2728[TAPS] 2019 Nature Biotech. - Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution</li> <li>MeDIP</li> <li>2022 NCOMMN. - The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors</li> <li>2020 Nat Medicine - Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes</li> <li>\u2728[cfMeDIP] 2019 Nature Protocol - Preparation of cfMeDIP-seq libraries for methylome</li> <li>\u2728[cfMeDIP] 2018 Nature - Sensitive tumour detection and classification using plasma cell-free DNA methylomes</li> <li>BS </li> <li>2022 Nature Cancer - cfDNA methylome profiling for detection and subtyping of small cell lung cancers</li> <li>2021 Nature Biomedical Engineering - Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning</li> <li>\u2728 [Targeted BS] 2021 Annals of Oncology - Grail and CCGA Consortium - Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set</li> <li>\u2728 [Targeted BS] 2020 Annals of Oncology - Grail and CCGA Consortium - Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA</li> <li>[chips] 2018 Nature - DNA methylation-based classification of central nervous system tumours</li> <li>[WGBS] 2017 Nature Genetics -  Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA</li> <li>[WGBS] 2013 PNAS - Noninvasive detection of cancer-associated genome- wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing</li> <li>5Hmc</li> <li>2019 Gut - Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma</li> <li>2019 Blood Adv - Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma</li> <li>2017 Cell Res - 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers</li> <li>Nanopore</li> <li>2022 Genome Biology - Detecting cell\u2010of\u2010origin and cancer\u2010specific methylation features of cell\u2010free DNA from Nanopore sequencing</li> </ul>"},{"location":"reading/seq.-tech./cfdna-seq-tech./#1-more-reading-on-cfdnamet-seq","title":"1. More reading on cfDNAmet-seq","text":"<ul> <li>2020 Sci Adv - Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma. </li> <li>2019 Clin Chem - Detection of Colorectal Cancer in Circulating Cell-Free DNA by Methylated CpG Tandem Amplification and Sequencing</li> <li>2017 Genomic Medicine - Empirical comparison of reduced representation bisulfite sequencing and Infinium BeadChip reproducibility and coverage of DNA methylation in humans.</li> <li>2015 Cell Res - Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients </li> <li>2014 Clin Epigenetics - Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma.</li> </ul>"},{"location":"reading/seq.-tech./cfdna-seq-tech./#2-validation-of-dnamet","title":"2. Validation of DNAmet","text":"<ul> <li>[mqMSP] 2021 PNAS - Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy</li> <li>[qMSP]2019  Clin Epigenetics - Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood</li> <li>[MSRE] 2016 Clin Epigenetics  - Detection and monitoring of hypermethylated RASSF1A in serum from patients with metastatic breast cancer</li> <li>[qMSP] 2019 Theranostics - Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA</li> </ul>"},{"location":"reading/seq.-tech./exrna-seq-tech/","title":"cfRNA-seq Tech.","text":"<p>PDFs</p>"},{"location":"reading/seq.-tech./exrna-seq-tech/#i-seq-protocols-technologies","title":"I. Seq Protocols &amp; Technologies","text":""},{"location":"reading/seq.-tech./exrna-seq-tech/#1-cfrna-seq","title":"1. cfRNA-seq","text":"<ul> <li>2022 Clin. Transl. Med. - Polyadenylation ligation-mediated sequencing (PALM-Seq) characterizes cell-free coding and non-coding RNAs in human biofluids</li> <li>\u2705 Purification: 2021 bioRxiv - Performance of RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study</li> <li>\u2705 Storage &amp; Transportation: 2021 Nature Commn. - Grail - A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection</li> <li>Comparison: RNA biology 2018 - Evaluation of methodologies for microRNA biomarker detection by next generation sequencing</li> <li>Barcode: Nature Methods 2015 - Simultaneous generation of many RNA-seq libraries in a single reaction</li> <li>Multiplex: Nature Methods 2019 - Simultaneous multiplexed amplicon sequencing and transcriptome profiling in single cells</li> <li>UMI: Nature Methods 2012 - Counting absolute numbers of molecules using unique molecular identifiers, Nature Methods 2014 - Quantitative single-cell RNA-seq with unique molecular identifiers</li> <li>SMART-seq2(TSO): Nature Protocol 2014 - Full length RNA-seq from single cells using Smart-seq2</li> <li>Pico-seq:</li> <li>\u2728 DASH/CRISPR: Genome Biology 2016 - Depletion of Abundant Sequences by Hybridization (DASH): using Cas9 to remove unwanted high-abundance species in sequencing libraries and molecular counting applications</li> <li>Pico Patent: Pico Patent Application Publication</li> <li>SILVER-seq: 2019 PNAS - Extracellular RNA in a single droplet of human serum reflects physiologic and disease states</li> </ul>"},{"location":"reading/seq.-tech./exrna-seq-tech/#ii-ev-and-purification-method","title":"II. EV and Purification Method","text":""},{"location":"reading/seq.-tech./exrna-seq-tech/#1-exosome-and-ev","title":"1. Exosome and EV","text":"<ul> <li>2022 bioRxiv - Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesicles</li> <li>RNP: 2021 Nature Cell Biol. - Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets</li> <li>2021 Nature Methods - Exosome detection via the ultrafast-isolation system: EXODUS</li> <li>\u2728 2021 JEV - Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium</li> <li>Extracellular carriers: Cell minireview 2019 - Mapping Extracellular RNA Sheds Lights on Distinct Carriers</li> <li>Exosome preview: Cell preview 2019 - Explicating Exosomes: Reclassifying the Rising Stars of Intercellular Communication</li> <li>\u2728 Exosome composition: Cell article 2019 - Reassessment of Exosome Composition</li> <li>exRNA carriers: Cell resource 2019 - exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids</li> <li>Exosome PD-L1: Cell article 2019 - Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory</li> </ul>"},{"location":"reading/seq.-tech./exrna-seq-tech/#2-ev-and-rnp-purification-method","title":"2. EV and RNP Purification Method","text":"<ul> <li>2022 JEV - Tetraspanins distinguish separate extracellular vesicle subpopulations in human serum and plasma \u2013 Contributions of platelet extracellular vesicles in plasma samples</li> <li>SEC: 2020 Molecular Therapy - Simple and Fast SEC-Based Protocol to Isolate Human Plasma-Derived Extracellular Vesicles for Transcriptional Research</li> <li>MV+sEV+RNP: 2017 Nature Communication - Coding and noncoding landscape of extracellular RNA</li> </ul>"},{"location":"reading/seq.-tech./exrna-seq-tech/#iii-commercial-kit","title":"III. Commercial Kit","text":"<ul> <li>V1-NEB: E7300-NEB small RNA kit</li> <li>V2-SMART: SMARTer smRNA-Seq Kit for Illumina User Manual</li> <li>V2-SMART: SMARTer Stranded Total RNA-Seq Kit - Pico Input Mammalian User Manual</li> <li>V3-Pico: Long cfRNA-seq Kit</li> <li>Clontech technology-low input RNA library kit</li> <li>Clontech technology-pico kit</li> </ul>"},{"location":"reading/seq.-tech./exrna-seq-tech/#iv-papers-recommended-by-hk-wang","title":"IV. Papers recommended by HK Wang","text":"<ul> <li>\u2705 [Smart-seq3]2020 Nature Biotech -Single-cell RNA counting at allele and isoform resolution using Smart-seq3 </li> <li>[UMI]2012 Nature Methods -Counting absolute numbers of molecules using unique molecular identi\ufb01ers </li> <li>[Barcode]2015 Nature Methods -Simultaneous generation of many rna-seq libraries in a single reaction </li> <li>\u2705 [DASH]2016 Genome Biology -Depletion of Abundant Sequences by Hybridization (DASH): using Cas9 to remove unwanted high-abundance species in sequencing libraries and molecular counting applications </li> <li>[Phospho\u2010seq]2019 EMBO J. -Phospho\u2010RNA\u2010seq - a modified small RNA\u2010seq method that reveals circulating mRNA and lncRNA fragments as potential biomarkers in human plasma </li> <li>[SILVER\u2010seq]2019 PNAS -Extracellular RNA in a single droplet of human serum re\ufb02ects physiologic and disease states </li> <li>[CATS\u2010seq]2014 RNA Biology -Capture and Amplification by Tailing and Switching (CATS) </li> <li>[Pico-similar]2013 RNA Biology -Peregrine - A rapid and unbiased method to produce strand-specific RNA-Seq libraries from small quantities of starting material</li> <li>[Review]2018 NAR -Capturing the \u2018ome\u2019: the expanding molecular toolbox for RNA and DNA library construction</li> </ul>"},{"location":"reading/seq.-tech./interaction-seq/","title":"Interaction-seq","text":""},{"location":"reading/seq.-tech./interaction-seq/#i-rna-rna","title":"I. RNA-RNA","text":"<ul> <li>\u2705 [review] 2024 Molecular Cell - Technological advancements in deciphering RNA-RNA interactions</li> <li>\u2705 2024 Nature Biotechnology - KARR-seq reveals cellular higher-order RNA structures and RNA\u2013RNA interactions</li> <li>2023 Nature - Complementary Alu sequences mediate enhancer\u2013promoter selectivity</li> <li>[review] 2022 Current Opinion in Genetics &amp; Development - Architecture of RNA\u2013RNA interactions</li> <li>\u2705 2020 Nature - RIC-seq for global in situ profiling of RNA\u2013RNA spatial interactions</li> </ul>"},{"location":"reading/seq.-tech./interaction-seq/#ii-rna-dna","title":"II. RNA-DNA+","text":"<ul> <li>\u2705 MUSIC-seq: 2024 Nature - Single-cell multiplex chromatin and RNA interactions in ageing human brain</li> <li>2022 Nature Protocols - SPRITE: a genome-wide method for mapping higher-order 3D interactions in the nucleus using combinatorial split-and-pool barcoding</li> <li>2017 Nature Biotech. - GRID-seq reveals the global RNA\u2013chromatin interactome</li> </ul>"},{"location":"reading/seq.-tech./single-cell-seq-tech./","title":"Single-Cell-seq Tech.","text":""},{"location":"reading/seq.-tech./single-cell-seq-tech./#0-novel-rna-seq","title":"0. Novel RNA-seq","text":"<ul> <li>\u2705 2024 Nature Biotech. - RIP-PEN-seq identifies a class of kink-turn RNAs as splicing regulators</li> <li>\u2705 2021 NBT - Quantitative mapping of the cellular small RNA landscape with AQRNA-seq</li> </ul>"},{"location":"reading/seq.-tech./single-cell-seq-tech./#i-sc-total_rna","title":"I. sc-Total_RNA","text":"<ul> <li>2024 Nature Communications - Single-cell total-RNA pro\ufb01ling unveils regulatory hubs of transcription factors</li> <li>\u2705 2022 Nature Biotech. - High-throughput total RNA sequencing in single cells using VASA-seq</li> <li>2022 Nature Biotech. Spatial mapping of the total transcriptome by in situ polyadenylation</li> <li>[mbRNA split-pool]  2020 Science - Microbial single-cell RNA sequencing by split-pool barcoding</li> <li>\u2705 [scRNA split-pool] - 2018 Science - SPLiT-seq reveals cell types and lineages in the developing brain and spinal cord </li> </ul>"},{"location":"reading/seq.-tech./single-cell-seq-tech./#ii-scmulti-omics","title":"II. scMulti-Omics","text":"<ul> <li>\u2705 2024 Nature - Single-cell multiplex chromatin and RNA interactions in ageing human brain</li> <li>[Review] 2024 EMM - Advances in single-cell omics and multiomics for high-resolution molecular profiling</li> <li> [Review] 2023 Nature Genetics - Methods and applications for single-cell and spatial multi-omics</li> <li>\u2705 2022 Nature Methods - ISSAAC-seq enables sensitive and flexible multimodal profiling of chromatin accessibility and gene expression in single cells</li> <li>\u2705 [Split-pool RNA+ATAC] 2020 Cell - Chromatin Potential Identi\ufb01ed by Shared Single-Cell Pro\ufb01ling of RNA and Chromatin</li> <li>[Split-pool RNA+ATAC] 2019 Nature Structure Molecular Biology -  An ultra high-throughput method for single-cell joint analysis of open chromatin and transcriptome</li> <li>[scATAC - split-pool] 2019 Nat. Biotechnol. - Droplet-based combinatorial indexing for massive-scale single-cell chromatin accessibility.</li> <li>[review] 2017 Trend in Genetics - Single-Cell Multiomics: Multiple Measurements from Single Cells *</li> </ul>"},{"location":"reading/seq.-tech./single-cell-seq-tech./#iii-scrna-mod","title":"III. scRNA-mod","text":"<ul> <li>\u2705 2023 Nature Biotechnology - Single-cell m6A mapping in vivo using picoMeRIP\u2013seq</li> <li>2023 Nature Review - The roles and implications of RNA m6A modification in cancer</li> <li>2023 Nature Commn. - scm6A-seq reveals single-cell landscapes of the dynamic m6A during oocyte maturation and early embryonic development</li> <li>\u2705  2022 Nature Methods - Multiplexed profiling facilitates robust m6A quantification at site, gene and sample resolution</li> <li>2022 Nature Biotech. - Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI</li> <li>2022 Mol. Cell  - scDART-seq reveals distinct m6A signatures and mRNA methylation heterogeneity in single cells. </li> <li>[RNA mod Review] - 2022 Experimental &amp; Molecular Medicine - Detection technologies for RNA modifications</li> <li>2019 PNAS - Transcriptome-wide profiling of multiple RNA modifications simultaneously at single-base resolution</li> </ul>"},{"location":"reading/seq.-tech./single-cell-seq-tech./#iv-scribo-seq","title":"IV. scRibo-seq","text":"<ul> <li>\u2705 2021 Nature - Single-cell Ribo-seq reveals cell cycle-dependent translational pausing</li> <li>2022 NAR - Identifying ribosome heterogeneity using ribosome pro\ufb01ling</li> </ul>"},{"location":"writing/writing/","title":"Tips for Paper Writing","text":"<p>Example Manuscripts</p> <p>ENDNOTE Libs</p> <p>Publication Tips (Cover Letter, Status Enquiry Letter, etc)</p>"},{"location":"writing/writing/#i-format","title":"I. Format","text":"<p>Files for Submission</p> <ol> <li>Cover Letter.docx (1 page)</li> <li>Suggested Reviewers.docx (6 reviewers)</li> <li>Manuscript - Main text.docx (see sections below)</li> <li>Figures.pdf (save as from PPT file)</li> <li>Supplementary Info.pdf (save as from docx file)</li> <li>Supplementary file 1.xlsx, Supplementary file 2.xlsx, ... </li> </ol> <p>Sections in Main text</p> <ol> <li>Title, Authors and Affiliations</li> <li>Abstract and Keywords</li> <li>Introduction</li> <li>Results</li> <li>Conclusion and Discussion</li> <li>(Online) Methods</li> </ol> <p>Font and Line Space</p> <ol> <li>Check Font: Times New Roman, 11pt or 10.5pt</li> <li>Check Line: double space (except for References)</li> <li>No indent for the first sentence of a new paragraph.</li> </ol> <p>Abstract</p> <ul> <li>(1) Background - (2) Results - (3) Conclusions</li> </ul> <p>Keywords</p> <ul> <li>Replace with the key words we want to be searched. If number of key words is limited, we may not repeat with title only if this keyword is very important.</li> </ul>"},{"location":"writing/writing/#ii-writing-rules","title":"II. Writing Rules","text":""},{"location":"writing/writing/#terms","title":"Terms","text":"<ol> <li>Check the writing of specific terms in right format in the whole paper:</li> <li>noncoding, cross-validation</li> <li>P-value (italicize and capitalize the P here)</li> <li>vs. (lower case with one dot after)</li> <li>i.e., something ( \",\" is needed) </li> <li>e.g., something ( \",\" is needed)</li> <li>Check if the Abbreviations are consistent in the whole paper. Check if full name is used when it is mentioned first time. Occasionally, we may use full time several times in the beginning of Introduction, Methods and Suppl. Info., because they are separated documents when published.)</li> </ol>"},{"location":"writing/writing/#grammar","title":"Grammar","text":"<p>Grammarly (app.grammarly.com) is very helpful. It has web version, desktop (MAC/Windows) version and chrome/firefox/safari plugin. You can also install it into your office word from this add-in.</p> <ol> <li>Check plural or single.</li> <li>Check if Past tense is used when we describe results (e.g., \"We sequenced 50 samples ...\").</li> <li>Check if Present tense is used when we make a claim or conclusion (e.g., usually in the last sentence of a paragraph, \"This result suggests that \u2026\" ).</li> <li>Check number list (First, Second, Third, ...) see Firstly, Secondly, Thirdly - Grammarly Blog</li> <li>Check When do you use 'the' in English? - Learning English Grammar </li> </ol>"},{"location":"writing/writing/#figure-and-figure-legend","title":"Figure and Figure Legend","text":"<p>Figure and Figure legend sometimes are more IMPORTANT than main text, because many senior readers read figures first.</p> <ol> <li>Check if Figure Legends contain sufficiently detailed descriptions. (We got this suggestion from a previous reviewer who rejected our paper.)</li> <li>Check if the colors are easy to see.  (We got this suggestion from a previous reviewer who rejected our paper.)</li> <li>Font, key's and axis label's fonts in particular, in Figure need to be as large as possible.</li> </ol>"},{"location":"writing/writing/#main-text","title":"Main Text","text":"<ol> <li>Check first and last sentence in the whole paper. To make it easy to read, in every paragraph, first and last sentences are important. Usually, first sentence introduces and summarizes the whole paragraph; last sentence concludes the whole paragraph (e.g. \"This result suggests that ...\").</li> <li>Check voice: </li> <li> n Results, we prefer active voice, such as \"We analyzed the data \u2026\", not \"The data were analyzed \u2026\". </li> <li>In Methods, we may use passive voice sometimes , such as \" The difference was tested by a paired t test.\".</li> <li>Recommended words:</li> <li>We performed RT-qPCR (RNA-seq \u2026) for \u2026 \u2192 XX was validated (sequenced ...) by RT-qPCR.</li> <li>We built  a Random Forest model \u2026 \u2192 We used/developed a Random Forest model to \u2026</li> <li>We assayed/analyzed \u2026 datasets.</li> <li>We assessed, calculated, detected, estimated, evaluated, examined, ...</li> <li>We curated/collected \u2026 datasets from \u2026 OR 100 datasets were curated/collected from ...</li> <li>XX was significantly enriched in the noncoding sequences (t test P-value: 0.002).</li> <li>The enrichment is/was calculated with RNApromo (ref.). The P-value cutoff is/was 0.001; the xx is/was 0.5; the xx is/was 0.8. (depends on if you are talking to the audience about a plot or describe a result you have done.)</li> </ol>"},{"location":"writing/writing/#statistics","title":"Statistics","text":"<ol> <li>Check every result to see if it needs statistical test: Was a test used? Which one? What is the P-value?</li> <li>Check  every enrichment to see if it was statistically determined to be enriched:  What test was used? Which one? What is the P-value?</li> </ol>"},{"location":"writing/writing/#using-the-right-tense","title":"Using the right tense","text":"<p>In your scientific paper, use verb tenses (past, present, and future) exactly as you would in ordinary writing. Use the past tense to report what happened in the past: what you did, what someone reported, what happened in an experiment, and so on. Use the present tense to express general truths, such as conclusions (drawn by you or by others) and atemporal facts (including information about what the paper does or covers). Reserve the future tense for perspectives: what you will do in the coming months or years. Typically, most of your sentences will be in the past tense, some will be in the present tense, and very few, if any, will be in the future tense.</p> <ul> <li>Past tense</li> </ul> <p>Work done\\ We collected blood samples from . . .\\ Groves et al. determined the growth rate of . . .\\ Consequently, astronomers decided to rename . . .\\ \\ Work reported\\ Jankowsky reported a similar growth rate . . .\\ In 2009, Chu published an alternative method to . . .\\ Irarr\u00e1zaval observed the opposite behavior in . . .\\ \\ Observations\\ The mice in Group A developed, on average, twice as much . . .\\ The number of defects increased sharply . . .\\ The conversion rate was close to 95% . . .\\ </p> <ul> <li>Present tense</li> </ul> <p>General truths\\ Microbes in the human gut have a profound influence on . . .\\ The Reynolds number provides a measure of . . .\\ Smoking increases the risk of coronary heart disease . . .\\ \\ Atemporal facts\\ This paper presents the results of . . .\\ Section 3.1 explains the difference between . . .\\ Behbood's 1969 paper provides a framework for . . .\\ </p> <ul> <li>Future tense</li> </ul> <p>Perspectives\\ In a follow-up experiment, we will study the role of . . .\\ The influence of temperature will be the object of future research . . .\\ </p> <p>Note the difference in scope between a statement in the past tense and the same statement in the present tense: \"The temperature increased linearly over time\" refers to a specific experiment, whereas \"The temperature increases linearly over time\" generalizes the experimental observation, suggesting that the temperature always increases linearly over time in such circumstances.</p> <p>In complex sentences, you may have to combine two different tenses \u2014 for example, \"In 1905, Albert Einstein postulated that the speed of light is constant . . . . \" In this sentence, postulated refers to something that happened in the past (in 1905) and is therefore in the past tense, whereas is expresses a general truth and is in the present tense.</p>"},{"location":"writing/writing/#iii","title":"III. \u7f51\u53cb\u7684\u5199\u4f5c\u5efa\u8bae","text":"<p>{% embed url=\"https://www.nature.com/scitable/topicpage/effective-writing-13815989\" %} Effective Writing by Nature</p> <p>\u5199\u51fa\u7b2c\u4e00\u7a3f</p> <ul> <li>\u4e24\u6b65\u8d70\uff1a1\u3001\u5199\u51fa\u5c3d\u53ef\u80fd\u591a\u7684\u5185\u5bb9\uff0c\u4e0d\u8981\u62c5\u5fc3\u8bed\u6cd5\u3001\u62fc\u5199\u3001\u7ec4\u7ec7\uff1b2\u3001\u4fee\u6539\u6587\u7a3f\u53d8\u5f97\u66f4\u597d\u3002\uff08\u53c2\u8003\u6d77\u660e\u5a01\u7684\u5199\u4f5c\u65b9\u5f0f\uff09</li> <li>\u5f53\u4f60\u5199\u4f5c\u65f6\uff0c\u4e0d\u8981\u7f16\u8f91\uff01\u5199\u4f5c\u548c\u7f16\u8f91\u4f7f\u7528\u4e0d\u540c\u7684\u534a\u8111\uff0c\u4ea4\u53c9\u8fd9\u4e24\u4ef6\u4e8b\u4e0d\u5bb9\u6613\u3002</li> <li>\u6bcf\u4e2a\u7ed3\u679c\u548c\u76f8\u5e94\u7684\u8ba8\u8bba\u4e00\u8d77\u5199\uff0c\u4ee5\u514d\u4e4b\u540e\u5fd8\u8bb0\u7ed3\u679c\u7684\u89e3\u91ca\u548c\u610f\u4e49\u3002\u518d\u5199\u65b9\u6cd5\uff0c\u6700\u540e\u5199\u4ecb\u7ecd\uff08\u57fa\u4e8e\u7ed3\u679c\u548c\u8ba8\u8bba\uff09\u3002</li> <li>\u7528\u7167\u7247\u505a\u7c7b\u6bd4\uff1a   *</li> <li>Introduction\uff1aWhy was the picture taken?</li> <li>Results\uff1aWhat do you see?</li> <li>Conclusion and Discussion\uff1aWhat does it mean?</li> <li>Methods\uff1aHow was it taken\uff1f</li> </ul> <p>\u7f16\u8f91\u6700\u7ec8\u7a3f</p> <ul> <li>\u9605\u8bfb\u6295\u7a3f\u671f\u520a\u7684\u300eInstructions for authors\u300f\uff0c\u4e86\u89e3\u671f\u520a\u671f\u671b\u7684\u884c\u6587\u98ce\u683c\u3002</li> <li>\u4ecb\u7ecd\u90e8\u5206\u8bf4\u660e\u672c\u7814\u7a76\u7684\u7406\u7531\uff0c\u4e0d\u662f\u6587\u732e\u7efc\u8ff0\u3002\u8ba8\u8bba\u90e8\u5206\u4e0d\u7528\u300e\u53ef\u80fd\u300f\uff0c\u5982\u679c\u4e0d\u786e\u5b9a\u7ed3\u8bba\uff0c\u505a\u66f4\u591a\u7684\u5b9e\u9a8c\u3002</li> <li>\u7ed3\u679c\u90e8\u5206\u4e0d\u4f7f\u7528\u300ecould\u300f\u3001\u300ecan\u300f\uff08\u53d7\u4e2d\u6587\u5f71\u54cd\uff09\uff0c\u51cf\u5c11\u4e0d\u786e\u5b9a\u6027\u3002</li> <li>\u4e0d\u4f7f\u7528\u300eetc\u300f\u3001\u300eand so on\u300f\uff0c\u8fd9\u4e9b\u8bcd\u8bf4\u660e\u4f5c\u8005\u61d2\u3002</li> <li>\u300eobserved\u300f\u5f88\u5f31\u5f88\u88ab\u52a8\uff0c\u6539\u7528\uff1aassess, calculate, detect, estimate, evaluate, examine...</li> <li>\u4e0d\u7528\u300eobviously\u300f\uff0c\u8bfb\u8005\u4e0d\u4e00\u5b9a\u5bb9\u6613\u7406\u89e3\u3002</li> <li>\u7ed3\u679c\u90e8\u5206\u907f\u514d\u300esignificantly\u300f\uff0c\u6539\u4e3a\u62a5\u544aP-value\u3002\u8ba8\u8bba\u90e8\u5206\u53ef\u7528\u3002</li> </ul>"}]}